Rapid extracellular vesicle surface decoration with targeting moieties based on a fluorescein binding single chain variable fragment snorkel.
| Johannes Grillari @lbitrauma |
[Open Access]
#extracellularvesicle #targeting #fluorescein
doi.org/10.1016/j.jconrel.2025.114558
Journal of Controlled Release
The Journal of Controlled Release is a biweekly peer-reviewed medical journal and the official journal of the Controlled Release Society. The journal covers research on the controlled release and delivery of drugs and other biologically active agents. Announcements and reports of future meetings pertaining to the activities of the Controlled Release Society are also included. More on Wikipedia
-
J Controlled Release
@JCRnEDITORS
-
J Controlled Release
@JCRnEDITORS
Localized inflammasome inhibition mitigates foreign body response to subcutaneous long-acting antiretroviral therapy for HIV.
| Alessandro Grattoni @Nanomed_hmri |
[Open Access]
#subcutaneous #implant #longacting #antiviral
doi.org/10.1016/j.jconrel.2025.114559 -
J Controlled Release
@JCRnEDITORS
Nanochirality-programmed type-I photosensitizer enables deep-tumor photodynamic therapy by reducing extracellular-matrix adhesion.
| Yichun Wang @NDCBE |
[Open Access]
#graphene #photodynamic #extracellularmatrix
doi.org/10.1016/j.jconrel.2025.114572 -
J Controlled Release
@JCRnEDITORS
Engineered nanoparticles for subconjunctival delivery to the retinal pigment epithelium: A multi-target therapy for dry AMD.
| Xiyuan Zhou, Chongqing Medical Univ. |
[Open Access]
#subconjunctivaldelivery #oculardisease
doi.org/10.1016/j.jconrel.2025.114563 -
J Controlled Release
@JCRnEDITORS
Engineered hemolysin-secreting bacteria enable intracellular bisphosphonate self-assembly to enhance antitumor immunity.
| Jinhui Wu @NanjingUnivers1 |
[50 days' free access]
#selfassembly #engineeredbacteria #biophosphonate
authors.elsevier.com/a/1mJencI2-9n2j -
J Controlled Release
@JCRnEDITORS
Hepatocyte-specific partial cellular reprogramming via selective OSK mRNA lipid nanoparticle attenuates liver fibrosis.
| Min Qiu @FudanUniversity |
[50 days' free access]
#mrnadelivery #lipidnanoparticle #hepatocyte #fibrosis
authors.elsevier.com/a/1mJv-cI2-9n5y -
J Controlled Release
@JCRnEDITORS
Multifunctional microfluidic-directed polymer/hydrogel fabrics towards pH-responsive drug delivery, wound monitoring and wearable sensing.
| Ji-Dong Liu, Anhui Polytechnic Univ. |
[50 days' free access]
#hydrogel #micofluidic #phmonitoring
authors.elsevier.com/a/1mJv-cI2-9n5I -
J Controlled Release
@JCRnEDITORS
Multifaceted mesoporous silica-based nanoplatform to co-deliver honokiol and baicalin for integrative therapy of drug-resistant bacteria infection.
| Pengfei Yue, Jiangxi Univ. of Chinese Medicine |
[50 days' free access]
#silicananoparticle
authors.elsevier.com/a/1mJyncI2-9mxQ -
J Controlled Release
@JCRnEDITORS
Octopus-inspired polymeric nanovaccine enables high antigen loading and robust T cell activation for cancer immunotherapy.
| Shixian Lv @PKU1898 |
[50 days' free access]
#nanovaccine #antigenloading #immunotherapy
authors.elsevier.com/a/1mKWtcI2-9n4v -
J Controlled Release
@JCRnEDITORS
Loading of therapeutic cell penetrating peptides into extracellular vesicles for pulmonary fibrosis.
| Randy P. Carney @UCDavisBME |
[Open Access]
#extracellularvesicle #cellpenetratingpeptide #fibrosis
doi.org/10.1016/j.jconrel.2025.114561 -
J Controlled Release
@JCRnEDITORS
Biodynamers as prodrugs with controlled uptake and activity.
| Sangeun Lee @Saar_Uni | @CRS_DeChAt_LC
[Open Access]
#prodrug #biodynamer
doi.org/10.1016/j.jconrel.2025.114538 -
J Controlled Release
@JCRnEDITORS
Guanidinylated polymers enable safe and efficient dsRNA delivery in plant cells.
| Peter Dubruel @ugent | @CRSBeNeLuxFr
[Open Access]
#dsrnadelivery #plantcell #polyplex
doi.org/10.1016/j.jconrel.2025.114517 -
J Controlled Release
@JCRnEDITORS
A dual-responsive AI-designed peptide P9-conjugate disrupts E6–E6AP Interface to restore p53 and suppress HPV16-driven cervical cancer.
| Yang Shen, Southeast Univ. |
[Open Access]
#peptideconjugate #artificialintelligence #cervicalcancer
doi.org/10.1016/j.jconrel.2025.114536 -
J Controlled Release
@JCRnEDITORS
Development of a light-induced gas phase nitric oxide generator and its use in killing biofilm bacteria in vitro and ex vivo.
| Steven P. Schwendeman @UMBiointerfaces |
[Open Access]
#nitricoxide #antibacterial
doi.org/10.1016/j.jconrel.2025.114483 -
J Controlled Release
@JCRnEDITORS
mRNA based in vivo MG1113 antibody production as a potential therapeutic approach for hemophilia.
| Hyukjin Lee @SNU_Pharm | @KoreaCRS
[Open Access]
#mrna #antibody #lipidnanoparticle #hemophilia
doi.org/10.1016/j.jconrel.2025.114520 -
J Controlled Release
@JCRnEDITORS
Understanding excipient interactions unlocks untapped potential of RNA-lipid nanoparticles in dry powder formulations for local pulmonary delivery.
| Benjamin Winkeljann @LMU_Muenchen | @CRS_DeChAt_LC
[Open Access]
#sirnadelivery #drypowder #excipient
doi.org/10.1016/j.jconrel.2025.114539 -
J Controlled Release
@JCRnEDITORS
Modulating tumor mechanics and vascular barriers to enhance chemotherapy efficacy in pancreatic tumors and melanoma.
| Fotios Mpekris @NeuroGeneticsCy |
[Open Access]
#mechanotherapeutics #ultrasound
doi.org/10.1016/j.jconrel.2025.114546 -
J Controlled Release
@JCRnEDITORS
Antigen-conjugated scaffolds enable sustained delivery of antigen and enrichment of antigen-specific T-cells.
| Aaron H. Morris @UMBME |
[Open Access]
#antigenconjugation #sustaineddelivery
doi.org/10.1016/j.jconrel.2025.114564 -
J Controlled Release
@JCRnEDITORS
Combined M1 macrophage inhibition and thermotherapy for controlled fibroplasia and accelerated wound repair via an oxygenating ROS-responsive hydrogel.
| Mohammad-Ali Shahbazi @umcg |
[Open Access]
#hydrogel #rosresponsive #thermotherapy
doi.org/10.1016/j.jconrel.2025.114554 -
J Controlled Release
@JCRnEDITORS
Supramolecular antioxidant conductive injectable hydrogel encapsulating L-arginine for synergistic modulation of myocardial infarction.
| Yan Li, Fourth Military Medical Univ. |
[50 days' free access]
#hydrogel #supramolecule #myocardialinfarction
authors.elsevier.com/a/1mIF2cI2-9n3I -
J Controlled Release
@JCRnEDITORS
Cyclization and thermal modulation of a β-hairpin peptide for efficient cellular delivery.
| Junfeng Shi @hunanuniv |
[50 days' free access]
#peptidedelivery #cyclization
authors.elsevier.com/a/1mIZ1cI2-9n36 -
J Controlled Release
@JCRnEDITORS
Dose optimization of lymph node-targeted cyclosporine-A for lupus-driven vasculopathy.
| M.N.V. Ravi Kumar @UofAlabama |
[50 days' free access]
#lymphnode #vasculopathy
authors.elsevier.com/a/1mIp5cI2-9n3U -
J Controlled Release
@JCRnEDITORS
Biomimetic siRNA therapeutics attenuate mitochondrial DNA damage and cytokine storm in sepsis.
| Jiang Zhu, Soochow Univ. |
[50 days' free access]
#sirnadelivery #sepsis
authors.elsevier.com/a/1mIVncI2-9n2F -
J Controlled Release reposted
CRS Korea Chapter
@KoreaCRS
Congrats! Prof.Seok-Hyun Kim for his group's recent article on a double mRNA and Protein vaccination strategy published in @JCRnEDITORS.
J Controlled Release
@JCRnEDITORS
A single extracellular vesicle-based platform supporting both RBD protein and mRNA vaccination against SARS-CoV-2.
| Seok-Hyun Kim @EwhaWomansUniv | @KoreaCRS
[50 days' free access]
#mrnavaccine #extracellularvesicle
authors.elsevier.com/a/1mEyGcI2-9mzQ -
J Controlled Release
@JCRnEDITORS
Dual-targeted molybdenum nanomedicine treats acute pancreatitis by blocking mitochondrial DNA-triggered cGAS-STING signaling via ROS modulation.
| Kelong Ai @CentralSouth_U |
[50 days' free access]
#molybdenum #bloodbrainbarrier #mitochondria
authors.elsevier.com/a/1mIVncI2-9n2k -
J Controlled Release
@JCRnEDITORS
Self-assembled Cu-alendronate nanoneedle sonozymes promoting infected bone regeneration via synergistic sonodynamic and chemodynamic therapy.
| Longxiang Shen @sjtu1896 |
[50 days' free access]
#nanoneedle #sonozyme
authors.elsevier.com/a/1mIZ1cI2-9n3y -
J Controlled Release
@JCRnEDITORS
Aptamer-functionalized nanoparticles for CRISPR-Cas9 delivery to circulating malignant cells for therapeutic efficacy evaluation.
| Si-Xue Cheng @WHU_1893 |
[50 days' free access]
#genedelivery #aptamer #geneediting
authors.elsevier.com/a/1mHXxcI2-9n1h -
J Controlled Release
@JCRnEDITORS
Engineering natural killer cell-derived extracellular vesicles for disease therapy.
| Yinghong Shi, Jiangsu Univ. |
[50 days' free access]
#extracellularvesicle #naturalkillercell
authors.elsevier.com/a/1mHXxcI2-9n0e -
J Controlled Release
@JCRnEDITORS
Engineering surfaces of polymer-based medical implants for tissue repair and regeneration.
| Jun Yue @sysu_1924 |
[50 days' free access]
#implant #surfaceengineering
authors.elsevier.com/a/1mHlS_3r0J7O6Y -
J Controlled Release
@JCRnEDITORS
Phosphatase and tensin homolog mRNA complexed with hyaluronated lipid nanoparticles for transdermal cancer immunotherapy.
| Sei Kwang Hahn @postech1986 | @KoreaCRS
[50 days' free access]
#mrnadelivery #lipidnanoparticle #transdermal
authors.elsevier.com/a/1mHrJcI2-9mzu -
J Controlled Release
@JCRnEDITORS
The effect of hyperthermic cycling on intratumoral liposome accumulation and triggered drug release.
| Timo L.M. ten Hagen @ErasmusMC | @CRSBeNeLuxFr
[Open Access]
#liposome #thermosensitive
doi.org/10.1016/j.jconrel.2025.114544 -
J Controlled Release
@JCRnEDITORS
Acid neutralization and metal-phenolic nanomedicine on-demand release microspheres for reversing cartilage degeneration.
| Chunli Wang, Hubei Univ. of Chinese Medicine |
[50 days' free access]
#microsphere #cartilage
authors.elsevier.com/a/1mHXx_3r0J7O6H -
J Controlled Release
@JCRnEDITORS
Glutathione-responsive self-assembling peptide-coated Salmonella for antitumor therapy.
| Junfeng Shi @hunanuniv |
[50 days' free access]
#selfassembly #peptide #glutathione
authors.elsevier.com/a/1mIp5cI2-9n2X -
J Controlled Release
@JCRnEDITORS
Inhalable nanosystem promote in situ packaging of IL-11 antisense oligonucleotides into macrophage-derived vesicles for idiopathic pulmonary fibrosis.
| Yan Zhang @ZZU_China |
[50 days' free access]
#lungdelivery #extracellularvesicle #fibrosis
authors.elsevier.com/a/1mJQHcI2-9n3h -
J Controlled Release
@JCRnEDITORS
In situ reprogramming of tumor associated macrophages with versatile nano-epigenetic inhibitor for lung cancer therapy.
| Lingmin Zhang, Guangzhou Medical Univ. |
[50 days' free access]
#macrophagereprogramming #tumormicroenvironment
authors.elsevier.com/a/1mFpgcI2-9mwf -
J Controlled Release
@JCRnEDITORS
Design of biomimetic chylomicrons based on 1,3-diolein grafted hyaluronic acid to drive biomacromolecules across the intestinal mucosal barrier.
| Xin Zhang, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#oraldelivery #hyaluronicacud #chylomicron
authors.elsevier.com/a/1mGBTcI2-9mxo -
J Controlled Release
@JCRnEDITORS
Redox-responsive chitosan hydrogel releases mitochondria-targeted fullerenol to reprogram M1/M2 macrophage balance for diabetic wound healing.
| Yu-Chun Lin @xmuchina |
[50 days' free access]
#hydrogel #mitochondriatargeting
authors.elsevier.com/a/1mGCwcI2-9my4 -
J Controlled Release
@JCRnEDITORS
Stimuli-responsive nanomedicines for hepatic diseases: mechanism, design, recent advances, and clinical translation.
| Kui Luo @SCUCN |
[50 days' free access]
#nanomedicine #stimuliresponsive
authors.elsevier.com/a/1mHXxcI2-9m~e -
J Controlled Release
@JCRnEDITORS
Machine learning-driven insights into the mechanical performance of polymeric microneedle array patches.
| Choon Fu Goh @USMSCOMM |
[50 days' free access]
#microneedle #machinelearning
authors.elsevier.com/a/1mHXxcI2-9mx~ -
J Controlled Release
@JCRnEDITORS
Dissolving microneedle co-deliver mitochondria-targeted nanozyme and tofacitinib for synergistic treatment of Rosacea.
| Yongzhong Du @ZJU_China |
[50 days' free access]
#microneedle #mitochondria #nanozyme #acne
authors.elsevier.com/a/1mG1vcI2-9n0G -
J Controlled Release
@JCRnEDITORS
Escherichia coli Nissle 1917 outer membrane vesicles encapsulating oncolytic virus remodel tumor-associated macrophages and kill prostate cancer cells.
| Qi-Dong Xia @2024_HUST |
[50 days' free access]
#bacterialvesicle #oncolyticvirus
authors.elsevier.com/a/1mGWycI2-9mzP -
J Controlled Release
@JCRnEDITORS
Host-pathogen hybrid glycocalyx mimicking lipid nanoparticles induce trained immunity as a promising platform for universal vaccines.
| Yihui Deng, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#vaccine #glycocalyx #lysosomalescape
authors.elsevier.com/a/1mGBTcI2-9mvQ -
J Controlled Release
@JCRnEDITORS
Pulmonary macrophage-targeted RNAi and mRNA co-delivery via SORT lipid nanoparticles enhances immunotherapy in lung cancer.
| Shugeng Gao, Peking Union Medical College |
[50 days' free access]
#macrophagetargeting #mrnadelivery #lipidnanoparticle
authors.elsevier.com/a/1mG55cI2-9m~4 -
J Controlled Release
@JCRnEDITORS
Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins' activity for fascia regeneration.
| Xinliang Chen @sjtu1896 |
[50 days' free access]
#golgitargeting #copperdelivery #fasciaregeneration
authors.elsevier.com/a/1mG55cI2-9m~S -
J Controlled Release
@JCRnEDITORS
Hydrogel-based drug delivery systems for localized eradication of bacterial biofilms: Advances, challenges and future directions.
| Line Hagner Nielsen @DTU_HealthTech |
[Open Access]
#hydrogel #biofilm
doi.org/10.1016/j.jconrel.2025.114509 -
J Controlled Release
@JCRnEDITORS
Oral (poly)peptide delivery: On the emulsifying properties of inverted lipid phases under gastrointestinal conditions.
| Andreas Bernkop-Schnürch, Univ. of Innsbruck |
[Open Access]
#oraldelivery #peptide #selfemulsification
doi.org/10.1016/j.jconrel.2025.114508 -
J Controlled Release
@JCRnEDITORS
A single extracellular vesicle-based platform supporting both RBD protein and mRNA vaccination against SARS-CoV-2.
| Seok-Hyun Kim @EwhaWomansUniv | @KoreaCRS
[50 days' free access]
#mrnavaccine #extracellularvesicle
authors.elsevier.com/a/1mEyGcI2-9mzQ -
J Controlled Release
@JCRnEDITORS
Ionic liquid-coated lipid nanoparticles demonstrate prolonged circulation and brain uptake via red blood cell hitchhiking.
| Devika S Manickam @UTHealthHouston |
[50 days' free access]
#ionicliquid #lipidnanoparticle
authors.elsevier.com/a/1mDvFcI2-9mv2 -
J Controlled Release
@JCRnEDITORS
Bilayer gelatin-methacryloyl scaffold for pulp inflammation suppression and dentin-like tissue regeneration.
| Marco C. Bottino @UMichDentistry |
[Open Access]
#scaffold #tissueregeneration
doi.org/10.1016/j.jconrel.2025.114469 -
J Controlled Release
@JCRnEDITORS
Ultrasound-responsive Pickering emulsions enable extracellular matrix disruption for enhanced sonodynamic immunotherapy.
| Ping Zhou @CentralSouth_U |
[50 days' free access]
#emulsion #ultrasound #extracellularmatrix #sonodynamic
authors.elsevier.com/a/1mHrJcI2-9n0w -
J Controlled Release
@JCRnEDITORS
Self-driven Janus nanomotors empowering gastric mucus and biofilm penetration to potentiate antibiotic eradication of Helicobacter pylori.
| Xiaohong Li @swjtu1896 |
[50 days' free access]
#oraldelivery #nanomotor #antibiotic
authors.elsevier.com/a/1mHufcI2-9n2w -
J Controlled Release
@JCRnEDITORS
Tumor targeted radionuclide-nanomedicine for clinical translation: From carrier innovation to precision therapy.
| Xiaoyuan Chen @NUSingapore |
[50 days' free access]
#radionuclide #targeteddelivery
authors.elsevier.com/a/1mHzvcI2-9n1t -
J Controlled Release
@JCRnEDITORS
Smart photo-enabled micelles for cancer therapy: Mechanisms, challenges, and innovations.
| Fu-Gen Wu, Southeast Univ. |
[50 days' free access]
#micelle #lightresponsive #photodynamic #photothermal
authors.elsevier.com/a/1mHzvcI2-9mt0 -
J Controlled Release
@JCRnEDITORS
Promoting probiotic delivery and colonization through controllable polymer surface display.
| Jiaheng Liu @SCUCN |
[50 days' free access]
#probiotic #polymercoating
authors.elsevier.com/a/1mEfHcI2-9myG -
J Controlled Release
@JCRnEDITORS
Nanoprodrug targeting tumor-associated intracellular bacteria enhances colorectal cancer immunotherapy.
| Hui Gao, Tiangong Univ. |
[50 days' free access]
#prodrug #intracellularbacteria #immunotherapy
authors.elsevier.com/a/1mFIDcI2-9mz1 -
J Controlled Release
@JCRnEDITORS
Screening of sinapic acid as a polyphenol stabilizing agent for enhanced miR-124 delivery in ulcerative colitis therapy.
| Shengpeng Wang @UM_1981 |
[50 days' free access]
#mirnadelivery #polyphenol #colitis
authors.elsevier.com/a/1mF5RcI2-9mxc -
J Controlled Release
@JCRnEDITORS
Taurine-loaded covalent organic frameworks for alleviating post-radiation bone regeneration disorder.
| Yue He @sjtu1896 |
[50 days' free access]
#metalorganicframework #boneregeneration
authors.elsevier.com/a/1mDjk_3r0J7O5o -
J Controlled Release
@JCRnEDITORS
Engineered microalgae–driven gel platform promotes the repairing of senescence-associated intervertebral disc degeneration in rats and goats.
| Weibin Sheng @XJMUOfficial |
[50 days' free access]
#hydrogel #nanozyme #discregeneration
authors.elsevier.com/a/1mDzacI2-9mxD -
J Controlled Release
@JCRnEDITORS
Balancing stability and activation: A pseudoparabolic activity spectrum guides fatty acid chain length optimization in prodrug-albumin nanoparticles.
| Qikun Jiang, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#stability #prodrug #albumin
authors.elsevier.com/a/1mEyGcI2-9mzD -
J Controlled Release
@JCRnEDITORS
Self-lytic nano-bacterial biohybrid reprograms Intratumoral microbiome–immune interactions for cancer immunotherapy.
| Qi Shen @sjtu1896 |
[50 days' free access]
#intratumoral #bacterial #microbiome
authors.elsevier.com/a/1mEyGcI2-9myr -
J Controlled Release
@JCRnEDITORS
A matrix metalloproteinase-responsive hydrogel delivers dendritic cell-targeting nanoparticles for sustained antitumor immunity.
| Chaoliang He @USTCGlobal |
[50 days' free access]
#nanoparticle #polypeptide #hydrogel #metalloproteninase
authors.elsevier.com/a/1mEfHcI2-9mxE -
J Controlled Release
@JCRnEDITORS
A dual responsive nanohydrogel system for sustained drug delivery and cartilage penetration in osteoarthritis therapy.
| Zhiyong Qian @SCUCN |
[50 days' free access]
#hydrogel #sustaineddelivery #osteoarthritis
authors.elsevier.com/a/1mDe1cI2-9mwB -
J Controlled Release
@JCRnEDITORS
Design strategies of biomaterial-based intra-articular drug delivery system for osteoarthritis therapy.
| Guang Han @HenanUniversity |
[50 days' free access]
#intraarticular #osteoarthritis
authors.elsevier.com/a/1mDhUcI2-9mwT -
J Controlled Release
@JCRnEDITORS
Stepwise exfoliated microneedle patch for immediate and concomitant targeted booster vaccination.
| Huayu Tian @xmuchina |
[50 days' free access]
#microneedle #patch #vaccine #cpg
authors.elsevier.com/a/1mDzacI2-9mvc -
J Controlled Release
@JCRnEDITORS
Tumor-specific glyco-detonators: A neuraminidase-3-gated programmable DNA nanoarchitectonics for liver cancer-exclusive chemotherapy.
| Jingying Li @Fuzhou_Uni |
[50 days' free access]
#dnananostructure #targeteddelivery #neuraminidase
authors.elsevier.com/a/1mEKRcI2-9mwN -
J Controlled Release
@JCRnEDITORS
A cascade-regulated nanoadjuvant for antigen oxidation and capture to potentiate in-situ cancer vaccination.
| Minjie Sun, China Pharmaceutical Univ. |
[50 days' free access]
#nanoadjuvant #cancervaccine
authors.elsevier.com/a/1mEVGcI2-9ms2 -
J Controlled Release
@JCRnEDITORS
Immunological conversion of triple-negative breast cancer by engineered extracellular vesicle-mediated pyroptosis.
| Zhaogang Yang, Jilin Univ. |
[50 days' free access]
#extracellularvesicle #pyroptosis
authors.elsevier.com/a/1mDxDcI2-9mv- -
J Controlled Release
@JCRnEDITORS
The use of Xenon magnetic lipid bubbles to detect and treat intermittent hypoxia-induced cognitive impairment.
| Qiang Zhang @TJMU_China |
[Open Access]
#lipidbubble #xenon #hypoxia
doi.org/10.1016/j.jconrel.2025.114478 -
J Controlled Release
@JCRnEDITORS
Ultraflexible lipid vesicles loaded with cyanocobalamin or cyclosporin A downregulate acute and chronic immuno-inflammatory skin states.
| Antonio José Guillot @UV_EG |
[Open Access]
#lipidvesicle #transfersome #ethosome
doi.org/10.1016/j.jconrel.2025.114461 -
J Controlled Release
@JCRnEDITORS
Targeted therapeutics for IBD unraveling the potential of stimulus-responsive nanoparticles.
| Bruno Sarmento @i3S_UPorto | @CRS_SPLC @brunocsarmento
[Open Access]
#stimulusresponsive #inflammatoryboweldisease
doi.org/10.1016/j.jconrel.2025.114466 -
J Controlled Release
@JCRnEDITORS
Engineered mesenchymal stem cells for targeted delivery of H2S to suppress cGAS-STING inflammation and enhance cardioprotection in myocardial ischemia-reperfusion.
| Zhihua Wang @FudanUniversity |
[50 days' free access]
#stemcell #cardioprotection
authors.elsevier.com/a/1mDOvcI2-9mud -
J Controlled Release
@JCRnEDITORS
Replacing cholesterol in liposomes by an Astragaloside IV derivative prolongs the circulation time and improves drug delivery to the fibrotic heart.
| Jian-lin Wu, Macau Univ. of Science and Technology |
[50 days' free access]
#liposome #cholesterol
authors.elsevier.com/a/1mDOvcI2-9mv1 -
J Controlled Release
@JCRnEDITORS
Glutarimide-derived ionizable lipid enables mRNA lipid nanoparticle vaccines with enhanced safety and immunogenicity.
| Xihui Gao @FudanUniversity |
[50 days' free access]
#mrnadelivery #ionizablelipid #vaccine #safety
authors.elsevier.com/a/1mCwK_3r0J7O5e -
J Controlled Release
@JCRnEDITORS
Urate-responsive hydrogel microneedles with rapid bubble separation for simplified long-term gout management.
| Xun Sun @SCUCN |
[50 days' free access]
#microneedle #hydrogel #gout
authors.elsevier.com/a/1mCwKcI2-9mvo -
J Controlled Release
@JCRnEDITORS
A Sandwich-like metabolic regulator activated γδ T cells for dual immunotherapy.
| Shu-Lan Li, Tiangong Univ. |
[50 days' free access]
#cuproptosis #reactiveoxygenspecies #immunotherapy
authors.elsevier.com/a/1mDMacI2-9ms- -
J Controlled Release
@JCRnEDITORS
Lipidated peptide nanostructures for stabilizing hydrogels with sustained skincare bioactivity.
| Meiwen Cao @CUP1953 |
[50 days' free access]
#hydrogel #selfassembly #stability #skincare
authors.elsevier.com/a/1mDOvcI2-9mwr -
J Controlled Release
@JCRnEDITORS
Lipid nanoparticle-mediated CRISPR/Cas9 delivery enables efficient trabecular meshwork gene editing in mice.
| Wenjun Xiong @CityUHongKong |
[50 days' free access]
#lipidnanoparticle #geneediting
authors.elsevier.com/a/1mDOvcI2-9mx1 -
J Controlled Release
@JCRnEDITORS
Nanozymes: Reshaping the landscape of age-related disease therapy through multifaceted redox regulation.
| Ying Li, Hubei Univ. of Chinese Medicine |
[50 days' free access]
#nanozyme #oxidativestress
authors.elsevier.com/a/1mDOvcI2-9mup -
J Controlled Release
@JCRnEDITORS
Nanoassemblies for oral protein delivery — The case of monoclonals for inflammatory bowel disease.
| María José Alonso @cimususc | @CRS_SPLC
[Open Access]
#oraldelivery #proteindelivery
doi.org/10.1016/j.jconrel.2025.114455 -
J Controlled Release
@JCRnEDITORS
Unveiling the potential of neuron-targeted dendriplexes for siRNA delivery using a PNS-CNS-on-Chip.
| Ana P. Pêgo @i3S_UPorto | @CRS_SPLC
[Open Access]
#sirnadelivery #dendriplex
doi.org/10.1016/j.jconrel.2025.114422 -
J Controlled Release
@JCRnEDITORS
Breaking barriers: Engineering extracellular vesicles for enhanced endosomal escape and therapeutic delivery.
| In-San Kim @KistPublic | @KoreaCRS
[Open Access]
#extracellularvesicle #endosomalescape
doi.org/10.1016/j.jconrel.2025.114462 -
J Controlled Release
@JCRnEDITORS
VyPAL2 peptide asparaginyl ligase enables versatile workflows for radiolabeling single-domain antibody-based theranostics.
| Jessica Bridoux @VUBrussel | @CRSBeNeLuxFr
[Open Access]
#theranostic #radiolabeling #antibody #imaging
doi.org/10.1016/j.jconrel.2025.114361 -
J Controlled Release
@JCRnEDITORS
Incorporation of a polyamine into lipid nanoparticles increases the endosomal release and transfection of nucleic acids without toxicity.
| Shyh-Dar Li @ubcpharmacy |
[Open Access]
#lipidnanoparticle #polyamine #endosomalrelease
doi.org/10.1016/j.jconrel.2025.114366 -
J Controlled Release
@JCRnEDITORS
Incorporation of a polyamine into lipid nanoparticles increases the endosomal release and transfection of nucleic acids without toxicity.
| Shyh-Dar Li @ubcpharmacy |
[Open Access]
#lipidnanoparticle #endosomalrelease
doi.org/10.1016/j.jconrel.2025.114366 -
J Controlled Release
@JCRnEDITORS
Flash nano-encapsulation of probiotics: Bolstering environmental resistance and intestinal colonization to prevent necrotizing enterocolitis.
| Yu Lin, Fujian Medical Univ. |
[50 days' free access]
#encapsulation #probioti #enterocolitis
authors.elsevier.com/a/1mCuxcI2-9muE -
J Controlled Release
@JCRnEDITORS
Bioswitchable intracellular delivery of small activating RNA by tetrahedral framework nucleic acid: Application to p21-mediated anti-tumor therapy.
| Yunfeng Lin @SCUCN |
[50 days' free access]
#intracellulardelivery #nucleicacid #tetrahedral
authors.elsevier.com/a/1mCfKcI2-9mvE -
J Controlled Release
@JCRnEDITORS
Predicting human subcutaneous bioavailability of monoclonal antibodies using an open flow microperfusion porcine model.
| Marta Venczel @sanofiDE | @CRS_DeChAt_LC
[50 days' free access]
#antibody #bioavailability #microperfusion
authors.elsevier.com/a/1mCUtcI2-9mhi -
J Controlled Release
@JCRnEDITORS
A systemic evaluation of the effect of dsRNA contamination on mRNA vaccine expression and immunogenicity.
| Jae-Hwan Nam, The Catholic Univ. of Korea | @KoreaCRS
[50 days' free access]
#mrnavaccine #impurity #dsrna
authors.elsevier.com/a/1mC84cI2-9msd -
J Controlled Release
@JCRnEDITORS
Enhancing lipid nanoparticles-mediated RNA delivery to glioblastoma via targeted strategies.
| Muhammad Ismail @HenanUniversity |
[50 days' free access]
#rnadelivery #lipidnanoparticle #glioblastoma
authors.elsevier.com/a/1mCfKcI2-9msp -
J Controlled Release
@JCRnEDITORS
Sprayable proteinic adhesive microgel-based immunosuppressive therapeutic coating for effective xenograft transplantation.
| Hyung Joon Cha @postech1986 | @KoreaCRS
[50 days' free access]
#microgel #adhesive #sprayable
authors.elsevier.com/a/1mB7T_3r0J7O5Q -
J Controlled Release
@JCRnEDITORS
A wireless magnetoelectric-driven strategy to boost nose-to-brain drug delivery with сore-shell nanotransducers.
| Roman A. Surmenev, National Research Tomsk Polytechnic Univ. |
[50 days' free access]
#braindelivery #nanotransducer
authors.elsevier.com/a/1mB3wcI2-9mkl -
J Controlled Release
@JCRnEDITORS
Engineered self-assembly of mucoadhesive Helicobacter pylori vaccines: CD4+ T cell-dependent immunity prevents bacterial colonization.
| Haiyan Hu @sysu_1924 |
[50 days' free access]
#vaccine #mucoadhesive #helicobacter
authors.elsevier.com/a/1mCUtcI2-9mkA -
J Controlled Release
@JCRnEDITORS
Genome editing of Spp1 by inhalable CRISPR/Cas9 formulation for treating pulmonary fibrosis.
| Yuan Ping @ZJU_China |
[50 days' free access]
#inhalation #geneediting #pulmonaryfibrosis
authors.elsevier.com/a/1mCaPcI2-9mlJ -
J Controlled Release
@JCRnEDITORS
Long-acting lipid-based nanomedicines: rethinking from structure-based rational design to in vivo fate evaluation.
| Changyou Zhan @FudanUniversity |
[50 days' free access]
#lipidnanoparticle #longacting
authors.elsevier.com/a/1mC84_3r0J7O5N -
J Controlled Release
@JCRnEDITORS
Hypoxia-responsive modules via tunable hydrophobicity reversal enhance renal-targeted release of CD36-interfering nanoparticles to ameliorate acute kidney injury.
| Yaxi Chen, Chongqing Medical Univ. |
[50 days' free access]
#sirnadelivery #kidneyinjury
authors.elsevier.com/a/1mBJkcI2-9mpn -
J Controlled Release
@JCRnEDITORS
Oral gene delivery platform based on glycol chitosan-PEG-lactoferrin conjugate.
| Dong Yun Lee @i_hanyang | @KoreaCRS
[50 days' free access]
#oraldelivery #genedelivery #chitosan #conjugate
authors.elsevier.com/a/1mB9lcI2-9mrO -
J Controlled Release
@JCRnEDITORS
Boronate-crosslinked hydrogel enables localized chemoimmunotherapy to remodel the immune microenvironment in triple-negative breast cancer.
| Ying Chen, Guangdong Institute for Drug Control |
[50 days' free access]
#hydrogel #crosslinking
authors.elsevier.com/a/1mC84cI2-9msR -
J Controlled Release
@JCRnEDITORS
Clinical translation of nanomedicines for brain diseases: Current challenges and future directions.
| Bingyang Shi, Univ. of Technology Sydney | @AustralianCRS
[50 days' free access]
#nanomedicine #braindisease
authors.elsevier.com/a/1mAs4cI2-9mlb -
J Controlled Release
@JCRnEDITORS
Breaking barriers in immunotherapy: harnessing ultrasound for enhanced drug delivery and immune activation.
| Xin Pang, Henan Univ. of Chinese Medicine |
[50 days' free access]
#ultrasound #sonothermal #immunotherapy
authors.elsevier.com/a/1mAT6cI2-9mpz -
J Controlled Release
@JCRnEDITORS
Bindarit-loaded hydrogel sustained-release system alleviates periodontitis in mice via CC motif chemokine ligand 2-dependent monocyte chemotaxis.
| Jiang Chen, Fujian Medical Univ. |
[50 days' free access]
#hydrogel #sustainedrelease #chemotaxis
authors.elsevier.com/a/1mAYg_3r0J7O59 -
J Controlled Release
@JCRnEDITORS
In vivo stability of polymeric micelles revealed by analysis of intact nanocarriers.
| Wei Wu @FudanUniversity |
[50 days' free access]
#micelle #stability
authors.elsevier.com/a/1m31kcI2-9mf4 -
J Controlled Release
@JCRnEDITORS
Three-in-one bilayer microneedle patch for ultrasound-activated antibacterial therapy and immune modulation in wound healing
| Wei Li @WHU_1893 |
[50 days' free access]
#microneedle #ultrasound #woundhealing
authors.elsevier.com/a/1m2-XcI2-9mdf -
J Controlled Release
@JCRnEDITORS
Enhancing TIM-3 immunotherapy with epirubicin-loaded pH sensitive fusion membrane nanoparticles for effective glioblastoma treatment.
| Jinbing Xie, Southeast Univ. |
[50 days' free access]
#phsensitive #glioblastoma
authors.elsevier.com/a/1m2VTcI2-9mcK -
J Controlled Release
@JCRnEDITORS
Microenvironment-targeted strontium delivery system reshapes redox homeostasis to halt degenerative cascades in intervertebral discs.
| Zhong Fang @2024_HUST |
[50 days' free access]
#microenvironment #strontium #intervertebraldisc
authors.elsevier.com/a/1mABwcI2-9mpC -
J Controlled Release
@JCRnEDITORS
Modulating cationic-hydrophobic balance in hydrogel polymer nanoparticles for enhanced membrane interactions and antibacterial functions.
| Mingming Liu @HZAU_China |
[50 days' free access]
#hydrogel #polymer #cationic #antibacterial
authors.elsevier.com/a/1mA7AcI2-9mpb -
J Controlled Release
@JCRnEDITORS
Sustained progesterone supplementation with state-of-the-art 3D printed intravaginal ring for the treatment of infertility.
| S. Rahima Benhabbour @jointbme |
[50 days' free access]
#intravaginal #3dprinting
authors.elsevier.com/a/1mAN9cI2-9mmA -
J Controlled Release
@JCRnEDITORS
An in situ immunogenicity-amplifying payload delivery system for immunotherapy of Kirsten rat sarcoma viral oncogene homolog–mutant cancer.
| Ha Rin Kim, Kookmin Univ. | @KoreaCRS
[50 days' free access]
#peptidedrugconjugate #pyroptosis
authors.elsevier.com/a/1m8KkcI2-9meK -
J Controlled Release
@JCRnEDITORS
Enzyme-powered micellar nanoreactors enable tumor-specific, cascade-amplified prodrug activation for synergistic oxidation–chemo–immunotherapy.
| Wence Zhou @iLZU1909 |
[50 days' free access]
#micelle #enzyme #prodrug
authors.elsevier.com/sd/article/S0168-3659(25)00977-0 -
J Controlled Release
@JCRnEDITORS
Nanoparticle-mediated bone regeneration: From molecular mechanisms to clinical translation.
| Michael Mak @StonyBrookMed |
[50 days' free access]
#mechanotransduction #boneregeneration
authors.elsevier.com/a/1mAN9cI2-9mix -
J Controlled Release
@JCRnEDITORS
Integrin/CD44-targeted liposomes remodel the pulmonary microenvironment to alleviate acute exacerbation of pulmonary fibrosis.
| Yonglong Xiao, Nanjing Univ. of Chinese Medicine |
[50 days' free access]
#liposome #fibrosis
authors.elsevier.com/a/1mA41cI2-9mln -
J Controlled Release
@JCRnEDITORS
Selective accumulation of nanoparticles in infected cells for targeted drug delivery.
| Ruxandra Gref @UnivParisSaclay | @CRSBeNeLuxFr
[50 days' free access]
#targeteddelivery #nanoparticle #macrophage
authors.elsevier.com/a/1m8rLcI2-9mju -
J Controlled Release
@JCRnEDITORS
Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPsα as a therapeutic strategy for Alzheimer's disease.
| Ulrike C. Müller @IPMB_HD | @CRS_DeChAt_LC
[Open Access]
#braindelivery #liposome #genetherapy
doi.org/10.1016/j.jconrel.2025.114374 -
J Controlled Release
@JCRnEDITORS
Thioketal-linked glycol chitosan nanosystem for targeted and sustained drug delivery of mesalazine in inflammatory bowel disease.
| Dong Yun Lee @i_hanyang |
[50 days' free access]
#chitosan #sustaineddelivery #inflammatoryboweldisease
authors.elsevier.com/a/1m848_3r0J7O4g -
J Controlled Release
@JCRnEDITORS
Targeted engineered exosomes alleviate myocardial infarction injury by enhancing angiogenesis and improving mitochondrial function.
| Yan Li, The Fourth Military Medical Univ. |
[50 days' free access]
#exosome #myocardialinfarction
authors.elsevier.com/a/1m94~cI2-9mi5 -
J Controlled Release
@JCRnEDITORS
An oral H2S nanotherapeutics for hypertensive chronic kidney disease via synergistic antihypertensive and renoprotective activities.
| Shiyong Zhang @SCUCN |
[50 days' free access]
#oraldelivery #kidneydisease
authors.elsevier.com/a/1m8zbcI2-9mkY -
J Controlled Release
@JCRnEDITORS
Enhanced intracellular delivery of multi-responsive and size-switchable nanoparticles via microneedles for targeted psoriasis therapy.
| Yijing Liu @2024_HUST |
[50 days' free access]
#microneedle #psoriasis
authors.elsevier.com/a/1m8w6cI2-9mp0 -
J Controlled Release
@JCRnEDITORS
Apoptotic-body-inspired nanoplatform targeting the lung-macrophage-mitochondrial axis for acute lung injury therapy.
| Rong Zeng @jnu1906 |
[50 days' free access]
#nanozyme #liposome #apoptoticbody
authors.elsevier.com/a/1m8oPcI2-9mjW -
J Controlled Release
@JCRnEDITORS
Controlled delivery of STING agonist and manganese ion in injectable PLGA implants for enhanced cancer immunotherapy.
| James J. Moon @UMichPharmacy |
[Open Access]
#implant #injectable
doi.org/10.1016/j.jconrel.2025.114410 -
J Controlled Release
@JCRnEDITORS
Combination of ionizable lipids with oleic acid and vitamin E scaffolds for RNA cancer vaccine delivery.
| Hidetaka Akita @TohokuUniPR |
[50 days' free access]
#rnavaccine #ionizablelipid
authors.elsevier.com/a/1m8MjcI2-9mji -
J Controlled Release
@JCRnEDITORS
Engineered potent DC vaccine enables closer DC-T cell contact to trigger personalized antitumor immunity.
| Tong Gao @QingdaoU |
[50 days' free access]
#vaccine #dendriticcell
authors.elsevier.com/a/1m8MjcI2-9ml~ -
J Controlled Release
@JCRnEDITORS
Integrated focused ultrasound and electromagnetic actuation (FUEM) system for enhanced targeted drug delivery in brain cancer treatment.
| Sukho Park, Daegu Gyeongbuk Inst. of Science and Technology | @KoreaCRS
[50 days' free access]
#focusedultrasound
authors.elsevier.com/a/1m7TTcI2-9mil -
J Controlled Release
@JCRnEDITORS
Pre-programming the protein corona: From avoidance to endogenous targeting.
| Neelesh Kumar Mehra @NIPERHyd | @CrsIndian
[50 days' free access]
#targeteddelivery #proteincorona
authors.elsevier.com/a/1m8oPcI2-9moq -
J Controlled Release
@JCRnEDITORS
A multifunctional M1-like cell vehicle to intravesically deliver ICG for photodynamic therapy of bladder cancer.
| Pu Zhang, Hangzhou Medical College |
[Open Access]
#intravesucal #mucoadhesive #photodynamic
doi.org/10.1016/j.jconrel.2025.114428 -
J Controlled Release
@JCRnEDITORS
Dendritic cell-derived biomimetic vesicles as cancer vaccine platforms for melanoma immunotherapy.
| Quangang Zhu @Tongji_Uni |
[50 days' free access]
#biomimeticvesicle #dendriticcell
authors.elsevier.com/a/1m8hdcI2-9miH -
J Controlled Release
@JCRnEDITORS
Preclinical assessment of genetically modified exosomes for colorectal cancer immunotherapy.
| Yong Zhang @USCMann |
[50 days' free access]
#exosome #immunotherapy
authors.elsevier.com/a/1m8decI2-9mlV -
J Controlled Release
@JCRnEDITORS
FormulationLAI: A physiology-based machine learning framework for accelerated development of long-acting injectable formulations.
| Defang Ouyang @UM_1981 |
[50 days' free access]
#machinelearning #longacting #injectable
authors.elsevier.com/a/1m8ZzcI2-9mkM -
J Controlled Release
@JCRnEDITORS
Nanoparticle immunoimaging reveals metabolic dysfunction fueling CCR2-dependent inflammation in infarcted hearts.
| Katrien Vandoorne @TechnionLive |
[Open Access]
#imaging #inflammation
doi.org/10.1016/j.jconrel.2025.114399 -
J Controlled Release
@JCRnEDITORS
An antioxidant metal-organic framework with functional coatings for oral anti-TNF-α antibody delivery in inflammatory bowel disease treatment.
| Ana Beloqui, UCLouvain | @AnaBeloqui1 @CRSBeNeLuxFr
[50 days' free access]
#oraldelivery #antibody
authors.elsevier.com/sd/article/S0168-3659(25)01025-9 -
J Controlled Release
@JCRnEDITORS
Design of messenger RNA vaccines based on lipid-polymer hybrid nanoparticles.
| Camilla Foged @UCPH_health |
[Open Access]
#hybridnanoparticle #mrnavaccine
doi.org/10.1016/j.jconrel.2025.114385 -
J Controlled Release
@JCRnEDITORS
A “sweeter” approach to cancer immunotherapy: Glycopolymers as diverse tools for immune modulation.
| Thomas Werfel @OleMiss |
[50 days' free access]
#glycopolymer #immunoengineering #immunotherapy
authors.elsevier.com/a/1m7FfcI2-9md5 -
J Controlled Release
@JCRnEDITORS
Enhanced macromolecule bioavailability in rats and pigs using an in situ forming synthetic epithelial lining.
| Giovanni Traverso @MITMechE |
[Open Access]
#oraldelivery #semaglutide #enhancer #polydopamine
doi.org/10.1016/j.jconrel.2025.114338 -
J Controlled Release
@JCRnEDITORS
Mitochondria-targeted carbon monoxide delivery nanoplatform for enhanced cancer immunotherapy through metabolic-immune reprogramming.
| Huijing Xiang @SHU19945 |
[50 days' free access]
#gasdelivery #carbonmonoxide #mitochondria
authors.elsevier.com/a/1m8KkcI2-9mg5 -
J Controlled Release
@JCRnEDITORS
Dopamine-functionalized bioinspired pre-chondrogenic hydrogel for cell-free cartilage regeneration.
| Yongzhong Du @ZJU_China |
[50 days' free access]
#hydrogel #cartilageregeneration
authors.elsevier.com/a/1m6LVcI2-9miZ -
J Controlled Release
@JCRnEDITORS
Tiny tools, big vision: A minireview on carbonized nanomaterials in ophthalmology.
| Huan-Tsung Chang @ChangGungUniv |
[50 days' free access]
#oculardelivery #nanomaterial
authors.elsevier.com/a/1m6JycI2-9mgx -
J Controlled Release
@JCRnEDITORS
Rapidly dissolving microneedle patch embedded with long-acting microspheres for sustained release of goserelin.
| Zhen Gu @ZJU_China |
[50 days' free access]
#microneedle #microsphere #sustainedrelease
authors.elsevier.com/a/1m6LlcI2-9mh7 -
J Controlled Release
@JCRnEDITORS
Bri2 BRICHOS, a molecular chaperone-like domain that can cross brain vascular endothelial cells and deliver proteins into neurons.
| Jan Johansson @karolinskainst |
[Open Access]
#braindelivery #chaperone #transport
doi.org/10.1016/j.jconrel.2025.114403 -
J Controlled Release
@JCRnEDITORS
Environment-adaptive microneedle design strategies for precision oral disease treatment: From material innovation to clinical translation.
| Xiaowei Xu, Jilin Univ. |
[50 days' free access]
#oraldelivery #microneedle
authors.elsevier.com/a/1m67KcI2-9mhu -
J Controlled Release
@JCRnEDITORS
Multifunctional macrophage membrane biomimetic nanoparticles for targeted therapy of neovascular age-related macular degeneration.
| Xingchao Shentu @ZJU_China |
[50 days' free access]
#intravitreal #macrophage #membrane
authors.elsevier.com/a/1m5XfcI2-9mgf -
J Controlled Release
@JCRnEDITORS
Fiber scaffolds augment aged bone regeneration by modulating energy metabolism, immunity and angiogenesis.
| Jidong Li @SCUCN |
[50 days' free access]
#scaffold #boneregeneration
authors.elsevier.com/a/1m5Y5cI2-9mgT -
J Controlled Release
@JCRnEDITORS
The application of nanomedicines in repairing damage in myocardial infarction.
| Haiyang Hu, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#nanomedicine #myocardialinfarction
authors.elsevier.com/a/1m5ZrcI2-9mfi -
J Controlled Release
@JCRnEDITORS
Equip your vehicle for the right terrain: Using features of local pathology to guide engineering of targeted drug delivery systems.
| Vladimir R. Muzykantov @PennMedicine |
[50 days' free access]
#targeteddelivery #pathology
authors.elsevier.com/sd/article/S0168-3659(25)01026-0 -
J Controlled Release
@JCRnEDITORS
Intraocular fate of surface charge-dependent nanomicelles via topical administration: Posterior delivery and transport pathway.
| Shirui Mao, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#intraocular #micelle #transport
authors.elsevier.com/a/1m5bccI2-9mh8 -
J Controlled Release
@JCRnEDITORS
Toward intelligent immune microneedles: Strategies for sensing, therapy, and immune regulation.
| Chwee Teck Lim @NUSingapore |
[50 days' free access]
#microneedle #sensing
authors.elsevier.com/a/1m5qvcI2-9mgg -
J Controlled Release
@JCRnEDITORS
A smart ROS-responsive hydrogel for on-demand antibacterial and platelet-rich plasma (PRP) activation in diabetic wound healing.
| Chun Zeng @smu_medical |
[50 days' free access]
#hydrogel #antibacterial #woundhealing
authors.elsevier.com/a/1m5qvcI2-9mgH -
J Controlled Release
@JCRnEDITORS
Non-cationic carriers for siRNA delivery: Current progress and potential applications.
| Meng Zheng @HenanUniversity |
[50 days' free access]
#sirnadelivery #noncationiccarrier
authors.elsevier.com/a/1m1HycI2-9mbf -
J Controlled Release
@JCRnEDITORS
CD47-targeted liposomal chemotherapy upregulates CD47 expression and induces microsatellite instability which enhances cancer immunotherapy.
| Bin Yang, Guangzhou Medical Univ. |
[50 days' free access]
#cd47 #liposome #immunotherapy
authors.elsevier.com/a/1m18dcI2-9mZs -
J Controlled Release
@JCRnEDITORS
A biocompatible tea polyphenol nanoplatform for efficient cytosolic delivery of protein therapeutics.
| Xiang Gao, Beijing Institute of Biotechnology |
[50 days' free access]
#cytosolicdelivery #stimuliresponsive #gout
authors.elsevier.com/a/1m0lHcI2-9mZH -
J Controlled Release
@JCRnEDITORS
Ionic liquids revolutionizing drug delivery: Recent advances and emerging opportunities.
| Zhongjian Chen @Tongji_Uni |
[50 days' free access]
#ionicliquid
authors.elsevier.com/a/1m0amcI2-9maR -
J Controlled Release
@JCRnEDITORS
Nano-strategy empowering trained immunity in vaccines.
| Lihua Luo @ZJU_China |
[50 days' free access]
#nanovaccine #adjuvant
authors.elsevier.com/a/1m0OScI2-9mb5 -
J Controlled Release
@JCRnEDITORS
Nintedanib-amplified effects of HSP47 siRNA on liver fibrosis therapy by inhibiting collagen secretion.
| Jian-Cheng Wang @PKU1898 |
[50 days' free access]
#sirnadelivery #liverfibrosis
authors.elsevier.com/a/1m3ricI2-9me7 -
J Controlled Release
@JCRnEDITORS
Thiourea-modified poly(l-lysine) carriers with multiple hydrogen bonding interactions for safe and robust mRNA vaccine therapy.
| Wantong Song, Changchun Institute of Applied Chemistry |
[50 days' free access]
#mrna #vaccine #polyplex
authors.elsevier.com/a/1m2IL_3r0J7O3v -
J Controlled Release
@JCRnEDITORS
Cell-specific mRNA delivery via nanobody-functionalized lipid nanoparticles.
| Linglong Chen @vet_ugent | @CRSBeNeLuxFr
[50 days' free access]
#mrnadelivery #nanobody
authors.elsevier.com/sd/article/S0168-3659(25)00979-4 -
J Controlled Release
@JCRnEDITORS
Novel single-domain antibodies targeting a unique transferrin receptor 1 epitope for cross-species delivery of drugs in the central nervous system.
| Michel Khrestchatisky @CNRS | @CRSBeNeLuxFr
[Open Access]
#transcytosis #bloodbrainbarrier
doi.org/10.1016/j.jconrel.2025.114344 -
J Controlled Release
@JCRnEDITORS
Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancer.
| Juliane Nguyen @UNCPharmacy |
[Open Access]
#antibody #ccr2 #breastcancer
doi.org/10.1016/j.jconrel.2025.114340 -
J Controlled Release
@JCRnEDITORS
Spatiotemporal STING activation via engineered bacterial vesicles enables safe and efficient cancer immunotherapy.
| Li-Li Huang @BIT1940 |
[50 days' free access]
#bacterialvesicle #immunotherapy
authors.elsevier.com/a/1m1QgcI2-9mav -
J Controlled Release
@JCRnEDITORS
In vivo nano-engineering T cells for CAR-T therapy.
| Zhiyuan Zhong, Soochow Univ. |
[50 days' free access]
#tcellengineering #polymersome #celltherapy
authors.elsevier.com/a/1m3LkcI2-9meJ -
J Controlled Release
@JCRnEDITORS
Gut-initiated mucosal and systemic immunity against SARS-CoV-2 via an oral hyaluronic acid/chitosan vaccine coacervate.
| Lihua Hou, Academy of Military Medical Sciences |
[Open Access]
#oralvaccine #coacervate #chitosan #hyaluronicacid
doi.org/10.1016/j.jconrel.2025.114376 -
J Controlled Release
@JCRnEDITORS
Molecular insights into the formation of polymeric nanoassemblies of the anticancer peptide PEN-FFW.
| Matthias G. Wacker @NUSingapore |
[50 days' free access]
#nanoassembly #peptide
authors.elsevier.com/a/1m2o1cI2-9mbs -
J Controlled Release
@JCRnEDITORS
Genetically engineered elastin-like polypeptide nanoparticles for enhanced protein delivery and therapeutic modulation in inflammatory bowel disease.
| Yuan Zhang @SCUT1918 |
[50 days' free access]
#proteindelivery #polypeptidenanoparticle #elastin
authors.elsevier.com/a/1m1QgcI2-9mai -
J Controlled Release
@JCRnEDITORS
mRNA nanomedicine reprograms the cell cycle to increase the effectiveness of targeted therapy for HER2-low breast cancers.
| Yao-Xin Lin @UCAS1978 |
[50 days' free access]
#mrna #cellcycle #breastcancer
authors.elsevier.com/a/1m3cpcI2-9meu -
J Controlled Release
@JCRnEDITORS
Nasal-to-brain siRNA delivery based on trace amine associated receptor for improving cognitive function.
| Lixing Xu, Nantong Univ. |
[50 days' free access]
#sirna #extracellularvesicle #nasal #brain
authors.elsevier.com/a/1m3ZscI2-9mdH -
J Controlled Release
@JCRnEDITORS
Antibody translocation into the cytosol: Mechanisms and engineering of endosomal escape.
| Yong-Sung Kim @AjouUniv | @KoreaCRS
[Open Access]
#antibody #endosomalescape #cytosol
doi.org/10.1016/j.jconrel.2025.114386 -
J Controlled Release
@JCRnEDITORS
Focused ultrasound-triggered doxorubicin liposomes reshape tumor microenvironment to boost checkpoint depletion in triple-negative breast cancer model.
| Yong Taik Lim @SKKU_1398 | @KoreaCRS
[50 days' free access]
#liposome #focusedultrasound
authors.elsevier.com/a/1m41d_3r0J7O4B -
J Controlled Release
@JCRnEDITORS
A two-pronged nanomedicine counteracts obesity by remodeling adipose niche.
| Yanping Li @SCUCN |
[50 days' free access]
#nanomedicine #obesity
authors.elsevier.com/a/1m41dcI2-9mfW -
J Controlled Release
@JCRnEDITORS
Circular RNA-based therapy provides sustained and robust expression of FGF2 to accelerate diabetic wound healing.
| Cheng-Cheng Deng @smu_medical |
[50 days' free access]
#circularrna #woundhealing
authors.elsevier.com/a/1m41dcI2-9mei -
J Controlled Release
@JCRnEDITORS
Fusobacterium nucleatum-targeted polymeric micelles disrupting biofilm-immune crosstalk for precision colorectal cancer immunotherapy.
| Hui Gao, Tiangong Univ. |
[50 days' free access]
#polymericmicelle #biofilm #immunotherapy
authors.elsevier.com/a/1m53rcI2-9mhW -
J Controlled Release
@JCRnEDITORS
Hydrogel formulations for sustained-release of broadly neutralizing antibodies.
| Eric A. Appel @StanfordMSE |
[50 days' free access]
#hydrogel #antibody #sustainedrelease
authors.elsevier.com/a/1m58KcI2-9mZU -
J Controlled Release
@JCRnEDITORS
Ultrasound-responsive nanocarriers for cancer therapy: Physiochemical features-directed design
| Jinshun Xu @UESTC1956 |
[50 days' free access]
#ultrasound #sonodynamic
authors.elsevier.com/a/1m0KAcI2-9maE -
J Controlled Release
@JCRnEDITORS
Hydrophobic drug particles adopt a complex biomolecular corona in ex vivo gastrointestinal fluids.
| Ben J. Boyd @UCPH_health |
[50 days' free access]
#proteinadsoprtion #proteincorona #drugparticle #proteomics
authors.elsevier.com/sd/article/S0168-3659(25)00968-X -
J Controlled Release
@JCRnEDITORS
Inflammation-targeted nanoparticles modulate macrophage polarization for coronary therapy in Kawasaki disease.
| Longfa Kou @WMU1958 |
[50 days' free access]
#bilirubin #polylysine #kawasakidisease
authors.elsevier.com/a/1m0JbcI2-9mZg -
J Controlled Release
@JCRnEDITORS
Tumor microenvironment-responsive metal-natural polyphenol nanozyme for radiosensitization by interfering glucose metabolism and redox homeostasis.
| Shi Gao, Jilin Univ. |
[50 days' free access]
#nanoenzyme #polyphenol #radiotherapy #hypoxia
authors.elsevier.com/a/1l-zNcI2-9mEw -
J Controlled Release
@JCRnEDITORS
Emerging drug delivery strategies for local immunomodulation in atherosclerosis.
| Lisa R. Volpatti @nu_chbe |
[50 days' free access]
#targeteddelivery #atherosclerosis
authors.elsevier.com/a/1lyIscI2-9mLZ -
J Controlled Release
@JCRnEDITORS
Topical mutant allele-specific siRNA delivery for treatment of Meesmann epithelial corneal dystrophy and elucidation of disease biomarkers.
| Tara Moore @UlsterUni | @UKICRS
[50 days' free access]
#sirnadelivery #biomarker #cornealdystrophy
doi.org/10.1016/j.jconrel.2025.114315 -
J Controlled Release
@JCRnEDITORS
Enhancing cisplatin therapy for small cell lung cancer via a dual strategy of combining surufatinib and CD47 blockade.
| Xiaolin Li, Nanjing Medical Univ. |
[50 days' free access]
#liposome #ferroptosis #macrophage
authors.elsevier.com/a/1l~YVcI2-9mZT -
J Controlled Release
@JCRnEDITORS
Hybrid nanovesicles enhance antitumor efficacy in KRAS-mutant non-small cell lung cancer.
| Zhe Lei, Soochow Univ. |
[50 days' free access]
#nanovesicle #lungcancer
authors.elsevier.com/a/1l~SucI2-9mY- -
J Controlled Release
@JCRnEDITORS
DNA nanotherapeutics facilitate efficient gynecological cancers treatment.
| Bing Chen, Fujian Medical Univ. |
[50 days' free access]
#dnavaccine #geneediting
authors.elsevier.com/a/1l~JKcI2-9mXU -
J Controlled Release
@JCRnEDITORS
Precisely targeting of engineered nanovesicles to implanted scaffolds via click chemistry for microenvironment regulation in acute spinal cord injury.
| Jian-Qing Gao @ZJU_China |
[50 days' free access]
#nasaldelivery #nanovesicle #spinalcordinjury
authors.elsevier.com/a/1l~ELcI2-9mVC -
J Controlled Release
@JCRnEDITORS
[Perspective] Unravelling drug delivery using in vitro Fluorescence Correlation Spectroscopy.
| Bas G.P. van Ravensteijn @UUUIPS | @CRSBeNeLuxFr
[Open Access]
#fluorescencecorrelationspectroscopy #livecellaanalysis
doi.org/10.1016/j.jconrel.2025.114311 -
J Controlled Release
@JCRnEDITORS
Engineered self-assembly of plant proteins into α-ketoglutarate-loaded nanoplatforms for osteoarthritis treatment.
| Shuqin Cao @SCUCN |
[50 days' free access]
#selfassembly #plantprotein #osteoarthritis
authors.elsevier.com/a/1l~0D_3r0J7O3C -
J Controlled Release
@JCRnEDITORS
Cell-free production of target-directed liposomes utilizing membrane localization peptides.
| Yutetsu Kuruma @JAMSTEC_PR |
[50 days' free access]
#liposome #peptide
authors.elsevier.com/a/1lzoecI2-9mYd -
J Controlled Release
@JCRnEDITORS
Music enhances lipid nanoparticle brain delivery and mRNA transfection in brain cells.
| Avi Schroeder @TechnionLive |
[Open Access]
#braindelivery #mrna #lipidnanoparticle
doi.org/10.1016/j.jconrel.2025.114301 -
J Controlled Release
@JCRnEDITORS
Remote loading of an autoantigen in PLGA nanoparticles for the treatment of multiple sclerosis.
| Steven P. Schwendeman @UMichPharmacy |
[50 days' free access]
#remoteloading #autoantigen #multiplesclerosis
authors.elsevier.com/a/1lyvRcI2-9mRP -
J Controlled Release
@JCRnEDITORS
Overcoming the mucus barrier: Optimization design of carriers to enhance mucus permeability, targeting, and responsiveness.
| Shaoping Nie @NCUniv1921 |
[50 days' free access]
#mucosaldelivery #mucus #permeability
authors.elsevier.com/a/1l~BRcI2-9mR~ -
J Controlled Release
@JCRnEDITORS
A multivalent nanoparticle vaccine elicits potent neutralizing antibody response against monkeypox virus.
| Yin-Feng Kang @smu_medical |
[50 days' free access]
#multivalantvaccine #monkeypoxvirus
authors.elsevier.com/a/1l~6bcI2-9mY2 -
J Controlled Release
@JCRnEDITORS
Hepatocyte-targeted lipid nanoparticle for full-length ATP7B mRNA delivery in Wilson disease
| Changyou Zhan @FudanUniversity |
[50 days' free access]
#mrnadelivery #lipidnanoparticle #wilsondisease
authors.elsevier.com/a/1lyyLcI2-9mSY -
J Controlled Release
@JCRnEDITORS
Dual-sensitization nanoformulation combining glutamine metabolism inhibition and Fas/FasL activation for enhanced colorectal cancer immunotherapy.
| Yaping Li @UCAS1978 |
[50 days' free access]
#nanocomplex #immunotherapy
authors.elsevier.com/a/1lyvRcI2-9mVb -
J Controlled Release
@JCRnEDITORS
Unlocking intracellular targets: Smart multistage-responsive polyionic vesicular platforms for advancing protein-based therapy.
| Qixian Chen @ZJU_China |
[50 days' free access]
#proteindelivery #phresponsive #stimuliresponsive
authors.elsevier.com/a/1lyU7cI2-9mUe -
J Controlled Release
@JCRnEDITORS
Peptide dendrimers: Novel therapeutic opportunities for peptide-based biomaterials in biomedicine.
| Anshan Shan, Northeast Agricultural Univ. |
[50 days' free access]
#peptide #dendrimer #biomaterial
authors.elsevier.com/a/1l~PccI2-9mVO -
J Controlled Release
@JCRnEDITORS
Improved biodistribution and antitumor effects of a Nectin4 and Trop2 bispecific fatty acid-modified nanobody conjugate.
| Dianwen Ju @FudanUniversity |
[50 days' free access]
#antibodydrugconjugate #fattyacid
authors.elsevier.com/a/1lyNjcI2-9mVn -
J Controlled Release
@JCRnEDITORS
Elastin-like peptides for efficient and safe delivery of mRNA.
| Jun Dai @2024_HUST |
[50 days' free access]
#mrnadelivery #elastin #peptide
authors.elsevier.com/a/1ly5rcI2-9mXg -
J Controlled Release reposted
CRS Korea Chapter
@KoreaCRS
Congrats to Gun-Ho Kim (@iUNIST) and @KoreaCRS for pioneering a cryogenic jet-based picoliter ice particle platform for transdermal extracellular vesicle delivery in skin disease treatment in @JCRnEDITORS.
#extracellularvesicle #transdermal
J Controlled Release
@JCRnEDITORS
Picoliter ice particles by supersonic cryogenic jets for transdermal drug delivery: Extracellular vesicle application for skin diseases.
| Gun-Ho Kim @iUNIST | @KoreaCRS
[Open Access]
#extracellularvesicle #transdermal
doi.org/10.1016/j.jconrel.2025.114184 -
J Controlled Release
@JCRnEDITORS
Claudin 5-binding small molecule transiently opens the blood-brain barrier and safely enhances brain drug delivery.
| Yoshiaki Okada @UOsaka_en |
[Open Access]
#bloodbrainbarrier #claudin
doi.org/10.1016/j.jconrel.2025.114314 -
J Controlled Release
@JCRnEDITORS
Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders.
| Marco Pravetoni @uwsomwwami |
[50 days' free access]
#vaccine #opioiddisorder
authors.elsevier.com/a/1lxz3cI2-9mQl -
J Controlled Release
@JCRnEDITORS
Cholesterol modulation in drug delivery systems and tumor therapy: Strategies and perspectives.
| Zhiping Zhang @2024_HUST |
[50 days' free access]
#cholesterol #drugdelivery
authors.elsevier.com/a/1ly5rcI2-9mUd -
J Controlled Release
@JCRnEDITORS
Engineering polyamidoamine dendrimer nanoparticles for targeted drug delivery to proximal tubular cells after renal ischemia/reperfusion injury.
| Leyuan Xu @YaleMed |
[50 days' free access]
#dendrimer #polyamidoamine
authors.elsevier.com/a/1ly7Q_3r0J7O39 -
J Controlled Release
@JCRnEDITORS
Smart biomaterials, gels, drug delivery and the giant.
| Sei Kwang Hahn, POSTECH |
[50 days' free access]
authors.elsevier.com/a/1lxz3cI2-9mRn -
J Controlled Release
@JCRnEDITORS
Surface-engineered robust hybrid lipid nanocapsules: A next-generation nanoplatform for mRNA delivery.
| Marcus T. Cicerone @GeorgiaTech |
[Oepn Access]
#lipidnanocapsule #mrnadelivery
doi.org/10.1016/j.jconrel.2025.114312 -
J Controlled Release
@JCRnEDITORS
A ratiometric theranostic nanoplatform with acid-triggered drug release and glutathione-activated fluorescence turn-on.
| Hélder A. Santos @univgroningen | @heldertsantos @CRSBeNeLuxFr
[Open Access]
#theranostic #ratiometric
doi.org/10.1016/j.jconrel.2025.114309 -
J Controlled Release
@JCRnEDITORS
Transdermal hydrogen therapy for psoriasis using cavity-embedded double-conical microneedles.
| Peng Chen @NTUsg |
[50 days' free access]
#microneedle #hydrogel #hydrogentherapy #psoriasis
authors.elsevier.com/a/1lxnVcI2-9mTz -
J Controlled Release
@JCRnEDITORS
Ultra-high concentration low-viscosity subcutaneous antibody formulations using ionic liquids.
| Samir Mitragotri @hseas | @SMitragotri
[50 days' free access]
#ionicliquid #formulation #viscosity
authors.elsevier.com/a/1lxelcI2-9mQx -
J Controlled Release
@JCRnEDITORS
Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density.
| Xing Tang, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#peptidedelivery #semaglutide #liganddensity
authors.elsevier.com/a/1lxZ~cI2-9mUR -
J Controlled Release
@JCRnEDITORS
Polyphosphocholination of liposomic vehicles extends blood circulation, enhances cellular uptake, and lowers immunogenicity relative to PEGylation.
| Jacob Klein @WeizmannScience |
[Open Access]
#pegylation #liposome #immunogenicity
doi.org/10.1016/j.jconrel.2025.114306 -
J Controlled Release
@JCRnEDITORS
Engineered lesion-homing liposomes encapsulating Rosuvastatin enhance spinal cord injury repair by preventing the formation of foamy macrophages.
| Chunyue Duan @CentralSouth_U |
[50 days' free access]
#liposome #spinalcordinjury
authors.elsevier.com/a/1lxZ~cI2-9mT0 -
J Controlled Release
@JCRnEDITORS
Encapsulated cells as an enzyme replacement therapy for metachromatic leukodystrophy.
| Françoise Piguet @Sorbonne_Univ_ | @CRSBeNeLuxFr
[50 days' free access]
#cellencapsulation #implant
authors.elsevier.com/a/1lxVNcI2-9mSq -
J Controlled Release
@JCRnEDITORS
A safe saponin-based nano-strategy for manganese-mediated STING activation.
| Yingpeng Li, Tianjin Univ. of Traditional Chinese Medicine |
[50 days' free access]
#saponin #metalloimmunotherapy
authors.elsevier.com/a/1lx9McI2-9mSA -
J Controlled Release
@JCRnEDITORS
Targeting post-extraction complications with functional hydrogels: Mechanistic insights, translational strategies, and clinical prospects.
| Yang Wu @WHU_1893 |
[50 days' free access]
#hydrogel #osteogenesis
authors.elsevier.com/a/1lwx6cI2-9mSM -
J Controlled Release
@JCRnEDITORS
Radiation-responsive Salmonella mediate therapeutics precise delivery for synergistic tumor radio-immunotherapy.
| Kai Yang, Soochow Univ. |
[50 days' free access]
#proteindelivery #radiationresponsive #radioimmunotherapy
authors.elsevier.com/a/1lwx6cI2-9mQY -
J Controlled Release
@JCRnEDITORS
Microorganism delivery of cancer vaccines.
| Yang Xi, Zhejiang Chinese Medical Univ. |
[50 days' free access]
#cancervaccine #viruslikeparticle
authors.elsevier.com/a/1lwx6cI2-9mPo -
J Controlled Release
@JCRnEDITORS
Pulmonary inhaled drug delivery systems: From bench to bedside.
| Wei He @TJU_China |
[50 days' free access]
#inhalation #pulmonarydelivery
authors.elsevier.com/a/1lwGecI2-9mR7 -
J Controlled Release
@JCRnEDITORS
Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drug.
| Paul Joyce @UniversitySA |
[Open Access]
#lungdelivery #helperlipid
doi.org/10.1016/j.jconrel.2025.114299 -
J Controlled Release
@JCRnEDITORS
Control of pharmacokinetics of radioimmunoconjugates using chelating agents containing poly(ethylene glycol).
| Masahiro Ono @KyotoU_News |
[50 days' free access]
#radioimmunoconjugate #pharmacokinetics
authors.elsevier.com/a/1lwBL_3r0J7O2g -
J Controlled Release
@JCRnEDITORS
Lipid and polymeric nanocarrier for siRNA delivery to the brain.
| Kun Cheng @UMKC |
[50 days' free access]
#sirnadelivery #lipidnanocarrier #polymericnanocarrier
authors.elsevier.com/a/1lvzvcI2-9mPZ -
J Controlled Release
@JCRnEDITORS
Targeting polyamine metabolism induces oxidative/carbonyl stress to reinvigorate antitumor immunity in prostate cancer.
| Nengwang Yu @ShandongU |
[Open Access]
#polyamine #metabolism #prostatecancer
doi.org/10.1016/j.jconrel.2025.114283 -
J Controlled Release
@JCRnEDITORS
Biomimetic immortalized mesenchymal stem cell-based nanoparticles suppress orthotopic postsurgical glioma via CD73 targeting and chemotherapy.
| Yunxiang Ji, Guangzhou Medical Univ. |
[50 days' free access]
#stemcell #nanoparticle #glioma
authors.elsevier.com/a/1lvfScI2-9mRD -
J Controlled Release
@JCRnEDITORS
doi.org/10.1016/j.jconrel.2025.114309
Santos' Lab
@SantosLab_UMCG
📢New publication out🚀@JCRnEDITORS @CRSScience “A ratiometric theranostic nanoplatform with acid-triggered drug release and glutathione-activated fluorescence turn-on”
👉 doi.org/10.1016/j.jconrel.2025.114309
Great collaboration across 🇲🇽🇳🇱teams🥳👏
#nanomedicine #theranostics #drugdelivery -
J Controlled Release
@JCRnEDITORS
Fibrotic collagen-targeted delivery system blocks pancreatic intercellular crosstalk to alleviate pancreatic fibrosis.
| Hu-Lin Jiang, China Pharmaceutical Univ. |
[50 days' free access]
#collagendelivery #pancreaticfibrosis
authors.elsevier.com/a/1lvOTcI2-9mOE -
J Controlled Release
@JCRnEDITORS
In situ enrichment and delivery of STING agonists by protamine-modified Salmonella for cancer immunotherapy.
| Jinhui Wu @NanjingUnivers1 |
[Open Access]
#salmonella #immunotherapy
doi.org/10.1016/j.jconrel.2025.114284 -
J Controlled Release
@JCRnEDITORS
Nanoparticle-driven reactive oxygen species therapy: A new frontier in osteosarcoma treatment.
| Sabine van Rijt @MERLN_UM | @CRSBeNeLuxFr
[Open Access]
#reactiveoxygenspecies
doi.org/10.1016/j.jconrel.2025.114289 -
J Controlled Release
@JCRnEDITORS
Multifunctional self-healing hydrogels for chronic wound repair: Design, mechanisms, and applications.
| Ping Hu @jnu1906 |
[50 days' free access]
#hydrogel #woundrepair
authors.elsevier.com/a/1lvEEcI2-9mO~ -
J Controlled Release
@JCRnEDITORS
Engineered tumor-symbiotic bacterial membrane nanovesicles enable precise immuno-chemotherapy of colorectal cancer.
| Huanlong Qin @Tongji_Uni |
[50 days' free access]
#nanovesicle #bacterialmembrane
authors.elsevier.com/a/1lv7lcI2-9mQM -
J Controlled Release
@JCRnEDITORS
Copper ionophore-autophagy interference nanoregulators for tumor self-defense reprograming to amplify cuproptotic stress and antitumor immunity.
| Meiwan Chen @UM_1981 |
[50 days' free access]
#cuproptosis #autophagy
authors.elsevier.com/a/1lv2gcI2-9mLa -
J Controlled Release
@JCRnEDITORS
Ultrasound-activatable nanovaccines amplify dual-modal ROS for cancer sono-immunotherapy.
| Kun Shao @DutOfficial |
[50 days' free access]
#nanovaccine #ultrasound
authors.elsevier.com/a/1lv2gcI2-9mPN -
J Controlled Release
@JCRnEDITORS
Tailored mechano-responsive micelles mimic the iron starvation response and impair pH homeostasis for triggered cancer therapy.
| Yanjun Zhao @TJU1895 |
[50 days' free access]
#mechanoresponsive #micelle
authors.elsevier.com/a/1luxKcI2-9mOQ -
J Controlled Release
@JCRnEDITORS
Development of a dissolving microneedle patch for transdermal delivery of SARS-CoV-2 mRNA vaccine with enhanced stability and immunogenicity.
| Teng Shen @FudanUniversity |
[50 days' free access]
#transdermaldelivery #mrnavaccine #microneedle
authors.elsevier.com/a/1luf8cI2-9mLm -
J Controlled Release
@JCRnEDITORS
Multi-interfacial microbubbles controlled sequential cavitation for synergistic vascular destruction/chemotherapeutic therapy.
| Fang Yang, Southeast Univ. |
[50 days' free access]
#microbubble #cavitation
authors.elsevier.com/a/1luf8cI2-9mPn -
J Controlled Release
@JCRnEDITORS
Glycoliposomes target lymphatic dendritic cells in a size-dependent manner to activate natural killer T cells against breast tumors.
| Horacio Cabral @UTokyo_News_en |
[Open Access]
#glycoliposome #dendriticcell
doi.org/10.1016/j.jconrel.2025.114274 -
J Controlled Release
@JCRnEDITORS
Nanoparticles across mucosal barriers: Differentiating mucoadhesion from mucopenetration using single particle tracking.
| Anja Boisen @DTUtweet |
[Open Access]
#mucosaldelivery #mucoadhesion #mucopenetration
doi.org/10.1016/j.jconrel.2025.114268 -
J Controlled Release
@JCRnEDITORS
Progress towards a prodrug/enzyme intranasal delivery system for rapid prevention/reversal of seizure emergency.
| Ronald A. Siegel @UMN_Pharmacy |
[50 days' free access]
#nasaldelivery #prodrug #seizure
authors.elsevier.com/a/1ltpDcI2-9mJm -
J Controlled Release
@JCRnEDITORS
Novel design of 3D printed tumbling microrobots for in vivo targeted drug delivery.
| David J. Cappelleri @PurdueME |
[50 days' free access]
#3dprinting #microrobot
authors.elsevier.com/a/1ltTocI2-9mNB -
J Controlled Release
@JCRnEDITORS
Interstitial drug delivery system: Physiological basis and (pre)clinical progress.
| Wufa Fan, Peking Union Medical College |
[50 days' free access]
#mrnavaccine #lymphnode
authors.elsevier.com/a/1ltQecI2-9mNm -
J Controlled Release
@JCRnEDITORS
Highly adhesive asynchronous drug-releasing membrane for facial care: Combined anti-acne and anti-inflammatory properties.
| Wenliang Song, Univ. of Shanghai for Science and Technology |
[50 days' free access]
#electrospinning #nanofiber #acne
authors.elsevier.com/a/1ltQecI2-9mLN -
J Controlled Release
@JCRnEDITORS
Natural biomaterials for contact lens-based ophthalmic drug delivery systems.
| Waree Tiyaboonchai @Naresuan_NU |
[50 days' free access]
#oculardelivery #contactlens #biomaterial
authors.elsevier.com/a/1liGccI2-9m7T -
J Controlled Release
@JCRnEDITORS
In situ formed chemo-immunotherapeutic hydrogel for suppression of postoperative glioma recurrence and intraoperative hemostasis.
| Qian Chen, Soochow Univ. |
[50 days' free access]
#fibringel #postoperative #glioma
authors.elsevier.com/a/1lii7cI2-9m6v -
J Controlled Release
@JCRnEDITORS
ApoE-Corona oncolytic adenovirus nanoparticles enable blood–brain barrier penetration for glioblastoma immunotherapy.
| Xiaozhou Mou, Hangzhou Medical College |
[50 days' free access]
#adenovirus #bloodbrainbarrier
authors.elsevier.com/a/1lqX0cI2-9mKX -
J Controlled Release
@JCRnEDITORS
Harnessing engineered adaptive nanoparticles to modulate macrophages for treating corneal alkali burns.
| Yi Shi @UESTC1956 |
[Open Access]
#nanoparticle #macrophage #cornealburn
authors.elsevier.com/a/1lqMP_3r0J7O21 -
J Controlled Release
@JCRnEDITORS
Understanding the kinetics of macrophage uptake and the metabolic fate of iron-carbohydrate complexes used for iron deficiency anemia treatment.
| Vanesa Ayala-Nunez @Empa_CH |
[Open Access]
#ironcarbohydratecomplex #anemia
doi.org/10.1016/j.jconrel.2025.114186 -
J Controlled Release
@JCRnEDITORS
Nanotechnology-based approaches to tackle bacterial infections.
| Ivana d'Angelo @unicampania | @CRS_Italia
[Open Access]
#nanotechnology #infection
doi.org/10.1016/j.jconrel.2025.114204 -
J Controlled Release
@JCRnEDITORS
Spatially-offset Raman spectroscopy for the non-invasive, real-time characterization of in situ skin implant formation and drug release kinetics.
| Andrea Heinz @uni_copenhagen |
[Open Access]
#implant #kinetics #ramanspectroscopy
doi.org/10.1016/j.jconrel.2025.114182 -
J Controlled Release
@JCRnEDITORS
Lipid nanoparticle mediated delivery of dsDNA to the murine retina.
| Renee C. Ryals @OHSUNews |
[Open Access]
#oculardelivery #lipidnanoparticle
doi.org/10.1016/j.jconrel.2025.114194 -
J Controlled Release
@JCRnEDITORS
Multiphysics modelling enhanced by imaging and artificial intelligence for personalised cancer nanomedicine: Foundations for clinical digital twins.
| Wenbo Zhan @aberdeenuni | @UKICRS
[Open Access]
#artificialintelligence #modeling #digitaltwin
doi.org/10.1016/j.jconrel.2025.114138 -
J Controlled Release
@JCRnEDITORS
Picoliter ice particles by supersonic cryogenic jets for transdermal drug delivery: Extracellular vesicle application for skin diseases.
| Gun-Ho Kim @iUNIST | @KoreaCRS
[Open Access]
#extracellularvesicle #transdermal
doi.org/10.1016/j.jconrel.2025.114184 -
J Controlled Release
@JCRnEDITORS
Raman spectroscopy as a tool to accelerate development of complex medicinal products.
| Richard H. Guy @lifesciencebath | @UKICRS
[Open Access]
#ramanspectroscopy #topicaldelivery #bioequivalence #regulatoryscience
doi.org/10.1016/j.jconrel.2025.114190 -
J Controlled Release
@JCRnEDITORS
Hydrogel-mediated delivery of chemotherapeutic agents to the brain after tumour resection.
| Wenbo Zhan @aberdeenuni | @UKICRS
{Open Access]
#braindelivery #hydrogel
doi.org/10.1016/j.jconrel.2025.114158 -
J Controlled Release
@JCRnEDITORS
Photochemical internalization with verteporfin-liposomes enhances oxaliplatin retention and efficacy in models of pancreatic cancer.
| Mans Broekgaarden @UGrenobleAlpes | @CRSBeNeLuxFr
[Open Access]
#liposome #photodynamic #lysosomalrelease
doi.org/10.1016/j.jconrel.2025.114201 -
J Controlled Release
@JCRnEDITORS
Encapsulation-enhanced switchable protein release from engineered probiotic lactobacilli.
| Shrikrishnan Sankaran @Saar_Uni | @CRS_DeChAt_LC
[50 days' free access]
#proteindelivery #encapsulation #probiotic
authors.elsevier.com/a/1ltLTcI2-9mLy -
J Controlled Release
@JCRnEDITORS
Engineering unnatural amino acids in peptide linkers enables cathepsin-selective antibody-drug conjugates for HER2-positive breast cancer.
| Marcin Poręba, Wroclaw Univ. of Science and Technology |
[Open Access]
#antibodydrugconjugate #peptidelinker
doi.org/10.1016/j.jconrel.2025.114269 -
J Controlled Release
@JCRnEDITORS
CTLA-4 nanovesicles disrupt dendritic cell-driven CD8 T cell priming for myocardial infarction therapy.
| Weiqian Chen, Soochow Univ. |
[50 days' free access]
#nanovesicle #myocardialinfarction
authors.elsevier.com/a/1lt15cI2-9mOD -
J Controlled Release
@JCRnEDITORS
Generation of a perfusable three-dimensional human neurovascular chip to model brain drug delivery and immune cell extravasation.
| Massimiliano Caiazzo @UUUIPS | @CRSBeNeLuxFr
[Open Access]
#bloodbrainbarrier #organonchip #nanobody #transcytosis
doi.org/10.1016/j.jconrel.2025.114257 -
J Controlled Release
@JCRnEDITORS
mRNA-LNP hydrogels promote skeletal muscle regeneration in situ.
| Bin Li @jnu1906 |
[50 days' free access]
#hydrogel #lipidnanoparticle #muscleregeneration
authors.elsevier.com/a/1lsQhcI2-9mK- -
J Controlled Release
@JCRnEDITORS
Hydroxychloroquine-functionalized ionizable lipids mitigate inflammatory responses in mRNA therapeutics.
| Jinzhong Lin @FudanUniversity |
[50 days' free access]
#mrnadelivery #ionizablelipid
authors.elsevier.com/a/1lsQh_3r0J7O2F -
J Controlled Release
@JCRnEDITORS
Overcoming cold chain challenges: Cryoprotection of self-amplifying mRNA polyplexes for long-term storage at ambient temperature.
| Niek Sanders @ugent |
[50 days' free access]
#mrnadelivery #polyplex #cryoprotection
authors.elsevier.com/a/1lsQhcI2-9mLB -
J Controlled Release
@JCRnEDITORS
Extracellular vesicles from hypoxia preconditioned bone marrow mesenchymal stem cell improve peri-implant osteogenesis under type 2 diabetes condition.
| Chun Xu @sjtu1896 |
[50 days' free access]
#implant #extracellularvesicle
authors.elsevier.com/a/1lsOAcI2-9mNy -
J Controlled Release
@JCRnEDITORS
Dual-responsive engineered bacteria with spatiotemporal controlled release of Cytolysin-A for oral management of colorectal cancer.
| Lei Ren @xmuchina |
[50 days' free access]
#engineeredbacteria
authors.elsevier.com/a/1lsJgcI2-9mM8 -
J Controlled Release
@JCRnEDITORS
FormulationMM: A universal computer-driven drug formulation platform.
| Defang Ouyang @UM_1981 |
[50 days' free access]
#formulation #molecularmodeling
authors.elsevier.com/a/1lrZgcI2-9mHh -
J Controlled Release
@JCRnEDITORS
Lipid nanomedicine simultaneously inhibits BRD4/PI3K and MDM2/XIAP signaling pathways for effective treatment of Medulloblastoma.
| Ram I. Mahato @unmc |
[50 days' free access]
#bloodbrainbarrier #lipidnanoparticle
authors.elsevier.com/a/1lrZgcI2-9mMK -
J Controlled Release
@JCRnEDITORS
Horizontal blocking of metastatic growth factors signaling by low molecular weight heparin derivative to control ovarian cancer progression.
| Taslim A. Al-Hilal @PHCEUutah |
[Open Access]
#heparinconjugate #ovariancancer
doi.org/10.1016/j.jconrel.2025.114273 -
J Controlled Release
@JCRnEDITORS
Enzyme-responsive oleoylethanolamide-releasing nanomedicine for sustained liver delivery and therapeutic improvement in early-stage metabolic dysfunction-accosicated steatohepatitis.
| Yukio Nagasaki @UNIV_TSUKUBA_EN |
[50 days' free access]
authors.elsevier.com/a/1lrCPcI2-9mKj -
J Controlled Release
@JCRnEDITORS
Ultraviolet-tyrosinase cascade caged antisense oligonucleotide for precise treatment of hyperpigmentation.
| Kai Lu, Southeast Univ. |
[50 days' free access]
#antisensedelivery #microneedle #hyperpigmentation
authors.elsevier.com/a/1lrBJcI2-9mH6 -
J Controlled Release
@JCRnEDITORS
Enhanced safety and potency in local angiogenic growth factor delivery via aptamer functionalization of hydrogels.
| Yong Wang @PennStateBME |
[50 days' free access]
#aptamer #hydrogel #growthfactor
authors.elsevier.com/a/1lrA5cI2-9mJy -
J Controlled Release
@JCRnEDITORS
Acyl-CoA synthetase long-chain family member 4 (ACSL4)-targeting fluorescent probes for precision intraoperative visualization of hepatocellular carcinoma.
| Xiaoying Wang @FudanUniversity |
[Open Access]
#fluorescentprobe #phagedisplay
authors.elsevier.com/a/1llK1cI2-9m5s -
J Controlled Release
@JCRnEDITORS
Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.
| Helena F. Florindo @facfarmaciaUL |
[Open Access]
#nanovaccine #neoantigen
doi.org/10.1016/j.jconrel.2025.114178 -
J Controlled Release
@JCRnEDITORS
Polymer-based chemo-immunotherapy: Combining immunogenic cell death induction and PD-L1 blockade enhances antitumor immunity in melanoma.
| Jiyuan Yang @PHCEUutah |
[Open Access]
#polymerdrugconjugate
doi.org/10.1016/j.jconrel.2025.114193 -
J Controlled Release
@JCRnEDITORS
Immunomodulatory microbubbles targeting integrin αvβ3 in combination with immunotherapy for the theranostic of anaplastic thyroid cancer in mice.
| Zhang Bo, China-Japan Friendship Hospital |
[50 days' free access[
#microbubble #theranostic
authors.elsevier.com/a/1lm4XcI2-9mAG -
J Controlled Release
@JCRnEDITORS
Novel TNF-α-targeting mRNA therapy for sustained psoriasis treatment and relapse prevention by suppressing IL-15-TRM signaling.
| Yuan He, China Pharmaceutical Univ. |
[50 days' free access]
#mrnadelivery #psoriasis
authors.elsevier.com/a/1lmAmcI2-9mEk -
J Controlled Release
@JCRnEDITORS
MiR-29a-loaded nanoparticles alleviate inflammatory bowel disease via Sgk1/Foxo3a axis.
| Shilong Wang @Tongji_Uni |
[50 days' free access]
#mirnadelivery #inflammatoryboweldisease
authors.elsevier.com/a/1lhQLcI2-9m82 -
J Controlled Release
@JCRnEDITORS
An Escherichia coli Nissle 1917-based live therapeutics platform with integrated phage resistance and programmable temperature sensitivity.
| Feng-Qing Wang, East China Univ. of Science and Technology |
[50 days' free access]
#livetherapeutics
authors.elsevier.com/a/1ljLvcI2-9mA4 -
J Controlled Release
@JCRnEDITORS
Antibacterial hyaluronic acid hydrogel with sustained release of larazotide as effective colitis treatment.
| Helin Xu @WMU1958 |
[50 days' free access]
#hydrogel #hyaluronicacid #colitis
authors.elsevier.com/a/1lk2e_3r0J7O1H -
J Controlled Release
@JCRnEDITORS
Ultra-long-acting injectable, biodegradable, and removable in-situ forming implant with cabotegravir for HIV prevention.
| S. Rahima Benhabbour @DPMP_UNC |
[50 days' free access]
#longacting #implant #insituforming
authors.elsevier.com/a/1lilJcI2-9m6d -
J Controlled Release
@JCRnEDITORS
Computation-aided design of rod-shaped nanoparticles for tumoral targeting.
| Yupeng Chen @UConn |
[50 days' free access]
#nanoparticle #computationaideddesign #rodshape
authors.elsevier.com/a/1lkm9cI2-9m75 -
J Controlled Release
@JCRnEDITORS
DNA nanostructures with 1D, 2D and 3D for intelligent drug delivery.
| Xing Guo @swjtu1896 |
[50 days' free access]
#dnananostructure #dnaorigami
authors.elsevier.com/a/1ljlZcI2-9m9f -
J Controlled Release
@JCRnEDITORS
Pulmonary delivery of small circular RNA vaccines for influenza prevention.
| Guizhi Zhu @UMichPharmacy |
[50 days' free access]
#circularrna #vaccine #lungdelivery
authors.elsevier.com/a/1llQacI2-9mBh -
J Controlled Release
@JCRnEDITORS
Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention.
| Changyou Zhan @FudanUniversity
[50 days' free access]
#endothelialcell #mrnadelivery #lipidnanoparticle
authors.elsevier.com/a/1llx9cI2-9m3a -
J Controlled Release
@JCRnEDITORS
Effects of nanoparticle physicochemical properties on macrophage polarization.
| Zifu Li @2024_HUST |
[50 days' free access]
#nanoparticlesize #stiffness #macrophage
authors.elsevier.com/a/1lm1TcI2-9mEG -
J Controlled Release
@JCRnEDITORS
Design of cathepsin-sensitive linkers for tumor-selective bioconjugate drug delivery.
| Simmyung Yook @skku_1398 | @KoreaCRS
[50 days' free access]
#bioconjugate #peptidelinker
authors.elsevier.com/a/1llN8cI2-9mBQ -
J Controlled Release
@JCRnEDITORS
Injectable self-expanding short-fiber scaffold reduces endometrial hyperplasia.
| Bufang Xu @sjtu1896 |
[50 days' free access]
#scaffold #hyperplasia
authors.elsevier.com/a/1lhbNcI2-9m7f -
J Controlled Release
@JCRnEDITORS
Nano-enabled repurposing of benproperine phosphate enhances pancreatic cancer chemotherapy through lethal autophagy arrest and immune activation.
| Qi Zhang @ZJU_China |
[50 days' free access]
#drugrepurposing #autophagy #benproperine
authors.elsevier.com/a/1ljHqcI2-9m9s -
J Controlled Release
@JCRnEDITORS
Outer membrane vesicle–coated ferrocene nanoparticles induce dual ferroptosis for cancer immunotherapy.
| Qi Shen @sjtu1896 |
[50 days' free access]
#ferroptosis #membranevesicle
authors.elsevier.com/a/1lknJcI2-9mCS -
J Controlled Release
@JCRnEDITORS
Targeting HMGB1 modulates cancer-associated fibroblasts and enhances radiotherapy in lung adenocarcinoma.
| Ni Chen, Anhui Medical Univ. |
[50 days' free access]
#cancerassociatedfibroblast #radiotherapy
authors.elsevier.com/a/1ll3hcI2-9mBt -
J Controlled Release
@JCRnEDITORS
Injectable PROTAC-loaded hydrogel remodels the tumor microenvironment to potentiate radio-immunotherapy.
| Laisheng Li @sysu_1924 |
[50 days' free access]
#hydrogel #radioimmunotherapy
authors.elsevier.com/a/1llC1cI2-9mBu -
J Controlled Release
@JCRnEDITORS
Disruption of mitochondrial homeostasis by bimetallic ca/cu nanocomposites against hepatocellular carcinoma.
| Xiaobo Wang, Guangxi Medical Univ. |
[50 days' free access]
#biometallic #mitochondria
authors.elsevier.com/a/1lqCjcI2-9mIv -
J Controlled Release
@JCRnEDITORS
Probiotic encapsulation strategies for controlled intestinal delivery and microbiome dysbiosis therapy.
| Ying Shi @ZJU_China |
[50 days' free access]
#intestinaldelivery #probiotic #encapsulation
authors.elsevier.com/a/1lqCjcI2-9mK8 -
J Controlled Release
@JCRnEDITORS
An ionic liquid nanoemulsion transdermal delivery system for targeted melanoma therapy.
| Jiaheng Zhang @HIT_China |
[50 days' free access]
#nanoemulsion #ionicliquid #melanoma
authors.elsevier.com/a/1lps5cI2-9mIj -
J Controlled Release
@JCRnEDITORS
Synergistic enhancement of anti-migraine efficacy through supramolecular self-assembly of tizanidine with meloxicam.
| Hongxun Hao @TJU1895 |
[50 days' free access]
#selfassembly #migraine
authors.elsevier.com/a/1lps5cI2-9mJO -
J Controlled Release
@JCRnEDITORS
Ileum targeted semaglutide delivery and pharmacokinetic study in an experimental porcine animal model via oesophagogastroduodenoscopic administration.
| Florian Föger, CYPRUMED GmbH |
[50 days' free access]
#oraldelivery #ileum #pharmacokinetic
authors.elsevier.com/a/1lhYe_3r0J7O0e -
J Controlled Release
@JCRnEDITORS
Factors affecting drug delivery system translation: A focus on advanced technologies, biological barriers, and regulatory challenges.
| Wei He @Tongji_Uni |
[50 days' free access]
#nanomedicine #regulation #manufacturing #organonchip
authors.elsevier.com/a/1lhQLcI2-9m6p -
J Controlled Release
@JCRnEDITORS
Balloon-like polymersomes with tunable charged and burstable interfaces for controlled drug delivery.
| Mingming Ding @SCUCN |
[50 days' free access]
#polymersome #copolymer #endocytosis
authors.elsevier.com/a/1lmn9cI2-9mGF -
J Controlled Release
@JCRnEDITORS
Adipocyte-selective mRNA lipid nanoparticles for cell programming with machine learning analysis.
| Hai-Quan Mao @JHUBME |
[50 days' free access]
#mrnadelivery #adipocyte #lipidnanoparticle
authors.elsevier.com/a/1lizPcI2-9m8Q -
J Controlled Release
@JCRnEDITORS
Are lateral lipid-phase diffusion coefficients pertinent to dermal absorption?
| Johannes M. Nitsche @ubcbe11 |
[50 days' free access]
#dermalabsorption #diffusion
authors.elsevier.com/a/1liUWcI2-9lAR -
J Controlled Release
@JCRnEDITORS
Hierarchical ROS-scavenging platform breaks vicious cycle of stem cell senescence, angiogenesis arrest, and immune dysregulation in diabetic wounds.
| Peng Li @NPUintl |
[50 days' free access]
#reactiveoxygenspecies #senescence #diabeticwound
authors.elsevier.com/a/1lps5cI2-9mJI -
J Controlled Release
@JCRnEDITORS
Oral multifunctional gel beads for the targeted treatment of inflammatory bowel disease.
| Shuyu Xie @HZAU_China |
[50 days' free access]
#oraldelivery #gelbead #hydrogel
authors.elsevier.com/a/1lppocI2-9mI9 -
J Controlled Release
@JCRnEDITORS
Safety and efficacy of KRAS antisense oligonucleotides and RIG-I agonists delivered by extracellular vesicles for pancreatic cancer peritoneal metastasis treatment.
| Minh T.N. Le @NUSingapore |
[Open Access]
#antisense #extracellularvesicle
doi.org/10.1016/j.jconrel.2025.114239 -
J Controlled Release
@JCRnEDITORS
SitoC7A-modified lipid nanoparticles for integrated mRNA delivery and targeted STING activation.
| Xiangrong Song @SCUCN |
[50 days' free access]
#mrnadelivery #lipidnanoparticle
authors.elsevier.com/a/1lpk0cI2-9mHy -
J Controlled Release
@JCRnEDITORS
Fluorinated albumin nanocages dually target CAFs and tumor cells to potentiate bladder cancer chemoimmunotherapy.
| Tao Yang, Soochow Univ. |
[50 days' free access]
#mucosaldelivery #albuminnanoparticle
authors.elsevier.com/a/1lphYcI2-9mJ6 -
J Controlled Release
@JCRnEDITORS
Organoids as predictive platforms: advancing disease modeling, therapeutic innovation, and drug delivery systems.
| Qiong Bian, Hangzhou Medical College |
[50 days' free access]
#organoid #modeling
authors.elsevier.com/a/1lmyZ_3r0J7O1Y -
J Controlled Release
@JCRnEDITORS
Nanodrug-based therapeutic interventions for tumor-associated microbiota modulation.
| Jing Yao, China Pharmaceutical Univ. |
[50 days' free access]
#tumormicroenvironment #microbiota
authors.elsevier.com/a/1lnBtcI2-9mBP -
J Controlled Release
@JCRnEDITORS
A general nanoplatform for nucleotide drug delivery: From molecular binding to antiviral therapy.
| Mingzhou Ye @USTCGlobal |
[50 days' free access]
#nucleotidedelivery #antiviral
authors.elsevier.com/a/1lpezcI2-9mIw -
J Controlled Release
@JCRnEDITORS
Antisense oligonucleotide-loaded nanozyme reverses tumor immune suppression through sonogenetic metabolic therapy.
| Haohao Yin @FudanUniversity |
[50 days' free access]
#antisense #nanozyme
authors.elsevier.com/a/1lpeT_3r0J7O1m -
J Controlled Release
@JCRnEDITORS
Biodegradable nanofibrous scaffolds enhance standard of care for glioblastoma via localized targeted therapy.
| Kristy M. Ainslie @DPMP_UNC |
[50 days' free access]
#scaffold #nanofiber #glioblastoma
authors.elsevier.com/sd/article/S0168-3659(25)00837-5 -
J Controlled Release
@JCRnEDITORS
Intravenous lipid-siRNA conjugate mediates gene silencing at the blood-brain barrier and blood-CSF barrier.
| Ethan S. Lippmann @VandyBME |
[50 days' free access]
#sirnadelivery #bloodbrainbarrier
authors.elsevier.com/a/1lnPEcI2-9mG3 -
J Controlled Release
@JCRnEDITORS
Bilayer self-assembly encapsulated by engineered vesicle disrupts glutathione to induce disulfidptosis-enhanced cuproptosis for tumor immunotherapy.
| Dawei Deng, China Pharmaceutical Univ. |
[50 days' free access]
#selfassembly #cuproptosis #immunotherapy
authors.elsevier.com/a/1lnVLcI2-9mGw -
J Controlled Release
@JCRnEDITORS
In situ forming silk fibroin hydrogel dressing accelerates acute wound healing via immunomodulation and extracellular matrix regeneration.
| Yulin Liu, Peking Union Medical College |
[50 days' free access]
#hydrogel #fibroin #insitugel #wouldhealing
authors.elsevier.com/a/1lnVLcI2-9mGL -
J Controlled Release
@JCRnEDITORS
Self-immolative fluorinated nanotheranostics amplifying 19F MRI signals for tumor-specific imaging and photodynamic therapy.
| Zhong Cao @sysu_1924 |
[50 days' free access]
#nanotheranostic #photodynamic #imaging
authors.elsevier.com/a/1lnVLcI2-9mEe -
J Controlled Release
@JCRnEDITORS
Alkaline phosphatase-responsive hydrogel for efficient management of autoimmune intraocular inflammation.
| Jianhong Zhou @WMU1958 |
[50 days' free access]
#hydrogel #intraocular
authors.elsevier.com/a/1lnVLcI2-9mGX -
J Controlled Release
@JCRnEDITORS
Bilayer nanofiber-coated stent integrating internal radiation and spatiotemporal IL-12 release promotes antitumor immune response.
| Hai-Dong Zhu, Southeast Univ. |
[50 days' free access]
#nanofiber #stent #radiotherapy
authors.elsevier.com/a/1lngGcI2-9mGk -
J Controlled Release
@JCRnEDITORS
Round window membrane extracellular vesicles facilitate inner ear drug delivery.
| A. Moatti @Pitt_OTOHNS |
[Open Access]
#extracellularvesicle #eardelivery
doi.org/10.1016/j.jconrel.2025.114153 -
J Controlled Release
@JCRnEDITORS
Mucosal and transdermal delivery strategies for mRNA: Transforming the clinical applications.
| Hongzhang Deng @XDUofChina |
[50 days' free access]
#mrnadelivery #transdermal #mucosal
authors.elsevier.com/a/1lnj0cI2-9mFI -
J Controlled Release
@JCRnEDITORS
Neutrophil extracellular traps: Formation, pathological roles, and nanoparticle-based therapeutic targeting strategies.
| Vladimir Torchilin @Northeastern |
[Open Access]
#neutrophilextracellulartrap #netosis
doi.org/10.1016/j.jconrel.2025.114220 -
J Controlled Release
@JCRnEDITORS
Sono-triggered nanoamplifier mediates ferroptosis-immune regulation against bacterial pneumonia.
| Xin Pang, Henan Univ. of Chinese Medicine |
[50 days' free access]
#sonosensitizer #ferroptosis
authors.elsevier.com/a/1lnm2cI2-9mHI -
J Controlled Release
@JCRnEDITORS
Dual STING activation and CD47/SIRPα blockade via chitooligosaccharide-based nanoparticles to amplify antitumor immunity.
| Chao Wang, Soochow Univ. |
[50 days' free access]
#chitooligosaccharide #nanoparticle #reactiveoxygenspecies
authors.elsevier.com/a/1lnxZcI2-9mHU -
J Controlled Release
@JCRnEDITORS
The JCR Best Award webinar has been cancelled. A new date will be announced once rescheduled. @CRS_DeChAt_LC @AustralianCRS @CRSBeNeLuxFr @CrsIndian @CRS_Italia @KoreaCRS @CRSMalaysia @CRSNordicLocal @nz_crs @CRS_Turkey @CRS_TW_Local @UKICRS @CRS_SPLC @brazilCRS
J Controlled Release
@JCRnEDITORS
2 days left: JCR Best Paper Award 2025 Webinar!
Zoom link : skku-edu.zoom.us/j/83336549003?pwd=PWahuaURx30RriW1jwfs8E…
@CRS_DeChAt_LC @AustralianCRS @CRSBeNeLuxFr @CrsIndian @CRS_Italia @KoreaCRS @CRSMalaysia @nz_crs @CRS_Turkey @CRS_TW_Local @UKICRS @CRS_SPLC @brazilCRS -
J Controlled Release
@JCRnEDITORS
2 days left: JCR Best Paper Award 2025 Webinar!
Zoom link : skku-edu.zoom.us/j/83336549003?pwd=PWahuaURx30RriW1jwfs8E…
@CRS_DeChAt_LC @AustralianCRS @CRSBeNeLuxFr @CrsIndian @CRS_Italia @KoreaCRS @CRSMalaysia @nz_crs @CRS_Turkey @CRS_TW_Local @UKICRS @CRS_SPLC @brazilCRS -
J Controlled Release
@JCRnEDITORS
Hydrodynamic focusing to synthesize lipid-based nanoparticles: Computational and experimental analysis of chip design and formulation parameters.
| Hagar I. Labouta @bme_uoft |
[Open Access]
#lipidnanoparticle #microfluidics
doi.org/10.1016/j.jconrel.2025.114192 -
J Controlled Release
@JCRnEDITORS
A senescence-responsive nanodrug amplifies radiotherapy efficacy.
| Kam W. Leong @ColumbiaBME |
[50 days' free access]
#senescence #radiotherapy
authors.elsevier.com/a/1loVVcI2-9mCG -
J Controlled Release
@JCRnEDITORS
Mitochondria-targeted hybrid nanovesicles trigger immunogenic cell death and remodel tumor neutrophils for enhanced colorectal cancer immunotherapy.
| Xi Cao, Anhui Medical Univ. |
[50 days' free access]
#mitochondriatargeting #nanovesicle
authors.elsevier.com/a/1logVcI2-9mIX -
J Controlled Release
@JCRnEDITORS
Factors influencing monoclonal antibody pharmacokinetics across varying immune perturbations.
| Omid Veiseh @Rice_BIOE |
[50 days' free access]
#antibody #pharmacokinetics
authors.elsevier.com/a/1loyB_3r0J7O13 -
J Controlled Release
@JCRnEDITORS
Don’t miss the JCR Best Paper Award 2025 Webinar!
Featuring Dr. Janin Germer on innovative CRISPR/Cas9 delivery
Opening: Stefaan De Smedt | Moderator: Yu Seok Youn
📅 Sept 24, 2025 | 14:00 CET | 08:00 ET | 21:00 KST
🔗 Zoom link: skku-edu.zoom.us/j/83336549003?pwd=PWahuaURx30RriW1jwfs8E… -
J Controlled Release
@JCRnEDITORS
Don’t miss the JCR Best Paper Award 2025 Webinar!
Featuring Dr. Janin Germer on innovative CRISPR/Cas9 delivery
Opening: Stefaan De Smedt | Moderator: Yu Seok Youn
📅 Sept 24, 2025 | 14:00 CET | 08:00 ET | 21:00 KST
🔗 Zoom link: skku-edu.zoom.us/j/83336549003?pwd=PWahuaURx30RriW1jwfs8E… -
J Controlled Release
@JCRnEDITORS
Don’t miss the JCR Best Paper Award 2025 Webinar!
Featuring Dr. Janin Germer on CRISPR/Cas9 delivery.
Opening: Stefaan De Smedt | Moderator: Yu Seok Youn
📅 Sept 24, 2025 | 14:00 CET | 08:00 ET | 21:00 KST
🔗 Zoom link inside the poster. -
J Controlled Release
@JCRnEDITORS
An industry perspective on clinical development and regulatory strategies for subcutaneously administered high-dose biologics.
| Beate Bittner @Roche |
[Open Access]
#subcutaneousroute #biologics #dose #regulation
doi.org/10.1016/j.jconrel.2025.114156 -
J Controlled Release
@JCRnEDITORS
Silica-coated polyion complexes for enhanced pulmonary messenger RNA delivery with optimized silica layer stability.
| Kanjiro Miyata @UTokyo_News_en |
[50 days' free access]
#rnadelivery #polyplex #silica
doi.org/10.1016/j.jconrel.2025.114136 -
J Controlled Release
@JCRnEDITORS
Customization of protein corona to reprogram cancer nanomedicines: Mechanistic insights and therapeutic implications.
| Jin Sun, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#nanomedicine #proteincorona
authors.elsevier.com/a/1lgdecI2-9m4p -
J Controlled Release
@JCRnEDITORS
Dual-network hyaluronic acid hydrogel incorporating FGF21 and layered black phosphorus nanosheets for anti-ferroptosis therapy in spinal cord injury.
| Zhouguang Wang @WMU1958 |
[50 days' free access]
#hydrogel #nanosheet #blackphosphorus #spinalcordinjury
authors.elsevier.com/a/1lgTScI2-9m5C -
J Controlled Release
@JCRnEDITORS
Syngeneic CAR T cells engineered for persistent delivery of desired proteins.
| Parijat Bhatnagar @SRI_Intl |
[50 days' free access]
#proteindelivery #car_tcell
authors.elsevier.com/a/1lgRGcI2-9ldg -
J Controlled Release
@JCRnEDITORS
Albubody: an engineered scFv variant platform for site-specific drug conjugation and enhanced tumor efficacy.
| Inchan Kwon @GIST_science | @KoreaCRS
[50 days' free access]
#drugconjugation #scfv
authors.elsevier.com/a/1lgH1cI2-9m6R -
J Controlled Release
@JCRnEDITORS
Macrophage hitchhiking for smart nanomedicine: Bridging immune navigation and targeted therapy.
| Mingxing Xie @2024_HUST |
[50 days' free access]
#macrophage #diagnosis
authors.elsevier.com/a/1lg9DcI2-9m4- -
J Controlled Release
@JCRnEDITORS
Microvascular and astrocytic responses to repeated magnetic resonance-guided focused ultrasound.
| Sébastien Rigollet @UGrenobleAlpes | @CRSBeNeLuxFr
[Open Access]
#focusedultrasound #mrfingerprinting
doi.org/10.1016/j.jconrel.2025.114151 -
J Controlled Release
@JCRnEDITORS
Hierarchically structured hydrogel exhibiting spatiotemporal release profiles: Enabling digital remote diagnosis and personalized therapeutics.
| Ting Wang @TJU1895 |
[50 days' free access]
#hydrogel #spatiotemporalrelease
authors.elsevier.com/a/1lg6bcI2-9m5g -
J Controlled Release
@JCRnEDITORS
LIPUS-responsive meropenem-loaded nanobubbles enable biofilm disruption and bone repair in orthopedic implant-associated infections.
| Wenbo Mu, Xinjiang Medical Univ. |
[Open Access]
#nanobubble #infection
doi.org/10.1016/j.jconrel.2025.114119 -
J Controlled Release
@JCRnEDITORS
Sorbitol-responsive in situ gel improves rat ischemic hearts: Supporting mesenchymal stem cell survival and enhancing paracrine effect.
| Tetsuji Yamaoka, Natl. Cerebral and Cardiovascular Center Research Institute |
[50 days' free access]
authors.elsevier.com/a/1lfgR_3r0J7O0N -
J Controlled Release
@JCRnEDITORS
Biomembrane-inspired lipid nanoparticles enhance CRISPR-Cas9 editing for hemophilia A.
| Xiao-Bing Zhang, Peking Union Medical College |
[50 days' free access]
#lipidnanoparticle #geneediting #hemophilia
authors.elsevier.com/a/1lekwcI2-9m2d -
J Controlled Release
@JCRnEDITORS
The role of PEGylation in the pulmonary delivery of antifibrotic liposomal therapies.
| Susana Carregal-Romero @brta_eus | @CRS_SPLC
[Open Access]
#lungdelivery #liposome #pegylation #antifibrotic
doi.org/10.1016/j.jconrel.2025.114134 -
J Controlled Release
@JCRnEDITORS
Magnetic field-targeting and ultrasound-responsive antibiotic delivery for enhanced penetration and eradication of bacterial biofilms.
| Lianhui Wang, Nanjing Univ. of Posts and Telecommunications |
[50 days' free access]
#ultrasound #magneticfield
authors.elsevier.com/a/1leqmcI2-9m4R -
J Controlled Release
@JCRnEDITORS
Glycerol monostearate-based solid oleogels for dosage form individualization by molding designed using Design of Experiments.
| Ann-Christin Jacobsen @UniSouthDenmark |
[Open Access]
#oraldeivery #solidlipidformulation #oleogel
doi.org/10.1016/j.jconrel.2025.114140 -
J Controlled Release
@JCRnEDITORS
Nanocomposite hydrogel to integratively inhibit bacteria and inflammation for infected wound repair.
| Xin Chen @XJTU_China |
[50 days' free access]
#hydrogel #goldnanoparticle #woundrepair
authors.elsevier.com/a/1lf2ccI2-9m3C -
J Controlled Release
@JCRnEDITORS
Expressing Vitreoscilla hemoglobin in Escherichia coli Nissle 1917 enhances its probiotic potential for alleviating ulcerative colitis.
| Yongzhen Xia @ShandongU |
[50 days' free access]
#probiotic #colitis
authors.elsevier.com/a/1lf5WcI2-9m3s -
J Controlled Release
@JCRnEDITORS
www.controlledreleasesociety.org/about-crs/careers
Controlled Release Society
@CRSScience
Whether you're hiring for an open position or exploring the next step in your career, the CRS Online Career Center is the place to begin. CRS members can post job openings & upload resumes, helping connect the candidates with the opportunities. Browse now: www.controlledreleasesociety.org/about-crs/careers
-
J Controlled Release
@JCRnEDITORS
Stimulator of interferon genes-targeted positron emission tomography tracks early microbiota-induced tumor immune remodeling and guides immunotherapy.
| Dan Li @sysu_1924 |
[50 days' free access}
#tomography #microbiota #immunotherapy
authors.elsevier.com/a/1leQwcI2-9m1C -
J Controlled Release
@JCRnEDITORS
Light-controlled sequential nanoregulators for antibacterial and anti-inflammatory effects on promoting chronic wound healing.
| Wei Li, Naval Medical Univ. |
[50 days' free access]
#mxene #photoresponsive
authors.elsevier.com/a/1leQwcI2-9m2p -
J Controlled Release
@JCRnEDITORS
A novel ionizable lipid with comprehensive improvements in transfection potency, immune profile and safety of lipid nanoparticle.
| Ang Lin, China Pharmaceutical Univ. |
[50 days' free access]
#ionizablelipid #transfection #safety
authors.elsevier.com/a/1leMOcI2-9m0A -
J Controlled Release
@JCRnEDITORS
Apoptotic neutrophil membrane-modified nanoparticles promote wound healing by enhancing efferocytotic capacity of dendritic cells.
| Chenggang Yi @ZJU_China |
[50 days' free access]
#membranecoating #neutrophil #liposome #woundhealing
authors.elsevier.com/a/1leMOcI2-9m0M -
J Controlled Release
@JCRnEDITORS
Constructing natural phenolic acid mesopores to enhance chemotherapy and reduce accompanied intestinal damage.
| Dawei Deng, China Pharmaceutical Univ. |
[50 days' free access]
#mesoporousnanoparticle #phenolicacid
authors.elsevier.com/a/1ldvpcI2-9l-z -
J Controlled Release
@JCRnEDITORS
Integrating artificial intelligence and physiologically based pharmacokinetic modeling to predict in vitro and in vivo fate of amorphous solid dispersions.
| Defang Ouyang @UM_1981 |
[50 days' free access]
#soliddispersion #artificial_intelligence
authors.elsevier.com/a/1le7PcI2-9l-n -
J Controlled Release
@JCRnEDITORS
Pre-silencing of TNF-α by targeted siRNA delivery mitigates glucocorticoid resistance of dexamethasone in rheumatoid arthritis.
| Zhiyuan Zhong, Soochow Univ. |
[50 days' free access]
#sirnadelivery #polymersome #arthritis
authors.elsevier.com/a/1leA2cI2-9l-b -
J Controlled Release
@JCRnEDITORS
Homeostatic remodeling platform for reprogramming Iron Intraspatial orientation to reverse liver fibrosis.
| Hu-Lin Jiang, China Pharmaceutical Univ. |
[50 days' free access]
#micelle #ferroptosis #liverfibrosis
authors.elsevier.com/a/1ldtF_3r0J7N-u -
J Controlled Release
@JCRnEDITORS
🚨 Exciting Event!
JCR Symposium at Nanjing Forestry University, China (Sept 13, 2025). Face-to-face with JCR Editor-in-Chief Stefaan De Smedt. @DesmedtSmedt @JCRnEDITORS
Insights into JCR’s mission & submission tips & Scholarly showcase. -
J Controlled Release
@JCRnEDITORS
Oral ruthenium-based PAD4 inhibitor modulates immunogenic cell death and neutrophil extracellular traps in triple-negative breast cancer.
| Yuji Wang, Capital Medical Univ. |
[50 days' free access]
#oraldelivery #ruthenium #neutrophilextracellulartrap
authors.elsevier.com/a/1ldqKcI2-9m1O -
J Controlled Release
@JCRnEDITORS
Adenosine triphosphate-triggered aggregable DNA micelles for triple enhanced photothermal therapy in the second near-infrared window.
| Yue Zhang, Nanjing Univ. of Chinese Medicine |
[50 days' free access]
#dnamicelle #photothermal
authors.elsevier.com/a/1ldi1cI2-9m09 -
J Controlled Release
@JCRnEDITORS
Regulated PEGylation of cationic nanogels for enhanced siRNA delivery and orthotopic ovarian tumor therapy.
| Junyou Wang, East China Univ. of Science and Technology |
[50 days' free access]
#sirnadelivery #nanogel #pegylation
authors.elsevier.com/a/1ldfQcI2-9m0Y -
J Controlled Release
@JCRnEDITORS
Cross-linked selenolipoic acid nanoplatform modulates intracellular and extracellular reactive oxygen species for cancer immunotherapy.
| Shiyong Zhang @SCUCN |
[50 days' free access]
#reactiveoxygenspecies #immunotherapy
authors.elsevier.com/a/1lddAcI2-9m0q -
J Controlled Release
@JCRnEDITORS
Co-delivery of SN38 and SR717 activates cGAS–STING for near-infrared II image-guided chemoimmunotherapy.
| Yuling Xiao @WHU_1893 |
[50 days' free access]
#fluorescenceimaging #longcirculating #codelivery
authors.elsevier.com/a/1lddAcI2-9m0e -
J Controlled Release
@JCRnEDITORS
Engineering a placenta-inspired biomimicking fibrous patch for chondrogenesis through immunomodulation.
| Bingcheng Yi, Donghua Univ. |
[50 days' free access]
#patch #chondrogenesis
authors.elsevier.com/a/1ldYX_3r0J7N-x -
J Controlled Release
@JCRnEDITORS
authors.elsevier.com/a/1la7PcI2-9lwx
#coldatmosphericplasma #obesity
CRS Korea Chapter
@KoreaCRS
Very interesting article by Prof. Junho Byun (@sookmyung1906) on a lipolysis-targeted nanomedicine for anti-obesity therapy in @JCRnEDITORS. Congrats!
J Controlled Release
@JCRnEDITORS
Targeted lipolysis for obesity treatment: Cold atmospheric plasma–responsive nanoparticles amplify reactive oxygen species generation in adipocytes.
| Junho Byun @sookmyung1906 | @KoreaCRS
[50 days' free access]
#reactiveoxygenspecies #lipolysis #obesity
authors.elsevier.com/a/1la7PcI2-9lwx -
J Controlled Release
@JCRnEDITORS
Cold atmospheric plasma as a novel “drug” for cancer therapy.
| Zhitong Chen @SIATnews |
[50 days' free access]
#coldatmosphericplasma #cancertherapy
authors.elsevier.com/a/1ldNCcI2-9l~x -
J Controlled Release
@JCRnEDITORS
Chimeric collagen-like proteins with tunable structural heterogeneity for precise control and targeted doxorubicin delivery.
| Xinyu Li, Inner Mongolia Univ. |
[50 days' free access]
#proteinnanoparticle #chimericprotein #collagenlikeprotein
authors.elsevier.com/a/1ldQAcI2-9m10 -
J Controlled Release
@JCRnEDITORS
Lymphatic-targeted amphotericin B nanocrystals delivered using microarray patches applied to cutaneous leishmaniasis.
| Alejandro J. Paredes @pharmacyatQUB |
[Open Access]
#nanocrystal #patch #microarray #leishmaniasis
doi.org/10.1016/j.jconrel.2025.114115 -
J Controlled Release
@JCRnEDITORS
A cell-free TLR5high MSC membrane nanoparticle therapy for Crohn's disease: Targeted immunomodulation via the flagellin/TLR5 axis.
| Bin Wang, Nanjing Univ. of Chinese Medicine |
[Open Access]
#biomimeticnanoparticle #inflammatoryboweldisease
doi.org/10.1016/j.jconrel.2025.114121 -
J Controlled Release
@JCRnEDITORS
Targeted lipolysis for obesity treatment: Cold atmospheric plasma–responsive nanoparticles amplify reactive oxygen species generation in adipocytes.
| Junho Byun @sookmyung1906 | @KoreaCRS
[50 days' free access]
#reactiveoxygenspecies #lipolysis #obesity
authors.elsevier.com/a/1la7PcI2-9lwx -
J Controlled Release
@JCRnEDITORS
Enhanced tumor retention and therapeutic potency in radionuclide therapy using GSH-induced self-assembling peptides.
| Xiao Zhang @2024_HUST |
[50 days' free access]
#selfassembly #radiotherapy
authors.elsevier.com/a/1lbJ1cI2-9lyY -
J Controlled Release
@JCRnEDITORS
The kinetics of endosomal disruption reveal differences in lipid nanoparticle induced cellular toxicity.
| Stephanie M. Bates @AstraZeneca |
[50 days' free access]
#lipidnanoparticle #endosomaldisruption
authors.elsevier.com/a/1law7cI2-9lrU -
J Controlled Release
@JCRnEDITORS
Fluorinated albumin nanoplatform for 19F MRI-guided synergistic chemo-chemodynamic therapy and immune activation in breast cancer.
| Zhong-Xing Jiang @2024_HUST |
[50 days' free access]
#albuminnanoparticle #chemodynamic
authors.elsevier.com/a/1lbSrcI2-9lxu -
J Controlled Release
@JCRnEDITORS
Reactive oxygen species mediate black phosphorus quantum dots assembled microneedle patches for keratitis therapy.
| Lishu Zhang @WMU1958 |
[50 days' free access]
#microneedle #patch #quantumdot #keratitis
authors.elsevier.com/a/1lbSrcI2-9l~k -
J Controlled Release
@JCRnEDITORS
Enhanced wound healing via stem cell migration using a substance P1-loaded cross-linked small intestinal submucosa scaffold.
| Moon Suk Kim @AjouUniv | @KoreaCRS
[50 days' free access]
#scaffold #substancep #woundhealing
authors.elsevier.com/a/1lbJ1cI2-9l~M -
J Controlled Release
@JCRnEDITORS
Structural characterization of mRNA lipid nanoparticles (LNPs) in the presence of mRNA-free LNPs.
| Zhuo Liu @HMU_UNI |
[50 days' free access]
#mrnadelivery #lipidnanoparticle
authors.elsevier.com/a/1lZe~cI2-9lx7 -
J Controlled Release
@JCRnEDITORS
Recent developments in the use of carbon-based nanomaterials in cancer therapy.
| Antonio Gil @UNavarra |
[Open Access]
#carbonnanomaterial #cancertherapy
doi.org/10.1016/j.jconrel.2025.114100 -
J Controlled Release
@JCRnEDITORS
Biomimetic lipid nanocarriers overcome hypoxia barriers in lung cancer therapy.
| Di Ning, Shandong First Medical Univ. |
[50 days' free access]
#lipidnanocarrier #hypoxia
authors.elsevier.com/a/1lZVJcI2-9lx~ -
J Controlled Release
@JCRnEDITORS
Lysosome-hijacking inhalable nanomimosa enhances ferroptosis for lung cancer therapy.
| Zhengwei Huang @jnu1906 |
[50 days' free access]
#lungdelivery #inhalation
authors.elsevier.com/a/1lY-WcI2-9lyM -
J Controlled Release
@JCRnEDITORS
Augmenting cGAS/STING-mediated innate immunity by copper-based nanoplatform for synergistic cancer immunotherapy via inducing irreversible DNA damage.
| Zhian Chen, Zhongshan City People's Hospital |
[50 days' free access]
#inorganicnanoparticle #platinum
authors.elsevier.com/a/1lY-WcI2-9lvy -
J Controlled Release
@JCRnEDITORS
Engineered extracellular vesicles for targeted FGF20 delivery enhance neuroplasticity and functional recovery in ischemic stroke.
| Xue Wang @WMU1958 |
[50 days' free access]
#extracellularvesicle #ischemicstroke
authors.elsevier.com/a/1lYzAcI2-9lwl -
J Controlled Release
@JCRnEDITORS
Synergistic integration of bio-mineralized nanoparticles and porous microsphere scaffolds for dual bioactive delivery in bone regeneration.
| Xulin Hu, Chengdu Univ. |
[50 days' free access]
#microsphere #boneregeneration
authors.elsevier.com/a/1lYglcI2-9lxi -
J Controlled Release
@JCRnEDITORS
Nanoparticles loaded with a CSF1R antagonist selectively depletes microglial cells and modulates inflammation in spinal cord injury.
| Anne des Rieux, UCLouvain | @CRSBeNeLuxFr
[50 days' free access]
#polymericnanoparticle #microglia #spinalcordinjury
authors.elsevier.com/a/1lYRccI2-9lwZ -
J Controlled Release
@JCRnEDITORS
Polymerized Apoferritin: A promising carrier for efficient compartmentalized and deep-layer delivery of calcium donors in tumor Ca overload therapy.
| Xiaole Qi, China Pharmaceutical Univ. |
[50 days' free access]
#apoferritin #phenylboronate
authors.elsevier.com/a/1lYNWcI2-9lxW -
J Controlled Release
@JCRnEDITORS
Molecular engineering of extracellular vesicles for drug delivery: Strategies, challenges, and perspectives.
| Devika S Manickam @UTHealthHouston |
[50 days' free access]
#extracellularvesicle #microvesicle #pharmacokinetics
authors.elsevier.com/a/1lXd9_3r0J7N-I -
J Controlled Release
@JCRnEDITORS
Respiratory mucosal vaccination of platycodin-functionalized biomimetic nanovaccines for amplifying immune response.
| Shirui Mao, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#mucosalvaccine #platycodin
authors.elsevier.com/a/1lXYMcI2-9lvm -
J Controlled Release
@JCRnEDITORS
Novel design of 3D printed tumbling microrobots for in vivo targeted drug delivery.
| David J. Cappelleri @PurdueME |
[50 days' free access]
#3dprinting #microrobot
authors.elsevier.com/a/1lYKGcI2-9lvN -
J Controlled Release
@JCRnEDITORS
Sprayable zwitterionic self-assembling powder for postoperative adhesion prevention.
| Lei Ye @ShandongU |
[50 days' free access]
#selfassembly #sprayable
authors.elsevier.com/a/1lXM9cI2-9lu- -
J Controlled Release
@JCRnEDITORS
Research progress of reactive oxygen species (ROS) scavenging nanoplatforms in the treatment of ocular diseases.
| Fen Chen, Liaoning Univ. of Traditional Chinese Medicine |
[50 days' free access]
#reactiveoxygenspecies #oculardisease
authors.elsevier.com/a/1lXQ1_3r0J7N-S -
J Controlled Release
@JCRnEDITORS
Hydrogel delivery systems in intervertebral disc degeneration: Current status and future perspectives.
| Haolin Sun @PKU1898 |
[Open Access]
#hydrogel #discregeneration
doi.org/10.1016/j.jconrel.2025.114066 -
J Controlled Release
@JCRnEDITORS
Bioinspired hierarchical fiber-hydrogel dressing with dual immunomodulatory and angiogenic functions for diabetic wound healing.
| Bin Ding, Donghua Univ. |
[50 days' free access]
#hydrogel #wounddressing
authors.elsevier.com/a/1lX5ccI2-9lu8 -
J Controlled Release
@JCRnEDITORS
Biomaterial scaffolds for therapeutic immune cell engineering and delivery.
| Quanyin Hu @BadgerPharmacy |
[50 days' free access]
#celldelivery #cellengineering #scaffold
authors.elsevier.com/a/1lW~0cI2-9lvZ -
J Controlled Release
@JCRnEDITORS
Emerging nano-vaccine technologies to overcome anti-microbial resistance.
| Sejin Son, Inha Univ. | @KoreaCRS
[50 days' free access]
#vaccine #antimicrobialresistance
authors.elsevier.com/a/1lW~0cI2-9lw8 -
J Controlled Release
@JCRnEDITORS
Relying solely on cost as a determinant of the economic value of a drug: Three major limitations. A reply to Murply et al., 2025.
| Carlo Lazzaro @unipv |
[50 days' free access]
authors.elsevier.com/a/1lWcmcI2-9luK -
J Controlled Release
@JCRnEDITORS
authors.elsevier.com/a/1lScYcI2-9lpt
CRS Korea Chapter
@KoreaCRS
Great read! Prof. Yu Seok Youn shares key insights on inorganic nanomaterials in drug delivery in @JCRnEDITORS.
-
J Controlled Release
@JCRnEDITORS
Polysaccharide-functionalized drug delivery system for metastatic cancer therapy.
| Qin He @SCUCN |
[50 days' free access]
#polysaccharide #metastaticcancer
authors.elsevier.com/a/1lWLtcI2-9lvB -
J Controlled Release
@JCRnEDITORS
Influence of ionisable lipid and sterol variations on lipid nanoparticle properties and performance.
| Yvonne Perrie @SIPBS_Strath | @UKICRS
[Open Access]
#mrnadelivery #lipidnanoparticle #sterol
doi.org/10.1016/j.jconrel.2025.114056 -
J Controlled Release
@JCRnEDITORS
Lung tissue-optimized gene editing in human cystic fibrosis models following topical application of lipid nanoparticles.
| Sarah Hedtrich @ubcpharmacy | @HedtrichLab
[Open Access]
#geneediting #lipidnanoparticle #transmucosal #cysticfibrosis
doi.org/10.1016/j.jconrel.2025.114053 -
J Controlled Release
@JCRnEDITORS
Ultrasound-responsive piezoelectric analgesic microspheres alleviate osteoarthritis pain.
| Xiaoyu Han, Chongqing Medical Univ. |
[50 days' free access]
#microsphere #ultrasound #pain
authors.elsevier.com/a/1lUdUcI2-9lrm -
J Controlled Release
@JCRnEDITORS
An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity.
| Emily A. Voigt @AAHITweets |
[50 days' free access]
#rnavaccine #intranasal #intramuscular
authors.elsevier.com/a/1lUdUcI2-9lsj -
J Controlled Release
@JCRnEDITORS
Nano-mechanochemical synergistic approach to reprogram tumor-associated macrophages for tumor immunotherapy.
| Yan Li @Tongji_Uni |
[50 days' free access]
#mechanochemical #macrophagereprogramming
authors.elsevier.com/a/1lUYycI2-9lty -
J Controlled Release
@JCRnEDITORS
Peptide-based lipid nanodiscs suppress eosinophil recruitment and chemotaxis.
| Gunther Marsche @MedUniGraz |
[Open Access]
#nanodisc #apolipoprotein #eosinophil
doi.org/10.1016/j.jconrel.2025.114060 -
J Controlled Release
@JCRnEDITORS
Low-dose inhalable amino acid-modified multilamellar nanoparticles activate STING for safe and effective regression of lung metastases.
| Rui Kuai @Tsinghua_Uni |
[50 days' free access]
#lungdelivery #inhalation
authors.elsevier.com/a/1lU~CcI2-9ltm -
J Controlled Release
@JCRnEDITORS
RVG29 and platelet membrane-modified pseudo-mitochondria for cascade targeting of cyclosporin a in traumatic brain injury.
| Xing Zhou, Kunming Medical Univ. |
[50 days' free access]
#plateletmembrane #mitochondria #braininjury
authors.elsevier.com/a/1lUYy_3r0J7N-1 -
J Controlled Release
@JCRnEDITORS
Naturally derived mucoadhesive nanosuspension for treatment of multiple staged ocular infections.
| Nasim Annabi @UclaCBE | @CRS_FG_Ocular
[Open Access]
#oculardelivery #nanosuspension #mucoadhesive
doi.org/10.1016/j.jconrel.2025.114046 -
J Controlled Release
@JCRnEDITORS
Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell types.
| Samir E.L. Andaloussi @karolinskainst |
[Open Access]
#geneeditordelivery #peptidenanoparticle #cellpenetratingpeptide
doi.org/10.1016/j.jconrel.2025.114038 -
J Controlled Release
@JCRnEDITORS
Comprehensive management of diabetic ulceration: strategies and perspectives.
| Lingling Xu, Anhui Medical Univ. |
[50 days' free access]
#diabeticulcer #biomaterial
authors.elsevier.com/a/1lUqAcI2-9ltN -
J Controlled Release
@JCRnEDITORS
Nanocarrier drug delivery systems for gynecological cancer therapeutics.
| Brittany E. Givens @ukyengineering |
[50 days' free access]
#metalnanoparticle #extracellularvesicle
authors.elsevier.com/a/1lTtocI2-9loS -
J Controlled Release
@JCRnEDITORS
Alleviation of dry eye disease with lyophilized extracellular vesicles.
| Jiwen Zhang, Shanghai Institute of Materia Medica |
[50 days' free access]
#extracellularvesicle #stability #cryoprotectant #dryeye
authors.elsevier.com/a/1lTsWcI2-9lqw -
J Controlled Release
@JCRnEDITORS
Advances in paclitaxel nanoformulations: A systematic review of in vivo therapeutic efficacy and safety enhancements.
| Erazuliana Abd Kadir, Universiti Sains Malaysia | @CRSMalaysia
[50 days' free access]
#nanoformulation #paclitaxel
authors.elsevier.com/a/1lTVbcI2-9lph -
J Controlled Release
@JCRnEDITORS
Ionizable lipid chemistry in lipid nanoparticles determines delivery efficiency to hepatic stellate cells.
| Yuta Suzuki, Eisai Co. |
[50 days' free access]
#lipidnanoparticle #ionizablelipid #stellatecell
authors.elsevier.com/a/1lUQccI2-9lsv -
J Controlled Release
@JCRnEDITORS
Prevention of hepatic ischemia-reperfusion injury by reactive oxygen species-responsive nanozymes.
| Heran Li, China Medical Univ. |
[50 days' free access]
#nanozyme #reactiveoxygenspecies
authors.elsevier.com/a/1lUK6cI2-9lt6 -
J Controlled Release
@JCRnEDITORS
Endoplasmic reticulum-targeted strategies for programmed cell death in cancer therapy: Approaches and prospects.
| Yong Gan, Shanghai Institute of Materia Medica |
[50 days' free access]
#endoplasmicreticulum #targeteddelivery
authors.elsevier.com/a/1lUHDcI2-9ltZ -
J Controlled Release
@JCRnEDITORS
Advances in RNA therapeutics and its delivery strategies against multiple myeloma.
| Kenneth C. Anderson @harvardmed |
[50 days' free access]
#rnadelivery #myeloma
authors.elsevier.com/a/1lUCLcI2-9lrg -
J Controlled Release
@JCRnEDITORS
Repurposing mesalamine for acute kidney injury through supramolecular assembly.
| Man Kyu Shim @KistPublic | @KoreaCRS
[Open Access]
#prodrug #supramolecule #nanoassembly #kidneyinjury
doi.org/10.1016/j.jconrel.2025.114041 -
J Controlled Release
@JCRnEDITORS
Comparative study on the redox-responsive properties and antitumor efficacy of polyurethane nanocarriers with mono-, di-, and trisulfide bonds.
| Lesan Yan, Wuhan Univ. of Technology |
[50 days' free access]
#redoxresponsive #polyurethane
authors.elsevier.com/a/1lS7P_3r0J7N~m -
J Controlled Release
@JCRnEDITORS
Antitumor efficacy achieved by targeting PEGylated nanomedicines to netrin-1 in the extracellular matrix or EphA2 on the cancer cell membrane.
| Steve R. Roffler @KMU1954TW |
[Open Access]
#pegylation #extracellularmatrix
doi.org/10.1016/j.jconrel.2025.114042 -
J Controlled Release
@JCRnEDITORS
Polymer-free tacrolimus microsphere implants for long-acting prevention of corneal neovascularization in rats by subconjunctival injection.
| Dengning Xia @sysu_1924 |
[50 days' free access]
#oculardelivery #microsphere #implant
authors.elsevier.com/a/1lT53cI2-9lqv -
J Controlled Release
@JCRnEDITORS
Extracellular vesicles derived from aspirin-treated macrophages promote osteochondral tissue regeneration.
| Shao-Jie Wang @xmuchina |
[50 days' free access]
#extracellularvesicle #macrophage #tissueregeneration
authors.elsevier.com/a/1lT2KcI2-9lsL -
J Controlled Release
@JCRnEDITORS
Engineered biomembrane-camouflaged nanoparticles: Promising strategies to treat inflammatory skeletal diseases.
| Mingru Bai @SCUCN |
[50 days' free access]
#membranecoating #skeletaldisease
authors.elsevier.com/a/1lSU3cI2-9lo3 -
J Controlled Release
@JCRnEDITORS
Formulation methods for peptide-modified lipid nanoparticles.
| Ester J. Kwon @ucsdbe |
[50 days' free access]
#lipidnanoparticle #peptide #formulation
authors.elsevier.com/a/1lSWbcI2-9lok -
J Controlled Release
@JCRnEDITORS
An in vivo combined induction strategy of whole cancer cell vaccines triggers systemic immunity to eradicate triple-negative breast cancer.
| Yihui Deng, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#cancervaccine
authors.elsevier.com/a/1lSWbcI2-9lr6 -
J Controlled Release
@JCRnEDITORS
[Editorial] Inorganic Nanomaterials for Drug Delivery and Therapeutic Applications: Promise, Pitfalls, and Publication Standards in Journal of Controlled Release.
By Yu Seok Youn @SKKU_1398 @ysyoun0915 @KoreaCRS
#inorganicnanomaterial
authors.elsevier.com/a/1lScYcI2-9lpt -
J Controlled Release reposted
Pharmaceutics Utrecht
@UUPharmaceutics
A novel injectable hydrogel system enables prolonged siRNA delivery directly to ovarian tumors, significantly delaying tumor growth in advanced-stage models.
A promising step forward in localized cancer therapy! by @CristinaCasadi1
J Controlled Release
@JCRnEDITORS
Injectable thermosensitive hydrogel for local and controlled delivery of siRNA-STAT3 polyplexes to treat advanced-stage ovarian cancer.
| Tina Vermonden @UUPharmaceutics | @CRSBeNeLuxFr
[50 days' free access]
#hydrogel #thermosensitive #sirna #polyplex
doi.org/10.1016/j.jconrel.2025.113890 -
J Controlled Release
@JCRnEDITORS
Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye.
| Katrien Remaut @UGent_Pharma |
[50 days' free access]
#intravitreal #rnadelivery
authors.elsevier.com/a/1lR-IcI2-9loG -
J Controlled Release
@JCRnEDITORS
Manganese oxide nanoparticle acts as a promising immune adjuvant via tuning ferroptosis signaling.
| Yuhong Jiang @swjtumedia |
[50 days' free access]
#adjuvant #manganeseoxide #ferroptosis
authors.elsevier.com/a/1lRqecI2-9lnV -
J Controlled Release
@JCRnEDITORS
Liposomal dexamethasone for intra-articular therapy: Functional strategies and clinical progress.
| Longfa Kou @WMU1958 |
[50 days' free access]
#intraarticular #liposome
authors.elsevier.com/a/1lRkgcI2-9lqL -
J Controlled Release
@JCRnEDITORS
Lecithin-modified hybrid nanocarriers for enhanced locoregional therapy of melanoma: Influence of surface modification on therapeutic response.
| Sergei A. Shipilovskikh @spbpu_official |
[50 days' free access]
#silica #lecithin #locoregional
authors.elsevier.com/a/1lRZpcI2-9lnI -
J Controlled Release
@JCRnEDITORS
Injectable microenvironment-responsive hydrogels encapsulating engineered NF-κB-targeting circular RNA for osteoarthritis therapy.
| Qinhao Wang, Fourth Military Medical Univ. |
[50 days' free access]
#circularrna #hydrogel #injectable
authors.elsevier.com/sd/article/S0168-3659(25)00660-1 -
J Controlled Release
@JCRnEDITORS
Peptide-based strategies for glioblastoma therapy: From small molecular drugs to delivery vehicles.
| Zhilin Yu, Nankai Univ. |
[50 days' free access]
#peptidedelivery #selfassembly #bloodbrainbarrier
authors.elsevier.com/a/1lRFXcI2-9lnh -
J Controlled Release
@JCRnEDITORS
Irinotecan and dexamethasone prodrug co-loaded liposomes for the treatment of breast cancer.
| Yu Zhang, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#prodrug #liposome #codelivery
authors.elsevier.com/a/1lRFXcI2-9lmq -
J Controlled Release
@JCRnEDITORS
Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma.
| Tali Ilovitsh @of_sagol |
[Open Access]
#rnadelivery #lipidnanoparticle #bloodbrainbarrier
doi.org/10.1016/j.jconrel.2025.114018 -
J Controlled Release
@JCRnEDITORS
Therapeutic nanoparticle safety in pregnancy: Bridging knowledge gaps with environmental insights and a translational roadmap.
| Jason P. Gleghorn @UDelaware |
[50 days' free access]
#nanoparticle #safety #pregnancy
authors.elsevier.com/a/1lR2YcI2-9loF -
J Controlled Release
@JCRnEDITORS
Microenvironment responsive nanoplatform for targeted removal of cholesterol and reshaping inflammatory microenvironment in atherosclerotic plaques.
| Jiansong Ji @WMU1958 |
[50 days' free access]
#liposome #peptidemodification
authors.elsevier.com/a/1lP~4cI2-9lk4 -
J Controlled Release
@JCRnEDITORS
Recent advances and challenges of injectable hydrogels in drug delivery.
| Huayu Tian @xmuchina |
[50 days' free access]
#hydrogel #injectable #tissueengineering
authors.elsevier.com/a/1lQpQ_3r0J7N~Y -
J Controlled Release
@JCRnEDITORS
Targeted delivery of therapeutics to metastatic lung cancer cells using aptamer-conjugated nanoemulsions.
| María de la Fuente Freire @idis_research | @CRS_SPLC
[50 days' free access]
#nanoemulsion #aptamer
authors.elsevier.com/a/1lQxYcI2-9low -
J Controlled Release
@JCRnEDITORS
The impact of peptide surface density on PD-L1 receptor inhibition as a therapeutic strategy for triple negative breast cancer.
| Debra T. Auguste @NU_ChemE |
[50 days' free access]
#liposome #pedtidedensity
authors.elsevier.com/a/1lQHkcI2-9ln6 -
J Controlled Release
@JCRnEDITORS
Pulmonary surfactant-based pirfenidone-loaded nanovesicles for inhalation therapy of idiopathic pulmonary fibrosis.
| Ji-Ho Park @kaistpr | @KoreaCRS
[Open Access]
#pulmonarysurfactant #nanovesicle #fibrosis
doi.org/10.1016/j.jconrel.2025.114005 -
J Controlled Release
@JCRnEDITORS
A delayed-melting cryomicroneedle system for probiotic delivery against invasive Candida albicans infection.
| Wei Wu @FudanUniv |
[50 days' free access]
#cryomicroneedle #probiotic
authors.elsevier.com/a/1lQFKcI2-9lme -
J Controlled Release
@JCRnEDITORS
Transfersome enhances nail penetration of antifungal drug and photosensitizer for chemo-photodynamic therapy of onychomycosis in a novel rat model.
| Chuanbin Mao @CUHKofficial |
[50 days' free access]
#transfersome #photosensitizer #onychomycosis
authors.elsevier.com/sd/article/S0168-3659(25)00650-9 -
J Controlled Release
@JCRnEDITORS
Enhancing antigen presentation in cancer stem cells via peptide-based nanoparticles for effective immunotherapy.
| Zhenzhen Chen @ZZU_China |
[50 days' free access]
#peptidenanoparticle #stemcell
authors.elsevier.com/a/1lPxOcI2-9lkG -
J Controlled Release
@JCRnEDITORS
Nanomodulation of blood-labyrinth barrier enhances neuroprotection and antioxidant intervention for noise-induced hearing loss.
| Xueling Wang @sjtu1896 |
[50 days' free access]
#bloodlabyrinthbarrier #hearingloss
authors.elsevier.com/a/1lPv3cI2-9ll1 -
J Controlled Release
@JCRnEDITORS
Poly(thioctic acid)-based supramolecular hydrogels with UV-triggered on-demand H2S release for burn wound healing.
| Baolin Guo @XJTU_China |
[50 days' free access]
#hydrogel #supramolecule #woundhealing
authors.elsevier.com/a/1lPMkcI2-9lhQ -
J Controlled Release
@JCRnEDITORS
Characterization of microbubble cavitation in theranostic ultrasound-mediated blood-brain barrier opening for gene delivery.
| Elisa E. Konofagou @ColumbiaBME |
[50 days' free access]
#genedelivery #microbubble #ultrasound
authors.elsevier.com/a/1lPKWcI2-9lh~ -
J Controlled Release
@JCRnEDITORS
High-resolution imaging reveals a cascade of interconnected cellular bioeffects differentiating the long-term fates of sonoporated cells.
| Jürgen Götz @UQ_News | @AustralianCRS
[Open Access]
#imaging #sonoporation
doi.org/10.1016/j.jconrel.2025.113974 -
J Controlled Release
@JCRnEDITORS
A super-long-acting anti-PD-L1 nanobody fused to elastin-like polypeptide for triple-negative breast cancer immunotherapy.
| Weiping Gao @PKU1898 |
[50 days' free access]
#longacting #nanobody #polypeptide
authors.elsevier.com/a/1lP02cI2-9lkS -
J Controlled Release
@JCRnEDITORS
Innovative solid lipid nanoparticle formulations for ocular therapeutics and related patents: A systematic review.
| Indu Pal Kaur @OfficialPU | @CrsIndian
[Open Access]
#oculardelivery #solidlipidnanoparticle
doi.org/10.1016/j.jconrel.2025.113992 -
J Controlled Release
@JCRnEDITORS
Allan S. Hoffman's leadership in drug delivery: A historical perspective.
| Buddy D. Ratner @UWBioE |
[50 days' free access]
authors.elsevier.com/a/1lOukcI2-9llD -
J Controlled Release
@JCRnEDITORS
Reactive oxygen species-responsive micelles targeting activated hepatic stellate cells for treating liver fibrosis.
| Ming Guan Piao, Yanbian Univ. |
[50 days' free access]
#micelle #reactiveoxygenspecies #fibrosis
authors.elsevier.com/a/1lOwfcI2-9ljc -
J Controlled Release
@JCRnEDITORS
Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment.
| Yang Jin @2024_HUST |
[Open Access]
doi.org/10.1016/j.jconrel.2025.113998 -
J Controlled Release
@JCRnEDITORS
Phosphatidylcholine-derived carriers facilitate brain tumor delivery and enhance glioblastoma therapy.
| Jiangbing Zhou @YNeurosurgery |
[50 days' free access]
#braindelivery #drugconjugate #glioblastoma
authors.elsevier.com/a/1lOo0cI2-9lju -
J Controlled Release
@JCRnEDITORS
Oncolytic microgels with regulated antibody release augment tumor immunotherapy.
| Chao Deng, Soochow Univ.|
[50 days' free access]
#microgel #antibody
authors.elsevier.com/a/1lOkicI2-9lke -
J Controlled Release
@JCRnEDITORS
Optimized bacterial delivery approaches for precision immunotherapy in breast cancer models.
| Seung-Hwan Park @kribb_pr | @KoreaCRS
[Open Access]
#bacterialdelivery #cytolysin
doi.org/10.1016/j.jconrel.2025.114004 -
J Controlled Release
@JCRnEDITORS
Iridium cluster/hafnium-porphyrin framework heterojunctions for biocatalytic ROS-scavenging and acute kidney injury alleviation.
| Chong Cheng @SCUCN |
[50 days' free access]
#metalorganicframework #reactiveoxygenspecies #acutekidneyinjury
authors.elsevier.com/a/1lOdTcI2-9lj1 -
J Controlled Release
@JCRnEDITORS
Liposomal all-trans retinoic acid boosts anti-tumor immunity of radiotherapy via mitigating cancer stemness and remedying tumor microenvironment.
| Zhiyuan Zhong, Soochow Univ. |
[50 days' free access]
#liposome #radiotherapy
authors.elsevier.com/a/1lOaRcI2-9ljP -
J Controlled Release
@JCRnEDITORS
In Memoriam: Professor Rimona Margalit (1941–2024).
| Yaron Dekel, Smadar Cohen, Dan Peer |
[50 days' free access]
authors.elsevier.com/a/1lMVwcI2-9ljD -
J Controlled Release
@JCRnEDITORS
Clinical cancer nanomedicines.
| Twan Lammers @RWTH | @twan_lammers @CRS_DeChAt_LC
[Open Access]
#nanomedicine #combinationtherapy #clinicaltranslation
doi.org/10.1016/j.jconrel.2025.113991 -
J Controlled Release
@JCRnEDITORS
A multivalent 9-O-acetylated sialic acid-conjugated bacteriophage platform for antiviral and immunomodulatory therapy for human coronavirus OC43.
| So Young Yoo @PusanUni | @KoreaCRS
[50 days' free access]
#lungdelivery #bacteriophage #antiviral
authors.elsevier.com/a/1lO8bcI2-9ljQ -
J Controlled Release
@JCRnEDITORS
Adipose stem cell-derived nanovesicles for cardioprotection: Production and identification of therapeutic components.
| Giorgia Pastorin @NUSingapore |
[50 days' free access]
#nanovescile #adiposestemcell
authors.elsevier.com/a/1lNbEcI2-9liS -
J Controlled Release
@JCRnEDITORS
Hematite-embedded mesoporous nanoparticles for ferroptosis-inducing cancer sonoimmunotherapy.
| Jae Hyung Park @SKKU_1398 | @KoreaCRS
[50 days' free access]
#mesoporousnanoparticle #hematite #sonoimmunotherapy
authors.elsevier.com/a/1lNOK_3r0J7N~3 -
J Controlled Release
@JCRnEDITORS
MSC-derived exosomes injectable hyaluronic acid hydrogel for enhanced chronic wound healing.
| Rijian Song, Anhui Univ. of Science and Technology |
[Open Access]
#exosome #hydrogel #woundhealing
doi.org/10.1016/j.jconrel.2025.113985 -
J Controlled Release
@JCRnEDITORS
Biocompatible self-illuminating sphingomyelin nanosystems for photodynamic-based cancer therapy.
| M. de la Fuente @UniversidadeUSC | @CRS_SPLC
[50 days' free access]
#sphingomyelin #photodynamic
authors.elsevier.com/a/1lNDxcI2-9lhE -
J Controlled Release
@JCRnEDITORS
In situ antigen-capture strategies for enhancing dendritic cell-mediated anti-tumor immunity.
| Heng Dong @NanjingUnivers1 |
[Open Access]
#nanovaccine #dendriticcell #antigen
doi.org/10.1016/j.jconrel.2025.113984 -
J Controlled Release
@JCRnEDITORS
Ultrasound-activated nanovesicles for adenosine exhaustion and immune checkpoint blockade in cancer immunotherapy.
| Lianzhong Zhang @ZZU_China |
[50 days' free access]
#nanovesicle #ultrasound #immunotherapy
authors.elsevier.com/a/1lN4ScI2-9liB -
J Controlled Release
@JCRnEDITORS
Transdermal hyaluronate/cationic solid lipid nanoparticle/siRNA complex for the treatment of skin cancer.
| Sei Kwang Hahn @postech2020 | @KoreaCRS
[50 days' free access]
#sirnadelivery #solidlipidnanoparticle #skincancer
authors.elsevier.com/a/1lKXVcI2-9lep -
J Controlled Release
@JCRnEDITORS
Nanomicelle with reversible surface properties as a general adjuvant for potentiating immune responses to multiple types of tumor antigens.
| Minjie Sun, China Pharmaceutical Univ. |
[50 days' free access]
#micelle #adjuvant
authors.elsevier.com/a/1lMEW_3r0J7N~0 -
J Controlled Release
@JCRnEDITORS
Mitochondria-targeted NAD+/O2 co-delivery interpenetrating network hydrogel for respiratory chain restoration and osteoarthritis therapy.
| Ye Tian, Naval Medical Univ. |
[50 days' free access]
#hydrogel #mitochondriatargeting #osteoarthritis
authors.elsevier.com/a/1lM0mcI2-9lgE -
J Controlled Release
@JCRnEDITORS
Camel milk extracellular vesicles-mediated co-delivery of siVEGF/sorafenib enhances the anti-hepatocellular carcinoma activity by dual-effect blocking the biological effects of VEGF.
| Kehai Liu @shou_1912 |
[50 days' free access]
#sirna #codelivery
authors.elsevier.com/a/1lLxRcI2-9lh1 -
J Controlled Release
@JCRnEDITORS
Nanoparticle-based methionine and AICAR delivery elicits a robust antitumor immune response.
| Jong Oh Kim @YeungnamUniv | @KoreaCRS
[50 days' free access]
#albuminnanoparticle #methione
authors.elsevier.com/a/1lLJTcI2-9lhD -
J Controlled Release
@JCRnEDITORS
Engineered hybrid membrane vesicles combined with autologous and synthetic antigens as therapeutic vaccines to efficiently suppress tumor recurrence.
| Jun Guo, Central China Normal Univ. |
[50 days' free access]
#extrcellularvesicle #antigen #vaccine
authors.elsevier.com/a/1lKyvcI2-9lgr -
J Controlled Release
@JCRnEDITORS
In situ construction of ossification micro-units for critical bone regeneration via sustained lifting of epigenetic suppression.
| Hongbo Zhang @sjtu1896 |
[Open Access]
#microgel #calciumphosphate #boneregeneration
doi.org/10.1016/j.jconrel.2025.113978 -
J Controlled Release
@JCRnEDITORS
Nano-golden adjuvant-polymersomes empower tumor photothermal-immunotherapy.
| Zhiyuan Zhong, Soochow Univ. |
[50 days' free access]
#polymersome #adjuvant #photothermal
authors.elsevier.com/a/1lKabcI2-9lgQ -
J Controlled Release
@JCRnEDITORS
Local delivery of IL-12 mRNA and indoximod prodrug potentiates antitumor immunity by increasing T cell effector function.
| Yeu-Chun Kim @kaistpr | @KoreaCRS
[50 days' free access]
#mrnadelivery #prodrug
authors.elsevier.com/a/1lJw9cI2-9lfT -
J Controlled Release
@JCRnEDITORS
Engineered bacterial extracellular vesicles for gastrointestinal diseases.
| Shaoping Nie @NCUniv1921 |
[50 days' free access]
#extracellularvesicle #gastrointestinaldisease
authors.elsevier.com/a/1lKUDcI2-9lfg -
J Controlled Release
@JCRnEDITORS
Exosome-based mucosal therapeutic and diagnostic system: towards clinical translation.
| Yuling Mao, Shenyang Pharmaceutical Univ. |
#exosome #mucosal
authors.elsevier.com/a/1lKRXcI2-9led -
J Controlled Release
@JCRnEDITORS
Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle array patch delivery.
| Joseph M. DeSimone @StanfordEng | @Joseph_DeSimone
[50 days' free access]
#vaccine #selfamplifyingrna #microneedle
authors.elsevier.com/a/1lK4VcI2-9lbC -
J Controlled Release
@JCRnEDITORS
Homotypic biomimetic nanotheranostics enhance locoregional Cherenkov radiation-induced photodynamic therapy and ferroptosis in early bone metastases.
| Chunyang Sun @TJMU_China |
[50 days' free access]
#theranostic #photodynamic
authors.elsevier.com/a/1lJy-cI2-9lff -
J Controlled Release
@JCRnEDITORS
Nucleic acid-based nanogels with “offensive and defensive”effects for enhanced chemo-immunotherapy.
| Jianqin Yan @QingdaoU |
[50 days' free access]
#nanogel #nucleicacid
authors.elsevier.com/a/1lJhk_3r0J7Nzs -
J Controlled Release
@JCRnEDITORS
Intravitreal injection of cell membrane-coated nanoparticles for retinoblastoma treatment.
| Weiping Wang @HKUniversity |
[Open Access]
#intravitrealdelivery #membranecoating
doi.org/10.1016/j.jconrel.2025.113939 -
J Controlled Release
@JCRnEDITORS
Programmable chronogenetic gene circuits for self-regulated circadian delivery of biologic drugs.
| Farshid Guilak @washumedicine |
[Open Access]
#circadiandelivery #chronogenetic
doi.org/10.1016/j.jconrel.2025.113959 -
J Controlled Release
@JCRnEDITORS
Dual-barrier traversing liposomes with ROS-responsive rigidity tuning for oral ischemic stroke therapy.
| Jianbo Li @ZZU_China |
[50 days' free access]
#liposome #rosresponsive #ischemicstroke
authors.elsevier.com/a/1lIbEcI2-9lc- -
J Controlled Release
@JCRnEDITORS
A biodegradable suction patch for sustainable transbuccal peptide delivery.
| Jean-Christophe Leroux @ETH_en |
[Open Access]
#peptidedelivery #transbuccal
doi.org/10.1016/j.jconrel.2025.113947 -
J Controlled Release
@JCRnEDITORS
Transdermal delivery of enfuvirtide using dissolving microneedles integrated with novel insertion and removal indicator.
| Ryan F. Donnelly @pharmacyatQUB | @UKICRS
[Open Access]
#transdermaldelivery #microneedle
doi.org/10.1016/j.jconrel.2025.113954 -
J Controlled Release
@JCRnEDITORS
Bone-targeting ZIF-8 based nanoparticles loaded with vancomycin for the treatment of MRSA-induced periprosthetic joint infection.
| Long Wang @CentralSouth_U |
[50 days' free access]
#bonetargeting #antibacterial #vancomycin
authors.elsevier.com/a/1lIErcI2-9leR -
J Controlled Release
@JCRnEDITORS
Targeting and exploiting macropinocytosis in cancer therapy.
| Ick Chan Kwon @KistPublic | @DoubleParr @KoreaCRS
[50 days' free access]
#macropinocytosis #albuminbinding #dextran
authors.elsevier.com/a/1lIErcI2-9le2 -
J Controlled Release
@JCRnEDITORS
Human Fc CH2 domain modifies cholix transcytosis pathway to facilitate efficient oral therapeutic protein delivery.
| Randall J. Mrsny @UniofBath | @UKICRS
[50 days' free access]
#oraldelivery #transcytosis
authors.elsevier.com/a/1lIEr_3r0J7Nze -
J Controlled Release
@JCRnEDITORS
Coordinated modulation of glucose metabolism and immunity via metal-drug nanovesicles for hepatocellular carcinoma therapy.
| Liyan Qiu @ZJU_China |
[50 days' free access]
#nanovesicle #metabolism
authors.elsevier.com/a/1lHwgcI2-9ldC -
J Controlled Release
@JCRnEDITORS
Affinity-based controlled release of interleukin-4 from scaffolds via biotin-streptavidin interactions for immunomodulation.
| Kara L. Spiller @drexelbiomed |
[50 days' free access]
#scaffold #biotin #streptavidin #immunomodulation
authors.elsevier.com/a/1lI6mcI2-9lb0 -
J Controlled Release
@JCRnEDITORS
Posttranslational remodeling micelle reverses cell-surface and exosomal PD-L1 immunosuppression in tumors resistant to PD-L1 antibody therapy.
| Xiaojiao Li @XJTU_China |
[Open Access]
#micelle #exosome
doi.org/10.1016/j.jconrel.2025.113961 -
J Controlled Release
@JCRnEDITORS
Advanced biomaterials for the targeted delivery of immune checkpoint inhibitors to solid tumors.
| Kevin J. McHugh @Rice_BIOE |
[50 days' free access]
#localdelivery #targeteddelivery
authors.elsevier.com/a/1lHBpcI2-9lcF -
J Controlled Release
@JCRnEDITORS
Targeting ferroptosis and mitophagy with neutrophil-inspired nanozyme for Parkinson's disease therapy.
| Yuanxiang Lin, Fujian Medical Univ. |
[50 days' free access]
#neutrophilmembrane #mitophagy
authors.elsevier.com/a/1lHBp_3r0J7NzQ -
J Controlled Release
@JCRnEDITORS
Nanomedicine-mediated macrophage polarization enhances the iron-depleting effect of desferrioxamine for breast cancer immunotherapy.
| Haiqing Dong @TJU_China |
[50 days' free access]
#irondepletion #deferoxamine #macrophage #polarization
authors.elsevier.com/a/1lH9EcI2-9ld0 -
J Controlled Release
@JCRnEDITORS
Novel biomarker discovery-coupled plasma therapy with enhanced tumor penetration for non-surgical treatment of cervical cancer.
| Gayong Shim @soongsil1897 | @KoreaCRS
[Open Access]
#plasmatherapy #biomarker
doi.org/10.1016/j.jconrel.2025.113946 -
J Controlled Release
@JCRnEDITORS
Polypeptide-protein conjugation: A new paradigm for therapeutic protein delivery.
| Fuwu Zhang @univmiami_Chem |
[50 days' free access]
#proteindelivery #conjugate
authors.elsevier.com/a/1lH2ycI2-9lcd -
J Controlled Release
@JCRnEDITORS
Bacteriophage lysin-MOFs nanomaterials for treating apical periodontitis.
| Yuhong Li @WHU_1893 |
[50 days' free access]
#bacteriophage #lysin #periodontitis
authors.elsevier.com/a/1lGMTcI2-9lbz -
J Controlled Release
@JCRnEDITORS
Double-layered core-shell microneedle patch integrated with microparticles for long-acting treatment of osteoporosis.
| Yunhua Gao @CAS__Science |
[50 days' free access]
#microneedle #patch #osteoporosis
authors.elsevier.com/a/1lGMTcI2-9lU4 -
J Controlled Release
@JCRnEDITORS
Advances in near-infrared responsive functional nanocomposites for bioimaging and antitumor research.
| Jibin Song @BeijingChemical |
[50 days' free access]
#imaging #theranostic
authors.elsevier.com/a/1lGUkcI2-9lUx -
J Controlled Release
@JCRnEDITORS
Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection.
| Natalie L. Trevaskis @MonashUni | @AustralianCRS
[Open Access]
#mrnadelivery #ionizablelipid
doi.org/10.1016/j.jconrel.2025.113945 -
J Controlled Release
@JCRnEDITORS
A cGAS-STING pathway activating cobalt(III) cyclam prodrug for combined chemotherapy and immunotherapy of breast cancer.
| Hanchen Zhang @CAS__Science |
[50 days' free access]
#prodrug #cobaltcyclam #immunotherapy
authors.elsevier.com/a/1lF-xcI2-9laq -
J Controlled Release
@JCRnEDITORS
Structural stability and RNase resistance of mRNA Polyplex micelles for systemic delivery.
| Kazunori Kataoka, Kawasaki Institute of Industrial Promotion |
[Open Access]
#mrnadelivery #micelle #stability
doi.org/10.1016/j.jconrel.2025.113935 -
J Controlled Release
@JCRnEDITORS
Oral delivery of tunable oxidation-responsive budesonide-loaded nanoparticles enhances inflammation modulation in intestinal colitis.
| Bruno Sarmento @i3S_UPorto | @CRS_SPLC @brunocsarmento
[Open Access]
#oraldelivery #colitis
doi.org/10.1016/j.jconrel.2025.113948 -
J Controlled Release
@JCRnEDITORS
A thermoresponsive magnetic nanocarrier with the DNA-mimetic base pairing-guided controlled release of methotrexate in the treatment of rheumatoid arthritis.
| Peng Cao @WMU1958 |
[50 days' free access]
#magneticcarrier #thermoresponsive
authors.elsevier.com/a/1lFnucI2-9lcR -
J Controlled Release
@JCRnEDITORS
Targeted delivery of engineered extracellular vesicles to simultaneously promote vascularization and muscle regeneration in ischemic limbs.
| Jianjun Guan @WashUengineers |
[Open Access]
#extracellularvesicle #muscleregeneration
doi.org/10.1016/j.jconrel.2025.113938 -
J Controlled Release
@JCRnEDITORS
Clinically relevant dosing of miR-145 micelles curbs atherosclerosis in vivo.
| Eun Ji Chung @USC |
[50 days' free access]
#mirnadelivery #micelle #atherosclerosis
authors.elsevier.com/a/1lFRQcI2-9lZ0 -
J Controlled Release
@JCRnEDITORS
Multimodal nanoparticles co-delivering bevacizumab and dichloroacetate for dual targeting of neoangiogenesis and hyperglycolysis in glioblastoma treatment.
| Bruno Sarmento @i3S_UPorto | @CRS_SPLC @brunocsarmento
[Open Access]
#intranasaldelivery
doi.org/10.1016/j.jconrel.2025.113931 -
J Controlled Release
@JCRnEDITORS
Harnessing RGDS peptides to regulate bacterial-host interfaces for targeted antimicrobial therapy.
| Jianyong Huang @PKU1898 |
[50 days' free access]
#peptide #antimicrobial #adjuvant
authors.elsevier.com/a/1lFRQcI2-9lXn -
J Controlled Release
@JCRnEDITORS
Immune regulation and repair of osteochondral defects using manganese-luteolin hydrogel scaffold.
| Yi Chen, Naval Medical Univ. |
[50 days' free access]
#hydrogel #tissueregeneration
authors.elsevier.com/a/1lFOZcI2-9lXP -
J Controlled Release
@JCRnEDITORS
Designing and modeling nanomedicines towards image-guided drug delivery in hematological malignancies.
| Alexandros Marios Sofias @RWTH | @CRS_DeChAt_LC
[Open Access]
#nanomedicine #imaging #modeling
doi.org/10.1016/j.jconrel.2025.113932 -
J Controlled Release
@JCRnEDITORS
Antibody-mediated ratiometric delivery of FLT3 and CDK4/6 dual inhibitors for targeted treatment of acute myeloid leukemia.
| Zhiyuan Zhong, Soochow Univ. |
[50 days' free access]
#ratiometric #leukemia
authors.elsevier.com/a/1lFOZcI2-9lZb -
J Controlled Release
@JCRnEDITORS
Tailored regulation of ferroptosis in periodontitis using thermosensitive ionic liquid hydrogel based on galangin/L-cysteine-decorated MoS2 nanoflowers.
| Shuangying Gui, Anhui Univ. of Chinese Medicine |
[50 days' free access]
#ionicliquid
authors.elsevier.com/a/1lFLbcI2-9lYk -
J Controlled Release
@JCRnEDITORS
Multifunctional nanocomposite hydrogel with dual-factor controlled release for stem cell recruitment, immunomodulation and bone remodeling.
| Qian Liu, The Fourth Military Medical Univ. |
[50 days' free access]
#hydrogel #silicananoparticle #bonerepair
authors.elsevier.com/a/1lFLbcI2-9lTJ -
J Controlled Release
@JCRnEDITORS
Self-assembled copper chlorogenic acid nanoparticles: Inducing pyroptosis and cuproptosis to activate antitumor immunity.
| Ruiping Zhang, Shanxi Medical Univ. |
[50 days' free access]
#selfasssembly #pyroptosis #cuproptosis
authors.elsevier.com/a/1lFLbcI2-9lap -
J Controlled Release
@JCRnEDITORS
Multifunctional delivery strategies and nanoplatforms of SN-38 in cancer therapeutics.
| Sylvia Daunert @umiamimedicine |
[50 days' free access]
#stimuliresponsive #multifunctional
authors.elsevier.com/a/1lF58cI2-9la9 -
J Controlled Release
@JCRnEDITORS
Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates.
| Kristy M. Ainslie @DPMP_UNC |
[50 days' free access]
#vaccine #influenza #multivalent
authors.elsevier.com/a/1lF6fcI2-9lZz -
J Controlled Release
@JCRnEDITORS
Advanced rational design of polymeric nanoparticles for the controlled delivery of biologics.
| Nicholas A. Peppas @UTBiomedical | @NPeppas
[50 days' free access]
#hydrogel #layerbylayer
authors.elsevier.com/a/1lE~lcI2-9lad -
J Controlled Release
@JCRnEDITORS
ATRA derived lipid nanoparticles for co-delivery of siCYP26A1 to overcome metabolic limitations of differentiation therapy in solid tumors.
| Yu Nie @SCUCN |
[50 days' free access]
#sirnadelivery #lipidnanoparticle #codelivery
authors.elsevier.com/a/1lEeM_3r0J7Nz9 -
J Controlled Release
@JCRnEDITORS
doi.org/10.1016/j.jconrel.2025.113944
Pharmacoengineering & Mol Pharmaceutics (DPMP UNC)
@DPMP_UNC
New publication out in @JCRnEDITORS featuring work from Jillian Perry, PhD “Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle Array patch delivery”
🔗 doi.org/10.1016/j.jconrel.2025.113944
@UNCPharmacy -
J Controlled Release
@JCRnEDITORS
Injectable hydrogel-based drug formulation for enhancing tertiary lymphoid structure formation and cancer immunotherapy efficacy.
| Zhou Ye @HKUniversity |
[Open Access]
#hydrogel #injectable #supramolecule
doi.org/10.1016/j.jconrel.2025.113897 -
J Controlled Release
@JCRnEDITORS
Effective head and neck cancer treatment combines radiation and local extended cisplatin release.
| Nataly Kravchenko-Balasha, The Hebrew Univ. of Jerusalem |
[Open Access]
#radiation #cisplatin
doi.org/10.1016/j.jconrel.2025.113923 -
J Controlled Release
@JCRnEDITORS
Dependence of endothelial drug delivery on monodisperse microbubble dynamics.
| Yuchen Wang, Erasmus MC | @CRSBeNeLuxFr
[Open Access]
#microbubble #endothelialcell #sonoporation
doi.org/10.1016/j.jconrel.2025.113867 -
J Controlled Release
@JCRnEDITORS
Functional lipid nanoparticles for safe delivery of macromolecular antibiotics to gram-negative bacteria.
| Yi Yan Yang @ASTARsg |
[50 days' free access]
#lipidnanoparticle #antibiotics
authors.elsevier.com/a/1lDj2cI2-9lVV -
J Controlled Release
@JCRnEDITORS
www.sciencedirect.com/science/article/pii/S01683659250001…
ibidi GmbH
@ibidiCells
⚗️ Congrats to Seth-Frerich Fobian, PhD & Prof. Timo Ten Hagen from @ErasmusMC on their new publication in @JCRnEDITORS !
📑 A 3D tumor-on-a-chip model to study PD-L1-targeted liposome delivery in cervical cancer under dynamic flow.
📖www.sciencedirect.com/science/article/pii/S01683659250001…
@ArleneLeonieOei -
J Controlled Release
@JCRnEDITORS
Metal-phenolic network-based polymeric nanocarriers facilitating antibody cytoplasmic delivery and anti-tumor effects to orthotopic breast tumors.
| Nobuhiro Nishiyama @tokyotech_en |
[Open Access]
#cytoplasmicdelivery #metalphenolicnetwork
doi.org/10.1016/j.jconrel.2025.113929 -
J Controlled Release
@JCRnEDITORS
A perspective on the apparent pKa of ionizable lipids in mRNA-LNPs.
| Jens B. Simonsen, Jbsimonsen Consult |
[50 days' free access]
#ionizablelipid #pka
authors.elsevier.com/a/1lDYScI2-9lR5 -
J Controlled Release
@JCRnEDITORS
CD44-targeted RIP3 gene delivery strategy for enhanced cancer therapy via necroptosis and immune modulation.
| Soon-Sun Hong @inhauniv | @KoreaCRS
[50 days' free access]
#genedelivery #phsensitive #necroptosis
authors.elsevier.com/a/1lDYScI2-9lPy -
J Controlled Release
@JCRnEDITORS
Microneedle-mediated biomimetic nanoparticles for targeted antioxidant and anti-inflammatory therapy in age-related macular degeneration.
| Jingling Tang @HMU_UNI |
[50 days' free access]
#microneedle #maculardegeneration
authors.elsevier.com/a/1lDYScI2-9lVW -
J Controlled Release
@JCRnEDITORS
Chitosan and mannose-modified dual-functional mRNA-LNP vaccines for robust systemic and mucosal immune responses.
| Aiping Zheng, Beijing Institute of Pharmacology and Toxicology |
[50 days' free access]
#mrna #chitosan #vaccine
authors.elsevier.com/a/1lCyycI2-9lSx -
J Controlled Release
@JCRnEDITORS
doi.org/10.1016/j.jconrel.2025.113936
Pharmacoengineering & Mol Pharmaceutics (DPMP UNC)
@DPMP_UNC
Latest in @JCRnEDITORS by Eric Bachelder, PhD & @AinslieLab w/ PhD students @GraceW_ChemE, Connor Murphy & Nicole Lukesh. “Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates” 🔗doi.org/10.1016/j.jconrel.2025.113936
@UNCPharmacy -
J Controlled Release
@JCRnEDITORS
Drug and therapeutic intravaginal delivery targeting diseases in the female reproductive tract: A mathematical modeling perspective.
| Hermann B. Frieboes @UofLBMES |
[50 days' free access]
#vaginaldelivery #modelling
authors.elsevier.com/a/1lDYScI2-9lY9 -
J Controlled Release
@JCRnEDITORS
Monocyte membrane-coated drug nanocrystals for enhanced targeted therapy of rheumatoid arthritis.
| Qing Lin @SCUCN |
[50 days' free access]
#nanocrystal #membranecoating #arthritis
authors.elsevier.com/a/1lDK-cI2-9lXJ -
J Controlled Release
@JCRnEDITORS
Impact of tail unsaturation in ionizable lipids on mRNA delivery efficiency and immunogenicity of lipid nanoparticles.
| Zhijia Liu @sysu_1924 |
[50 days' free access]
#mrnadelivery #ionizablelipid
authors.elsevier.com/a/1lCwScI2-9lVJ -
J Controlled Release
@JCRnEDITORS
Topical delivery of cultivated limbal stem cells via porous photocurable hydrogel: A noninvasive, convenient, and efficient stem cells delivery strategy for limbal stem cell deficiency.
| Zuguo Liu @xmuchina |
[50 days' free access]
#topical #stemcell
authors.elsevier.com/a/1lD2ycI2-9lUM -
J Controlled Release
@JCRnEDITORS
Hypoxia-sensitive macrocycle inclusion complexes for targeted protein degradation.
| Hongzhong Chen @sysu_1924 |
[50 days' free access]
#inclusioncomplex #hypoxia
authors.elsevier.com/a/1lCuIcI2-9lXb -
J Controlled Release
@JCRnEDITORS
Fully biodegradable dendrimers as novel nanodrugs for amyloid-β-induced neurotoxicity.
| Ana P. Pêgo @i3S_UPorto | @CRS_SPLC
[Open Access]
#dendrimer #neurotoxicity
doi.org/10.1016/j.jconrel.2025.113870 -
J Controlled Release
@JCRnEDITORS
Effects of modification modules-adjusted intermolecular forces on docetaxel prodrug Nanoassemblies: From assembly mechanisms to in vivo fate.
| Bingjun Sun, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#nanoassembly #prodrug
authors.elsevier.com/a/1lCV0cI2-9lTK -
J Controlled Release
@JCRnEDITORS
Self-enhanced ROS-responsive camptothecin prodrug nanoparticles elicit safe and efficient intravesical instillation therapy of bladder cancer.
| Qingsong Yu @BeijingChemical |
[50 days' free access]
#prodrug #intravesical
authors.elsevier.com/a/1lCV0cI2-9lV7 -
J Controlled Release
@JCRnEDITORS
Intestinal retentive delivery system for improved disease therapy.
| Kai Han, China Pharmaceutical Univ. |
[50 days' free access]
#oraldelivery #intestinalretention
authors.elsevier.com/a/1lCGccI2-9lUl -
J Controlled Release
@JCRnEDITORS
In vivo FAP-CAR macrophages enhance chemotherapy and immunotherapy against pancreatic cancer by removing the fibrosis barrier.
| Yong Yang, China Pharmaceutical Univ. |
[50 days' free access]
#chimericantigenreceptor #macrophage #fibrosis
authors.elsevier.com/a/1lCEBcI2-9lST -
J Controlled Release
@JCRnEDITORS
Genetically engineered extracellular vesicles expressing decoy protein TACI provide a therapeutic effect in systemic lupus erythematosus mouse model.
| Jianmin Zhang, Peking Union Medical College |
[Open Access]
#extracellularvesicle #lupuserythematosus
doi.org/10.1016/j.jconrel.2025.113886 -
J Controlled Release
@JCRnEDITORS
Tertiary amine N-oxide zwitterionic lipids facilitate muscle-selective mRNA vaccine delivery for enhancing cDC1-mediated antitumor efficacy.
| Yongming Chen @sysu_1924 |
[50 days' free access]
#zwitterioniclipid #mrnavaccine
authors.elsevier.com/a/1lC9UcI2-9lT7 -
J Controlled Release
@JCRnEDITORS
Amphiphilic dendrimer-assisted delivery of antisense nucleic acid mimics against E. coli
| Nuno F. Azevedo @UPorto | @CRS_SPLC
[Open Access]
#dendrimer #antisense
doi.org/10.1016/j.jconrel.2025.113850 -
J Controlled Release
@JCRnEDITORS
Multi-modality imaging for precise intra-arterial delivery of mRNA, AAVs, and antibodies to the head and neck area in mice.
| Piotr Walczak @UofMaryland |
[Open Access]
#mrnadelivery #intraarterial #imaging
doi.org/10.1016/j.jconrel.2025.113880 -
J Controlled Release
@JCRnEDITORS
Dual targeted ferritin-based delivery system blocks the crosstalk between cancer cells and cancer-associated fibroblasts to potentiate immunotherapy of colorectal cancer.
| Yanfeng Hu @smu_medical |
[50 days' free access]
#ferritin #immunotherapy
authors.elsevier.com/a/1lBaecI2-9lQj -
J Controlled Release
@JCRnEDITORS
Polymer-based coating of adeno-associated viral particles as a new strategy to evade immune response for DMD treatment.
| Marta Guerra-Rebollo @IQSbarcelona | @CRS_SPLC
[50 days' free access]
#viralvector #polymercoating #duchennemusculardystrophy
authors.elsevier.com/a/1lBaecI2-9lTi -
J Controlled Release
@JCRnEDITORS
A novel cationic liposome-formulated toll like receptor (TLR)7/8 agonist enhances the efficacy of a vaccine against fentanyl toxicity.
| Marco Pravetoni @uwsomwwami |
[50 days' free access]
#liposome #cationic #vaccine #fentanyl
authors.elsevier.com/a/1lBaecI2-9lUY -
J Controlled Release
@JCRnEDITORS
Peptide-based nanoassembly enhances ferroptosis in cancer to overcome paclitaxel resistance.
| Chunli Gan @HMU_UNI |
[50 days' free access]
#nanoassembly #peptide #ferroptosis
authors.elsevier.com/a/1lB8bcI2-9lTW -
J Controlled Release
@JCRnEDITORS
Rational design of stimuli responsive nanoparticle systems for the controlled, intracellular delivery of immunotherapeutic and chemotherapeutic agents.
| Nicholas A. Peppas @UTAustin | @NPeppas
[50 days' free access]
#sirnadelivery #nanoparticle
authors.elsevier.com/a/1lB9xcI2-9lQv -
J Controlled Release
@JCRnEDITORS
Cell microparticles loaded with pro-inflammatory factors and chloroquine collaborate with mechanical force to facilitate orthodontic tooth movement.
| Yumei Ding @2024_HUST |
[50 days' free access]
#cellmicroparticle #orthodontic
authors.elsevier.com/a/1lB9xcI2-9lPI -
J Controlled Release
@JCRnEDITORS
Synergistic blockade of SHP-2 and A2AR signal pathways with targeted nanoparticles restores anti-tumor immunity of CD8+ T cells.
| Zhi Ping Xu @AIBNatUQ | @AustralianCRS
[Open Access]
#tcelltargeting #nanoparticle #immunotherapy
doi.org/10.1016/j.jconrel.2025.113889 -
J Controlled Release
@JCRnEDITORS
New insights of transition metal sulfide nanoparticles for tumor precision diagnosis and treatment.
| Aiguo Wu, Ningbo Institute of Materials Technology and Engineering |
[50 days' free access]
#imaging #transitionmetal
authors.elsevier.com/a/1lATncI2-9lPm -
J Controlled Release
@JCRnEDITORS
Lanthanide nanocrystals-based direct triple-state energy converters for mitophagy and ferroptosis-induced antitumor immunoreaction.
| Chunxia Li @ShandongU |
[50 days' free access]
#nanocrystal #lanthanide #mitophagy
authors.elsevier.com/a/1lATncI2-9lSH -
J Controlled Release
@JCRnEDITORS
Screening scaffold proteins for improved functional delivery of luminal proteins using engineered extracellular vesicles.
| Xiuming Liang @karolinskainst |
[Open Access]
#extracellularvesicle #scaffold #intracellulardelivery
doi.org/10.1016/j.jconrel.2025.113882 -
J Controlled Release
@JCRnEDITORS
Engineered cell membrane-based nano therapies fight infectious diseases.
| Gang Liu @xmuchina |
[50 days' free access]
#cellmembrane #membranecoating #infectiousdisease
authors.elsevier.com/a/1lAn9cI2-9lRu -
J Controlled Release
@JCRnEDITORS
Postoperative tumor suppression via ROS scavenging, VEGF capture, and photothermal therapy using a split aptamer-loaded hydrogel.
| Won Jong Kim @CPostech | @KoreaCRS
[50 days' free access]
#hydrogel #aptamer #photothermal
authors.elsevier.com/a/1lA1AcI2-9lRi -
J Controlled Release
@JCRnEDITORS
Modulating binding affinity of aptamer-based loading constructs enhances extracellular vesicle-mediated CRISPR/Cas9 delivery.
| Olivier G. de Jong @UUUIPS | @CRSBeNeLuxFr
[Open Access]
#extracellularvesicle #aptamer #geneediting
doi.org/10.1016/j.jconrel.2025.113853 -
J Controlled Release
@JCRnEDITORS
Red blood cell membrane-derived phototherapeutic nanodiscs: A new platform for enhanced phototherapy.
| Yijie Chen @WMU1958 |
[50 days' free access]
#nanodisc #cellmembrane #redbloodcell #phototherapy
authors.elsevier.com/a/1l9mmcI2-9lQ8 -
J Controlled Release
@JCRnEDITORS
Toward successful retinal drug delivery after intravitreal injection: Current strategies to overcome the inner limiting membrane.
| Karen Peynshaert @UGent_Pharma | @CRSBeNeLuxFr @CRS_FG_Ocular
[50 days' free access]
#intravitreal #genetherapy
authors.elsevier.com/a/1l9XacI2-9lMR -
J Controlled Release
@JCRnEDITORS
A novel lipopolyplex platform for dual mRNA delivery via core- and surface-loading.
| Brigitta Loretz @Helmholtz_HIPS | @CRS_DeChAt_LC
[Open Access]
#mrnadelivery #lipopolyplex
doi.org/10.1016/j.jconrel.2025.113875 -
J Controlled Release
@JCRnEDITORS
Microenvironment-responsive MOF nanozymes armored cryogels promoted wound healing via rapid hemostasis, infection elimination and angiogenesis.
| Danru Wang @sjtu1896 |
[50 days' free access]
#cryogel #nanozyme #woundhealing
authors.elsevier.com/a/1l8-kcI2-9lKe -
J Controlled Release
@JCRnEDITORS
A TCR nanovesicle antibody for redirecting T cells and reversing immunosuppression as a tumor immunotherapy strategy.
| Yu Tang, Chongqing Medical Univ. |
[50 days' free access]
#tcellreceptor #antibody #immunotherapy
authors.elsevier.com/a/1l8zicI2-9lPU -
J Controlled Release
@JCRnEDITORS
Antibody polymer drug conjugates with increased drug to antibody ratio: CD38-targeting nanomedicines for innovative therapy of relapsed lymphomas.
| Tomáš Etrych @CzechAcademy |
[Open Access]
#polymerdrugconjugate #lymphoma
doi.org/10.1016/j.jconrel.2025.113876 -
J Controlled Release
@JCRnEDITORS
“Actual” peptide properties required for nanoparticle development in precision cancer therapeutic delivery.
| Tin Wui Wong, Universiti Teknologi MARA Selangor |
[50 days' free access]
#peptide #targeting
authors.elsevier.com/a/1lAObcI2-9lP5 -
J Controlled Release
@JCRnEDITORS
Conductive bioadhesive hydrogel with controlled astragaloside IV release for ferroptosis-mediated cardiac repair.
| Yun Liu, Nanjing Medical Univ. |
[50 days' free access]
#hydrogel #conductivenanoparticle #cardiacrepair
authors.elsevier.com/a/1lAQwcI2-9lQK -
J Controlled Release
@JCRnEDITORS
www.youtube.com/watch?v=xwDH2DXR8wg
Controlled Release Society
@CRSScience
Tune into the latest episode of "Spotlight Chats" hosted by Sara Cordeiro! She speaks with Prof Assaf Zinger, Chair of the Annual Meeting Program Committee , & CRS 2025 AM&E, the efforts that go on behind the scenes, & what attendees can expect. www.youtube.com/watch?v=xwDH2DXR8wg
-
J Controlled Release
@JCRnEDITORS
Injectable thermosensitive hydrogel for local and controlled delivery of siRNA-STAT3 polyplexes to treat advanced-stage ovarian cancer.
| Tina Vermonden @UUPharmaceutics | @CRSBeNeLuxFr
[50 days' free access]
#hydrogel #thermosensitive #sirna #polyplex
doi.org/10.1016/j.jconrel.2025.113890 -
J Controlled Release
@JCRnEDITORS
Advances in transcription factor delivery: Target selection, engineering strategies, and delivery platforms.
| In-San Kim @KISTKOREA | @KoreaCRS
[Open Access]
#transcriptionfactor #cellreprogramming
doi.org/10.1016/j.jconrel.2025.113885 -
J Controlled Release
@JCRnEDITORS
Long-acting glucose-responsive insulin with swift onset-of-action.
| Zhen Gu @ZJU_China |
[50 days' free access]
#insulindelivery #glucoseresponsive
authors.elsevier.com/a/1l9mFcI2-9lIq -
J Controlled Release
@JCRnEDITORS
Local controlled release of stabilized monoclonal antibodies.
| Steven P. Schwendeman @UMichPharmacy |
[50 days' free access]
#implant #antibody #controlledrelease
authors.elsevier.com/a/1l9SKcI2-9l5n -
J Controlled Release
@JCRnEDITORS
A combinatorial siRNA and mRNA approach for obesity treatment using targeting lipid nanoparticles.
| Xiaoyang Xu @NJIT |
[50 days' free access]
#sirna #mrna #lipidnanoparticle #obesity
authors.elsevier.com/a/1l8zWcI2-9lNg -
J Controlled Release
@JCRnEDITORS
Dissolving microneedles in transdermal drug delivery: A critical analysis of limitations and translation challenges.
| Davide Brambilla @pharm_umontreal |
[Open Access]
#transdermal #microneedle
doi.org/10.1016/j.jconrel.2025.113794 -
J Controlled Release
@JCRnEDITORS
Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy.
| I. Lentacker @UGent_Pharma | @CRSBeNeLuxFr
[50 days' free access]
#physicaltherapy #ablation #focusedultrasound #photothermal
authors.elsevier.com/a/1lA4ccI2-9l2M -
J Controlled Release
@JCRnEDITORS
Direct structural investigation of pH responsiveness in mRNA lipid nanoparticles: Refining paradigms.
| Peter Langguth, Johannes Gutenberg-Univ. | @CRS_DeChAt_LC
[Open Access]
#mrnadelivery #phresponsive
doi.org/10.1016/j.jconrel.2025.113848 -
J Controlled Release
@JCRnEDITORS
Artificial lipids and macrophage membranes coassembled biomimetic nanovesicles for thoracic aortic dissection treatment.
| Yuyu Li, Capital Medical Univ. |
[Open Access]
#macrophagemembrane #liposome
doi.org/10.1016/j.jconrel.2025.113844 -
J Controlled Release
@JCRnEDITORS
Predicting lymphatic transport potential using graph transformer based on limited historical data from in vivo studies.
| Sifei Han, China Pharmaceutical Univ. |
[50 days' free access]
#lymphatictransport #artificialintelligence #graphtransformer
authors.elsevier.com/a/1l95mcI2-9lM3 -
J Controlled Release
@JCRnEDITORS
Nano-immunomodulator amplifies STING activation in tumor-associated macrophages for cancer immunotherapy.
| Zhaohui Wang, Peking Union Medical College |
[50 days' free access]
#tumorassociatedmacrophage #immunotherapy
authors.elsevier.com/a/1l82fcI2-9lLt -
J Controlled Release
@JCRnEDITORS
Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9.
| Kristy M. Ainslie @DPMP_UNC | @AinslieLab
[50 days' free access]
#nasaldelivery #adjuvant #vaccine #selfassembly
authors.elsevier.com/a/1l8cjcI2-9lNI -
J Controlled Release
@JCRnEDITORS
Single particle charge detection mass spectrometry enables molecular characterization of lipid nanoparticles and mRNA packaging.
| Evan R. Williams @UCB_Chemistry |
[Open Access]
#lipidnanoparticle #mrna #packaging #massspectrometry
doi.org/10.1016/j.jconrel.2025.113856 -
J Controlled Release
@JCRnEDITORS
Receptor-mediated transcytosis of nanobodies targeting the heparin-binding EGF-like growth factor in human blood-brain barrier models/
| Massimiliano Caiazzo @UUUIPS | @CRSBeNeLuxFr
[Open Access]
#nanobody #transcytosis #bloodbrainbarrier
doi.org/10.1016/j.jconrel.2025.113852 -
J Controlled Release
@JCRnEDITORS
Mitochondria-targeted and ROS-sensitive main-chain ruthenium polymer overcomes cancer drug resistance.
| Qingfeng Zheng, Peking Union Medical College |
[50 days' free access]
#metalpolymer #ruthenium #mitochondria
authors.elsevier.com/a/1l82fcI2-9lKw -
J Controlled Release
@JCRnEDITORS
In situ therapeutic vaccines for leukemia by chemo-nanoadjuvant therapy.
| Zhiyuan Zhong, Soochow Univ. |
[50 days' free access]
#nanoadjuvant #vaccine #leukemia
authors.elsevier.com/a/1l82fcI2-9lMj -
J Controlled Release
@JCRnEDITORS
Focused ultrasound augments the delivery and penetration of model therapeutics into cerebral cavernous malformations.
| Richard J. Price @UVABME |
[50 days' free access]
#braindelivery #focusedultrasound #bloodbrainbarrier
authors.elsevier.com/a/1l857_3r0J7Ny1 -
J Controlled Release
@JCRnEDITORS
Developing bioinspired delivery systems for enhanced tumor penetration of macromolecular drugs.
| Xianghui Xu @hunanuniv |
[50 days' free access]
#macromolecule #tissuepenetration
authors.elsevier.com/a/1l857cI2-9lLh -
J Controlled Release
@JCRnEDITORS
Microneedle-adapted PAMAM-BSH delivery facilitates spatiotemporal matching for melanoma boron neutron capture therapy.
| Kui Chen @CAS__Science |
[50 days' free access]
#microneedle #dendrimer #boronneutroncapturetherapy
authors.elsevier.com/a/1l87jcI2-9lOX -
J Controlled Release
@JCRnEDITORS
Highly pure mRNA vaccine provides robust immunization against P. aeruginosa by minimizing type I interferon responses.
| Teiji Sawa, Kyoto Prefectural Univ. of Medicine |
[Open Access]
#mrnavaccine #purity #interferon
doi.org/10.1016/j.jconrel.2025.113860 -
J Controlled Release
@JCRnEDITORS
doi.org/10.1016/j.jconrel.2025.113855
Pharmacoengineering & Mol Pharmaceutics (DPMP UNC)
@DPMP_UNC
Latest findings in @JCRnEDITORS , "Broadly Protective Intranasal Influenza Vaccine Using a Nanocomplex Adjuvant" by @AinslieLab and Eric Bachelder, PhD; w/ PhD candidates @GraceW_ChemE, Connor Murphy, and Nicole Rose Lukesh.
🔗 doi.org/10.1016/j.jconrel.2025.113855
@UNCPharmacy -
J Controlled Release
@JCRnEDITORS
Lipopeptide-mediated delivery of CRISPR/Cas9 ribonucleoprotein complexes for gene editing and correction.
| Olivier G. de Jong @UniUtrecht | @CRSBeNeLuxFr
[Open Access]
#geneediting #lipopeptide
doi.org/10.1016/j.jconrel.2025.113854 -
J Controlled Release
@JCRnEDITORS
M2 macrophage-targeted metal-polyphenol networks (MPNs) for OPN siRNA delivery and idiopathic pulmonary fibrosis therapy.
| Xiaodong Han @NanjingUnivers1 |
[50 days' free access]
#sirnadelivery #metalpolyphenolnetwork #fibrosis
authors.elsevier.com/a/1l8AVcI2-9lOL -
J Controlled Release
@JCRnEDITORS
Cannabidiol-loaded hydrogel contact lenses for on-demand pH regulation and enhanced corneal alkali burn repair.
| Gang-Biao Jiang, South China Agricultural Univ. |
[50 days' free access]
#hydrogel #contactlense #ondemand
authors.elsevier.com/a/1l8AVcI2-9lNt -
J Controlled Release
@JCRnEDITORS
Virus-mimicking nanoparticle potentiates in-situ cancer vaccines by reversing intratumoral DCs via stimulating cytosolic nucleic acid sensors.
| Wenguang Wang, China Pharmaceutical Univ. |
[50 days' free access]
#cancervaccine #rnaanalog #stingagonist
authors.elsevier.com/a/1l7zBcI2-9lEr -
J Controlled Release
@JCRnEDITORS
In vitro-in vivo relationship and microstructural insights into long-acting levonorgestrel intrauterine systems.
| Diane J. Burgess @UConnPharmacy |
[50 days' free access]
#intrauterine #longacting
authors.elsevier.com/a/1l7wd_3r0J7Nx~ -
J Controlled Release
@JCRnEDITORS
Multivalent assembly of nucleolin-targeted F3 peptide potentiates TRAIL's tumor penetration and antitumor effects.
| Hao Yang @SCUCN |
[50 days' free access]
#peptideassembly #nucleolin #tumorpenetration
authors.elsevier.com/a/1l7JHcI2-9lKF -
J Controlled Release
@JCRnEDITORS
www.controlledreleasesociety.org/member-benefits-and-fees
Controlled Release Society
@CRSScience
CRS is a hub for leaders in the field of delivery science, making it the prime place to make connections with individuals worldwide through: local chapters, focus groups, the membership directory, Young Scientist activities, & CRS meetings. Learn more: www.controlledreleasesociety.org/member-benefits-and-fees
-
J Controlled Release
@JCRnEDITORS
Mitochondria-specific GPX4 inhibition enhances ferroptosis and antitumor immunity.
| Yang Liu, Nankai Univ. |
[50 days' free access]
#polydopamine #mitochondriatargeting
authors.elsevier.com/a/1l7DvcI2-9lL6 -
J Controlled Release
@JCRnEDITORS
Acid-activated mitochondria-targeting nanoprodrug for reactive oxygen species (ROS)-tolerant cancer therapy via antioxidant defense inhibition.
| Shuaidong Huo @xmuchina |
[50 days' free access]
#prodrug #mitochondriatargeting
authors.elsevier.com/a/1l6becI2-9lLU -
J Controlled Release
@JCRnEDITORS
Nanogel encapsulation improves pharmacokinetics and biodistribution of antimicrobial peptide LL37 upon lung deposition: In vivo evaluation by SPECT/CT.
| Hanne Mørck Nielsen @UCPH_health |
[Open Access]
#nanogel #formulation #pharmacokinetics
doi.org/10.1016/j.jconrel.2025.113817 -
J Controlled Release
@JCRnEDITORS
Sustained codelivery of heat shock protein peptide and rapamycin via nano-in-hydrogel induces immune tolerance in rheumatoid arthritis.
| Zhiyuan Zhong, Soochow Univ. |
[50 days' free access]
#sustaineddelivery #hydrogel #lymphnode #arthritis
authors.elsevier.com/a/1l6KAcI2-9lLI -
J Controlled Release
@JCRnEDITORS
Programmable hierarchical hydrogel dressing for sequential release of growth factor and DNase to accelerate diabetic wound healing.
| Ran Mo, China Pharmaceutical Univ. |
[50 days' free access]
#hydrogel #woundhealing
authors.elsevier.com/a/1l6IMcI2-9lIe -
J Controlled Release
@JCRnEDITORS
Dual-action membrane-chimeric liposomes with self-reinforcing targeting for acute lung injury treatment.
| Qin He @SCUCN |
[50 days' free access]
#liposome #cellmembrane
authors.elsevier.com/a/1l6CQcI2-9lHt -
J Controlled Release
@JCRnEDITORS
Long-circulating enzyme-activated HSP90–targeted camptothecin derivatives.
| Shulei Zhu @ECNUER |
[50 days' free access]
#longcirculating #camptothecin
authors.elsevier.com/a/1l69EcI2-9lKq -
J Controlled Release
@JCRnEDITORS
Particle size matters: The impact of particle size on properties and performance of long-acting injectable crystalline aqueous suspensions.
| Jiaying Liu @Merck |
[50 days' free access]
#particlesize #suspension #longacting
authors.elsevier.com/a/1l5v9cI2-9lDc -
J Controlled Release
@JCRnEDITORS
Biomimetic nanosystems for pancreatic cancer therapy: A review.
| Carmen Alvarez-Lorenzo @UniversidadeUSC | @calvarezlorenzo @CRS_SPLC
[Open Access]
#exosome #cellmembranecoating #nanoparticle #biomimetic
doi.org/10.1016/j.jconrel.2025.113824 -
J Controlled Release
@JCRnEDITORS
IgM-functionalized biomimetic nanovaccine for immunological activation and bacterial toxin neutralization.
| Yuan Yu, Naval Medical Univ. |
[50 days' free access]
#nanovaccine #igm
authors.elsevier.com/a/1l5rrcI2-9lKG -
J Controlled Release
@JCRnEDITORS
Preface: In honor of Leaf Huang.
| Yunching Chen @NTHU_TAIWAN |
[50 days' free access]
authors.elsevier.com/a/1l5dAcI2-9lHb -
J Controlled Release
@JCRnEDITORS
Unlock the sustained therapeutic efficacy of mRNA.
| Yizhou Dong @IcahnMountSinai | @yizhoudonglab
[50 days' free access]
#mrnadelivery
authors.elsevier.com/a/1l5XccI2-9lKS -
J Controlled Release
@JCRnEDITORS
Animal vaccine revolution: Nanoparticle adjuvants open the future of vaccinology.
| Kai Zhao, Taizhou Univ. |
[50 days' free access]
#adjuvant #animalvaccine
authors.elsevier.com/a/1l5bC_3r0J7NxV -
J Controlled Release reposted
Pharmacoengineering & Mol Pharmaceutics (DPMP UNC)
@DPMP_UNC
Special Issue in @JCRnEDITORS honors Dr. Leaf Huang—a pioneer in drug & gene delivery. Pioneering advances from liposomes to immunotherapy.
doi.org/10.1016/j.jconrel.2025.113818
Kudos to @AinslieLab, @JulieNguyenLab, Olivia Merkel & @ChenYBecky for curating it! @UNCPharmacy -
J Controlled Release reposted
CRS Korea Chapter
@KoreaCRS
A great work by Prof. Kun Na's group on LNP with prazole adjuvant for mRNA cancer vaccine published in @JCRnEDITORS.
J Controlled Release
@JCRnEDITORS
Lipid nanoparticles with prazole adjuvant to enhance the efficacy of mRNA cancer vaccines.
| Kun Na, The Catholic Univ. of Korea | @KoreaCRS
[50 days' free access]
#mrnavaccine #adjuvant
authors.elsevier.com/a/1l2s9cI2-9l7n -
J Controlled Release
@JCRnEDITORS
Biomimetic liposomal nanovesicles remodel the tumor immune microenvironment to augment sono-immunotherapy.
| Li Qiu @SCUCN |
[50 days' free access]
#liposome #sonodynamic #immunotherapy
authors.elsevier.com/a/1l5Bx_3r0J7NxY -
J Controlled Release
@JCRnEDITORS
Reversing the immunosuppressive tumor microenvironment via “Kynurenine starvation therapy” for postsurgical triple-negative breast cancer treatment.
| Quanshun Li, Jilin Univ. |
[50 days' free access]
#hydrogel #postsurgical
authors.elsevier.com/a/1l5BxcI2-9lJh -
J Controlled Release
@JCRnEDITORS
Extracellular vesicle as therapeutic agents in anti-aging: Mechanistic insights and future potential.
| Chaemin Lim, CHA Univ. | @KoreaCRS
[50 days' free access]
#extracellularvesicle #antiaging
authors.elsevier.com/a/1l5TC_3r0J7Nx0 -
J Controlled Release
@JCRnEDITORS
Intracerebral delivery of the ionic liquid form of edaravone via nose-to-brain delivery route for treating cerebral ischemia/reperfusion injury.
| Tatsuya Fukuta, Wakayama Medical Univ. |
[50 days' free access]
#intracerebraldelivery #ionicliquid
authors.elsevier.com/a/1l58FcI2-9lK3 -
J Controlled Release
@JCRnEDITORS
Neutrophil membrane engineered human umbilical cord MSC-derived sEVs enhance anti-tumor efficacy for gastric cancer via delivering pentraxin 3.
| Jiajia Jiang, Jiangsu Univ. |
[50 days' free access]
#exosome #neutrophil
authors.elsevier.com/a/1l4iAcI2-9lJ1 -
J Controlled Release
@JCRnEDITORS
Integrity of polymeric micelles regulates bioavailability of cyclosporine A: A FRET-based analysis during oral delivery.
| Xing Tang, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#oraldelivery #polymericmicelle #bioavailability
authors.elsevier.com/a/1l4DBcI2-9lJV -
J Controlled Release
@JCRnEDITORS
Formulation-optimized oncolytic viruses: Advancing systemic delivery and immune amplification.
| Yingying Hao, China Medical Univ. |
[Open Access]
#oncolyticvirus #systemicdelivery #encapsulation
doi.org/10.1016/j.jconrel.2025.113822 -
J Controlled Release
@JCRnEDITORS
Homologous magnetic targeted immune vesicles for amplifying immunotherapy via ferroptosis activation augmented photodynamic therapy against glioblastoma.
| Ruoning Wang, Nanjing Univ. of Chinese Medicine |
[50 days' free access]
#exosome #ferroptosis
authors.elsevier.com/a/1l3vZcI2-9lHD -
J Controlled Release
@JCRnEDITORS
Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy.
| Ronit Satchi-Fainaro @TelAvivUni | @RSFLab
[Open Access]
#nanoparticle #spheroid #radiotherapy
doi.org/10.1016/j.jconrel.2025.113812 -
J Controlled Release
@JCRnEDITORS
Ultrasound-responsive release of CD39 inhibitor overcomes adenosine-mediated immunosuppression in triple-negative breast cancer.
| Pintong Huang @ZJU_China |
[50 days' free access]
#ultrasound #sonodynamic
authors.elsevier.com/a/1l3olcI2-9lHc -
J Controlled Release
@JCRnEDITORS
Impact of pre-existing anti-polyethylene glycol (PEG) IgM on biodistribution and humoral response of intramuscularly administered PEGylated mRNA loaded lipid nanoparticle.
| Tatsuhiro Ishida @TokushimaUniv |
[50 days' free access]
#pegylation
authors.elsevier.com/a/1l3olcI2-9lI3 -
J Controlled Release
@JCRnEDITORS
Novel in vitro model for intravitreal drug dissolution and release studies of small molecules and their long-acting formulations.
| Astrid Subrizi @UniEastFinland |
[50 days' free access]
#intravitreal #longacting
authors.elsevier.com/sd/article/S0168-3659(25)00443-2 -
J Controlled Release
@JCRnEDITORS
Nanoparticles in nuclear medicine: From diagnostics to therapeutics.
| Roger M. Pallares @RWTH | @CRS_DeChAt_LC
[Open Access]
#nuclearmedicine #theranostic #imaging doi.org/10.1016/j.jconrel.2025.113815 -
J Controlled Release
@JCRnEDITORS
Dual-functional hCe-pHEMA contact lenses for ocular antibiotic release, antioxidant protection, and in vivo corneal bacterial infection treatment.
| Ruilong Sheng @U_Madeira | @CRS_SPLC
[50 days' free access]
#oculardelivery #contactlense #antibiotic
authors.elsevier.com/a/1l3Pw_3r0J7NxH -
J Controlled Release
@JCRnEDITORS
Metal phenolic networks-driven bufalin homodimeric prodrug nano-coassemblies for ferroptosis-augmented tumor therapy.
| Weihai Liu @sysu_1924 |
[50 days' free access]
#prodrug #metalphenolicnetwork #ferroptosis
authors.elsevier.com/a/1l3PXcI2-9lGr -
J Controlled Release
@JCRnEDITORS
Bioadhesive drug-loaded microparticles prolong drug retention in the middle ear and ameliorate cisplatin-induced hearing loss.
| Kai Xu, Nanchang Univ. |
[Open Access]
#microparticle #bioadhesive #hearingloss
doi.org/10.1016/j.jconrel.2025.113728 -
J Controlled Release
@JCRnEDITORS
Empowering bacteria with light: Optogenetically engineered bacteria for light-controlled disease theranostics and regulation.
| Fei Chen @CentralSouth_U |
[50 days' free access]
#theranostic #optogenetics #phototherapy
authors.elsevier.com/a/1l3N0cI2-9lCl -
J Controlled Release
@JCRnEDITORS
Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer.
| Álvaro Somoza @IMDEA_Nano | @CRS_SPLC
[50 days' free access]
#mirnamimic #magneticnanoparticle
authors.elsevier.com/a/1l3KkcI2-9lDE -
J Controlled Release
@JCRnEDITORS
Delivery of Itgb1-siRNA by triptolide-modified and anti-Flt1 peptide-guided ionizable cationic LNPs for targeted therapy of corneal neovascularization.
| Canwei Zhang, Nanchang Medical College |
[50 days' free access]
#sirnadelivery #ionizablelipid
authors.elsevier.com/a/1l2s9cI2-9lGS -
J Controlled Release
@JCRnEDITORS
Lipid nanoparticles with prazole adjuvant to enhance the efficacy of mRNA cancer vaccines.
| Kun Na, The Catholic Univ. of Korea | @KoreaCRS
[50 days' free access]
#mrnavaccine #adjuvant
authors.elsevier.com/a/1l2s9cI2-9l7n -
J Controlled Release
@JCRnEDITORS
Metal-phenolic epigallocatechin gallate‑zinc antioxidant nanoparticles for cataract treatment.
| Quankui Lin @WMU1958 |
[50 days' free access]
#metalphenolicnetwork #cataract
authors.elsevier.com/a/1l2s9cI2-9lEN -
J Controlled Release
@JCRnEDITORS
Hypoxia-responsive albumin nanoparticles co-delivering banoxantrone and STING agonist enhance immunotherapy of high-intensity focused ultrasound.
| Huanan Li, Chongqing Medical Univ. |
[50 days' free access]
#ultrasound #albuminnanoparticle
authors.elsevier.com/a/1l2mqcI2-9lCy -
J Controlled Release
@JCRnEDITORS
Targeted eradication of glioblastoma via venom decapeptide-conjugated dendrimers: Inducing nuclear translocation and autophagic cell death.
| Hang Fai Kwok @UM_1981 |
[50 days' free access]
#dendrimer #venompeptide #nucleartranslocation
authors.elsevier.com/a/1l2kqcI2-9lBc -
J Controlled Release
@JCRnEDITORS
Cardiosplenic axis-targeted immunomodulatory liposome for myocardial ischemia-reperfusion injury treatment.
| Weisheng Guo, Guangzhou Medical Univ. |
[50 days' free access]
#spleentargeting #liposome #ischemia
authors.elsevier.com/a/1l2eBcI2-9lEZ -
J Controlled Release
@JCRnEDITORS
An injectable hydrogel enhances intratumoral retention and antitumor efficacy of cytokine immunotherapy in murine triple negative breast tumor models.
| David A. Zaharoff @jointbme |
[Open Access]
#hydrogel #intratumoral #immunotherapy
doi.org/10.1016/j.jconrel.2025.113761 -
J Controlled Release
@JCRnEDITORS
Multilayer cascade-response nanoplatforms as metabolic symbiotic disruptors to reprogram the immunosuppressive microenvironment.
| Jie Li @ShandongU |
[50 days' free access]
#ultrasound #hyaluronidase #metabolicsymbiosis
authors.elsevier.com/a/1l1uCcI2-9lEB -
J Controlled Release
@JCRnEDITORS
Formulation of siRNA nanoparticles, transfection and enhanced adhesion -penetration in nasal mucosal tissue.
| Ravin Narain @UAlberta_Eng |
[Open Access]
#mucosaldelivery #sirna #transfection
doi.org/10.1016/j.jconrel.2025.113790 -
J Controlled Release
@JCRnEDITORS
Hybrid membrane-coated Cyclosporine A nanocrystals preventing secondary brain injury via alleviating neuroinflammatory and oxidative stress.
| Daozhou Liu, Air Force Medical Univ. |
[50 days' free access]
#nanocrystal #membranecoating
authors.elsevier.com/a/1l1dtcI2-9lD~ -
J Controlled Release
@JCRnEDITORS
Design Strategies for Hyaluronic Acid-based Drug Delivery Systems in Cancer Immunotherapy.
| Alessio Malfanti, UCLouvain | @CRSBeNeLuxFr
[Open Access]
#hyaluronicacid #immunotherapy
doi.org/10.1016/j.jconrel.2025.113784 -
J Controlled Release
@JCRnEDITORS
Smart on-demand drug release strategies for cancer combination therapy.
| Tingjie Yin, China Pharmaceutical Univ. |
[50 days' free access]
#ondemand #drugrelease #stimuliresponsive
authors.elsevier.com/a/1l1PC_3r0J7Nwo -
J Controlled Release
@JCRnEDITORS
Metal-phenolic networks reverse the immunosuppressive tumor microenvironment via dual metabolism regulation and immunogenic cell death.
| Yeu-Chun Kim @kaistpr | @KoreaCRS
[50 days' free access]
#zincoxide #tumormicroenvironment #metabolism
authors.elsevier.com/a/1l1KVcI2-9lAp -
J Controlled Release
@JCRnEDITORS
Nanoparticle-mediated dual targeting of stromal and immune components to overcome fibrotic and immunosuppressive barriers in hepatocellular carcinoma.
| Chihua Fang @smu_medical |
[50 days' free access]
#liposome #nanofiber #cancerassociatedfibroblast
authors.elsevier.com/a/1l1HHcI2-9lB- -
J Controlled Release
@JCRnEDITORS
Sequentially conquering transfection obstacles of primary human T cells via non-classical lipid nanoparticles delivering reformative transposon system.
| Can Zhang, China Pharmaceutical Univ. |
[50 days' free access]
#lipidnanoparticle #transfection
authors.elsevier.com/a/1l1HHcI2-9lBO -
J Controlled Release
@JCRnEDITORS
Understanding drug release mechanisms of risperidone in situ forming implant depots in rabbits.
| Diane J. Burgess @UConnPharmacy |
[50 days' free access]
#implant #insituforming #drugrelease
authors.elsevier.com/a/1l1HHcI2-9lCN -
J Controlled Release
@JCRnEDITORS
Targeting tumor extracellular matrix with nanoparticles to circumvent therapeutic resistance.
| Zhiwen Zhang @FudanUniv |
[50 days' free access]
#extracellularmatrix
authors.elsevier.com/a/1l1EYcI2-9lCZ -
J Controlled Release
@JCRnEDITORS
Reprogramming of radiation-deteriorated TME by liposomal nanomedicine to potentiate radio-immunotherapy.
| Teng Liu, Soochow Univ. |
[50 days' free access]
#liposome #hypoxia #tumormicroenvironment #radioimmunotherapy
authors.elsevier.com/a/1l1EYcI2-9lDQ -
J Controlled Release
@JCRnEDITORS
Amplifying STING activation by biomimetic manganese mRNA nanovaccines for local and systemic cancer immunotherapy.
| Jingjing Li @MedicalXuzhou |
[50 days' free access]
#mrnavaccine #lymphnode
authors.elsevier.com/a/1l18scI2-9lCm -
J Controlled Release
@JCRnEDITORS
Hierarchically structured conductive hydrogels for electrically programmable drug delivery in a diabetic wound healing electronic patch.
| Wei-Chen Huang @NYCU_official | @CRS_TW_Local
[50 days' free access]
#electronicpatch #microcapsule #woundhealing
authors.elsevier.com/a/1l0ntcI2-9l8R -
J Controlled Release
@JCRnEDITORS
Hydrogel-enabled ROS-GSH modulation for sustained copper-mediated chemodynamic therapy of oral squamous cell carcinoma.
| Ronghui Zhou @SCUCN |
[50 days' free access]
#hydrogel #chemodynamic
authors.elsevier.com/a/1l0lL_3r0J7Nwe -
J Controlled Release
@JCRnEDITORS
Hydrophobic ion pairing enables co-loading of water-soluble drugs in polymeric micelles.
| Tarun Ojha @RWTH | @CRS_DeChAt_LC
[Open Access]
#polymericmicelle #ionparing
doi.org/10.1016/j.jconrel.2025.113748 -
J Controlled Release
@JCRnEDITORS
Collagenase-modified polydopamine nanoparticles for safe and effective vitreolysis.
| Katrien Remaut @UGent_Pharma | @CRSBeNeLuxFr @CRS_FG_Ocular
[50 days' free access]
#polydopamine #collagenase #virteolysis
authors.elsevier.com/a/1l0aYcI2-9l7O -
J Controlled Release
@JCRnEDITORS
“Capture and kill” circulating fibrocytes by cisplatin prodrug loaded albumin disrupt the progress of pulmonary fibrosis in mice.
| Yang Liu @sysu_1924 |
[50 days' free access]
#prodrug #albumin #fibrocyte #fibrosis
authors.elsevier.com/a/1l0XqcI2-9lBo -
J Controlled Release
@JCRnEDITORS
Cell membrane nanoparticles in cancer therapy: From basic structure to surface functionalization.
| Yeu-Chun Kim @kaistpr | @KoreaCRS
[50 days' free access]
#cellmembranenanoparticle
authors.elsevier.com/a/1l0HScI2-9l7C -
J Controlled Release
@JCRnEDITORS
FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cells.
| Giuseppe Ercolano, Federico II University of Napoli | @CRS_Italia
[Open Access]
#nitricoxide #drugresistance
doi.org/10.1016/j.jconrel.2025.113732 -
J Controlled Release
@JCRnEDITORS
Soluble-microneedle enhance three T-cell activation signals as efficient tumor vaccines for melanoma prevention and treatment.
| Yongjun Liu @ShandongU |
[50 days' free access]
#microneedle #tumorvaccine #melanoma
authors.elsevier.com/a/1l0RScI2-9l37 -
J Controlled Release
@JCRnEDITORS
Transformable albumin-based nanocapsules selectively amplify tumor starvation and disulfidptosis through metabolic deception.
| Shouju Wang, Nanjing Medical Univ. |
[50 days' free access]
#nanocapsule #disulfidptosis
authors.elsevier.com/a/1l0RScI2-9l57 -
J Controlled Release
@JCRnEDITORS
Promoting retinal ganglion cell regeneration with targeted liposome-based delivery of MHY1485 for optic nerve repair.
| Renjun Pei @USTCGlobal |
[50 days' free access]
#liposome #ganglioncell #nerverepair
authors.elsevier.com/a/1l0RScI2-9lBC -
J Controlled Release
@JCRnEDITORS
Gastric-mucus penetrating and responsive microgels for alleviating Helicobacter pylori-induced gastritis.
| Yuan Li, China Agricultural Univ. |
[50 days' free access]
#microgel #mucus #gastritis
authors.elsevier.com/a/1l0Oe_3r0J7Nw9 -
J Controlled Release
@JCRnEDITORS
Centrifugally spun and ZnO-infiltrated PVA fibers with antibacterial activity for treatment of Acne vulgaris.
| Jan M. Macak @UniPardubice |
[50 days' free access]
#nanocrystal #zincoxide #antibacterial
authors.elsevier.com/a/1l0M7cI2-9lBB -
J Controlled Release
@JCRnEDITORS
Bioinspired hydrogel microspheres enhance nucleus pulposus regeneration through N-cadherin interaction with extracellular matrix mimicry.
| Yong Xu, Soochow Univ.|
[50 days' free access]
#hydrogel #microsphere #extracellularmatrix
authors.elsevier.com/a/1l0JRcI2-9lAE -
J Controlled Release
@JCRnEDITORS
Leech bionic Hirudin fusion protein prodrug loaded microneedles for long-term inhibition of thrombosis.
| Tianyue Jiang @NanjingTech |
[50 days' free access]
#microneedle #prodrug #thrombosis
authors.elsevier.com/a/1l02OcI2-9l8L -
J Controlled Release
@JCRnEDITORS
Unleashing the power of nucleic acid therapeutics through efficient cytosolic delivery.
| Fanfei Meng @UMassLowell |
[50 days' free access]
#cytosolicdelivery #nucleicacid
authors.elsevier.com/a/1k--JcI2-9lAd -
J Controlled Release
@JCRnEDITORS
Polymersome-enabled brain Codelivery of STAT3 siRNA and CpG oligonucleotide boosts chemo-immunotherapy of malignant glioma.
| Zhiyuan Zhong, Soochow Univ. |
[50 days' free access]
#sirnadelivery #cpg #glioma
authors.elsevier.com/a/1k-BmcI2-9l90 -
J Controlled Release
@JCRnEDITORS
A T7 autogene-mediated DNA vaccine platform for SARS-CoV-2: Overcoming DNA vaccine limitations with enhanced spike mRNA production.
| Hyung Jun Ahn @KISTKOREA | @KoreaCRS
[Open Access]
#dnavaccine #autogene #transcription #distribution
doi.org/10.1016/j.jconrel.2025.113776 -
J Controlled Release
@JCRnEDITORS
Expediting 3D printed medication development using vacuum compression moulding.
| Abdul W. Basit @ucl | @ProfAWBasit @UKICRS
[Open Access]
#3dprinting
doi.org/10.1016/j.jconrel.2025.113766 -
J Controlled Release
@JCRnEDITORS
The pharmacokinetic profile of mitomycin C released from an injectable supramolecular hydrogel in a rodent model.
| Nicole D. Bouvy, Maastricht Univ. | @CRSBeNeLuxFr
[Open Access]
#hydrogel #injectable #pharmacokinetic
doi.org/10.1016/j.jconrel.2025.113763 -
J Controlled Release
@JCRnEDITORS
A “Janus” structured nanoclay microgel system for targeted probiotic therapy in diarrhea-predominant irritable bowel syndrome.
| Lanjuan Li @ZJU_China |
[Open Access]
#microgel #nanoclay #probiotic
doi.org/10.1016/j.jconrel.2025.113769 -
J Controlled Release
@JCRnEDITORS
Targeted delivery of engineered adipose-derived stem cell secretome to promote cardiac repair after myocardial infarction.
| Jianjun Guan @WashU |
[Open Access]
#membranecoating #platelet #secretome #stemcell #cardiacrepair
doi.org/10.1016/j.jconrel.2025.113765 -
J Controlled Release
@JCRnEDITORS
Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation.
| Wooram Park @SKKU_1398 | @KoreaCRS
[50 days' free access]
#lipidnanoparticle #neutrophilextracellulartrap
authors.elsevier.com/a/1l08lcI2-9l4k -
J Controlled Release
@JCRnEDITORS
Cancer nanomedicine from a clinician-scientist perspective: Lessons and prospects.
| Alberto A. Gabizon @HebrewU |
[Open Access]
#liposome #lipidnanoparticle #immunotherapy
doi.org/10.1016/j.jconrel.2025.113731 -
J Controlled Release
@JCRnEDITORS
In vivo delivery of antioxidant enzymes with multi-functionalized lipid nanoparticles for sepsis therapy.
| Hiroyuki Koide, Univ. of Shizuoka |
[50 days' free access]
#lipidnanoparticle #sepsis
authors.elsevier.com/a/1k-B7cI2-9l4M -
J Controlled Release
@JCRnEDITORS
Stimuli-responsive hydrogel with spatiotemporal co-delivery of FGF21 and H₂S for synergistic diabetic wound repair.
| Zhou-Guang Wang @WMU1958 |
[50 days' free access]
#hydrogel #stimuliresponsive #woundrepair
authors.elsevier.com/a/1k~tNcI2-9l6k -
J Controlled Release
@JCRnEDITORS
Advancements in delivery Systems for Proteolysis-Targeting Chimeras (PROTACs): Overcoming challenges and expanding biomedical applications.
| Jianqing Gao @ZJU_China |
[50 days' free access]
#protac #proteolysis
authors.elsevier.com/a/1k~gXcI2-9l24 -
J Controlled Release
@JCRnEDITORS
Slow intravenous infusion reduces the accelerated blood clearance of PEGylated liposomes by removing anti-PEG antibodies.
| Yang Li, Chongqing Medical Univ. |
[50 days' free access]
#pegylation #liposome #infusion
authors.elsevier.com/a/1k~gXcI2-9l8p -
J Controlled Release
@JCRnEDITORS
Promoting mitocytosis via gene-engineered aligned fibers for fascia regeneration.
| Xinliang Chen @sjtu1896 |
[50 days' free access]
#genedelivery #nanofiber #mitocytosis #tissuerepair
authors.elsevier.com/a/1k~gXcI2-9l2x -
J Controlled Release
@JCRnEDITORS
Vinpocetine-mediated multidimensional active targeted delivery across the blood-brain barrier.
| Chong Li @smu_medical |
[50 days' free access]
#braindelivery #bloodbrainbarrier #vinpocetin
authors.elsevier.com/a/1k~gXcI2-9l9m -
J Controlled Release
@JCRnEDITORS
Sinomenine-glycyrrhizic acid self-assembly enhanced the anti-inflammatory effect of sinomenine in the treatment of rheumatoid arthritis.
| Anlong Xu, Beijing Univ. of Chinese Medicine |
[50 days' free access]
#hydrogel #selfassembly #sinomenine #arthritis
authors.elsevier.com/a/1k~iQcI2-9l1u -
J Controlled Release
@JCRnEDITORS
Hypoxia-responsive oncolytic conjugate triggers type-II immunogenic cell death for enhanced photodynamic immunotherapy.
| Xin Luan, Shanghai Univ. of Traditional Chinese Medicine |
[50 days' free access]
#conjugate #hypoxiaresponsive #photodynamic
authors.elsevier.com/a/1k~dWcI2-9l1i -
J Controlled Release
@JCRnEDITORS
Development of radioligands wtih an albumin-binding moiety of 4-(P-Iodophenyl)butyric acid for theranostic applications.
| Zhide Guo @xmuchina |
[50 days' free access]
#theranostic #radioligand
authors.elsevier.com/a/1k~7gcI2-9l7z -
J Controlled Release
@JCRnEDITORS
Brain-targeting biomimetic nanozyme enhances neuroprotection in ischemic stroke by remodeling the neurovascular unit.
| Wenxiu He @ShandongU |
[50 days' free access]
#braindelivery #nanozyme #neuroprotection
authors.elsevier.com/a/1k~4ycI2-9l6q -
J Controlled Release
@JCRnEDITORS
Linoleic acid co-administration promotes oral delivery of exenatide-loaded butyrate-decorated nanocapsules.
| Xing Tang, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#oraldelivery #nanocapsule #exenatide
authors.elsevier.com/a/1kzvmcI2-9l5z -
J Controlled Release
@JCRnEDITORS
Reversing hypoxia-induced immune evasion in tumors to enhance cancer immunotherapy.
| Lei Qiao @USTCGlobal |
[50 days' free access]
#redoxresponsive #chitosan #hypoxicmicroenvironment
authors.elsevier.com/a/1kzvmcI2-9l69 -
J Controlled Release
@JCRnEDITORS
If you want to go far, go together.
| Laura M. Ensign @HopkinsMedicine | @LauraEnsignPhD
[Open Access]
doi.org/10.1016/j.jconrel.2025.113746 -
J Controlled Release reposted
CRS Korea Chapter
@KoreaCRS
An interesting article by Prof. Yong-Sung Kim on intracellular drug delivery using an engineered IgG antibody published in @JCRnEDITORS @AjouUniv
J Controlled Release
@JCRnEDITORS
Engineering IgG antibodies for intracellular targeting and drug delivery.
| Yong-Sung Kim @AjouUniv | @KoreaCRS
[50 days' free access]
#intracellulartargeting #endosomalescape
authors.elsevier.com/a/1kxk~cI2-9l3J -
J Controlled Release
@JCRnEDITORS
Precisely edited gut microbiota by tungsten-doped Prussian blue nanoparticles for the treatment of inflammatory bowel disease.
| Lin Mei, Peking Union Medical College |
[50 days' free access]
#prussianblue #microbiota #inflammatoryboweldiesease
authors.elsevier.com/a/1kztz_3r0J7NwN -
J Controlled Release
@JCRnEDITORS
Intracellular processing of DNA-lipid nanoparticles: A quantitative assessment by image segmentation.
| Jörg Huwyler @UniBasel_en |
[Open Access]
#genedelivery #lipidnanoparticle #endosomalrecycling
doi.org/10.1016/j.jconrel.2025.113709 -
J Controlled Release
@JCRnEDITORS
Biomimetic hyaluronic acid-stabilized zinc oxide nanoparticles in acne treatment: A preclinical and clinical approach.
| Wenhu Zhou @CentralSouth_U |
[50 days' free access]
#zincoxide #hyaluronicacid #antibacterial
authors.elsevier.com/a/1kztzcI2-9l7a -
J Controlled Release
@JCRnEDITORS
Fate reversal: Exosome-driven macrophage rejuvenation and bacterial-responsive drug release for infection immunotherapy in diabetes.
| Haobo Wu @ZJU_China |
[50 days' free access]
#exosome #drugrelease
authors.elsevier.com/a/1kzmscI2-9l3n -
J Controlled Release
@JCRnEDITORS
It's not right, it's not even wrong.
| Michael V. Sefton @ChemEng_UofT |
[50 days' free access]
#hydrogel #tissueengineering
authors.elsevier.com/a/1ky5ZcI2-9l1V -
J Controlled Release
@JCRnEDITORS
Harnessing innovation in microneedle technology for Women's healthcare.
| Xin Dong Guo @BeijingChemical |
[50 days' free access]
#microneedle #vaccine
authors.elsevier.com/a/1kzMmcI2-9l04 -
J Controlled Release
@JCRnEDITORS
Gentle and efficient engineering of primary human NK cells by photoporation with polydopamine nanosensitizers.
| K. Braeckmans @UGent_Pharma | @CRSBeNeLuxFr
[50 days' free access]
#photoporation #polydopaminenanoparticle #naturalkillercell
authors.elsevier.com/a/1kyXKcI2-9l5b -
J Controlled Release
@JCRnEDITORS
Synergistic chemo-photothermal treatment via MXene-encapsulated nanoparticles for targeted melanoma therapy.
| Ki Su Kim @PusanUni | @KoreaCRS
[50 days' free access]
#mxene #photothermal #melanoma
authors.elsevier.com/a/1kyGfcI2-9l3h -
J Controlled Release
@JCRnEDITORS
Apigenin-loaded nanoparticles for obesity intervention through immunomodulation and adipocyte browning.
| Ryan M. Pearson @TerasakiInst |
[50 days' free access]
#nanoparticle #adipocytebrowning #inflammatorymicroenvironment
authors.elsevier.com/a/1kzaVcI2-9kwL -
J Controlled Release
@JCRnEDITORS
A ROS-responsive nanoprodrug-engineered phage biotherapy for precision treatment of multidrug-resistant Gram-negative bacterial pneumonia.
| Gaoxing Luo, Army Medical Univ. |
[50 days' free access]
#prodrug #phageengineering #pneumonia
authors.elsevier.com/a/1kzaVcI2-9l0H -
J Controlled Release
@JCRnEDITORS
Tough and waterproof microneedles overcome mucosal immunotolerance by modulating antigen release patterns.
| Xun Sun @SCUCN |
[50 days' free access]
#microneedle #mucosalvaccine #silicananoparticle
authors.elsevier.com/a/1kyl5cI2-9l5O -
J Controlled Release
@JCRnEDITORS
Tailoring the release of highly loaded amorphous solid dispersions via additive manufacturing.
| Martin Spoerk @tugraz |
[50 days' free access]
#soliddispersion #additivemanufacturing #3dprinting
authors.elsevier.com/a/1kyM9cI2-9l2k -
J Controlled Release
@JCRnEDITORS
Regulated cell death mechanisms in mitochondria-targeted phototherapy.
| Jong Seung Kim, Korea Univ. | @KoreaCRS
[50 days' free access]
#phototherapy #mitophagy
authors.elsevier.com/a/1ky30cI2-9l2A -
J Controlled Release
@JCRnEDITORS
Dimethylamino-based synthetic lipidoid nanoparticles for selective mRNA delivery to splenic antigen-presenting cells.
| Min Qiu @FudanUniv |
[50 days' free access]
#mrnadelivery #lipidoid #spleentargeting
authors.elsevier.com/a/1ky30cI2-9l4w -
J Controlled Release
@JCRnEDITORS
Potent therapeutic efficacy of intranasally deliverable paclitaxel modified with pH-sensitive and PEGylated polymeric micelle against glioblastoma.
| Chae-Ok Yun @i_hanyang | @KoreaCRS
[50 days' free access]
#intranasal #micelle #phsensitive
authors.elsevier.com/a/1kxOecI2-9l0l -
J Controlled Release
@JCRnEDITORS
Current strategies for senescence treatment: Focused on theranostic performance of nanomaterials.
| Hao Hong @NanjingUnivers1 |
[50 days' free access]
#theranostic #senescence
authors.elsevier.com/a/1kxZb_3r0J7Nvg -
J Controlled Release
@JCRnEDITORS
Engineering stable prodrug self-assemblies by introducing the bromination effect.
| Bingjun Sun, Shenyang Pharmaceutical Univ. |
[50 days' free access]
#prodrug #selfassembly
authors.elsevier.com/a/1kxOecI2-9k~s -
J Controlled Release
@JCRnEDITORS
Glycogen-inspired trimannosylated serum albumin nanocarriers for targeted delivery of toll-like receptor 7/8 agonists to immune cells and liver.
| Tanja Weil @mpi_polymer | @CRS_DeChAt_LC
[Open Access]
#albumincarrier #trimannose
doi.org/10.1016/j.jconrel.2025.113705 -
J Controlled Release
@JCRnEDITORS
Engineering IgG antibodies for intracellular targeting and drug delivery.
| Yong-Sung Kim @AjouUniv | @KoreaCRS
[50 days' free access]
#intracellulartargeting #endosomalescape
authors.elsevier.com/a/1kxk~cI2-9l3J -
J Controlled Release
@JCRnEDITORS
Oxidized fucoidan-based nanocomposite hydrogel for cryptotanshinone delivery and prevention of postoperative abdominal adhesions.
| Chunshun Zhao @sysu_1924 |
[50 days' free access]
#hydrogel #fucoidan
authors.elsevier.com/a/1kxk~cI2-9l4A -
J Controlled Release
@JCRnEDITORS
Enhancing the bystander effect of antibody-drug conjugate by using a novel caspase-3 cleavable peptide linker to overcome tumor heterogeneity.
| Youngro Byun @SeoulNatlUni | @KoreaCRS
[50 days' free access]
#antibodydrugconjugate #peptidelinker
authors.elsevier.com/a/1kxvi_3r0J7Nw6 -
J Controlled Release
@JCRnEDITORS
The therapeutic potential of mRNA-encoded SFTSV human monoclonal antibody encapsulated lipid nanoparticle in vivo.
| Jae-Hwan Nam, The Catholic Univ. of Korea | @KoreaCRS
[50 days' free access]
#mrna #antibody #lipidnanoparticle
authors.elsevier.com/a/1kx-qcI2-9l4Y -
J Controlled Release
@JCRnEDITORS
Congratulations on the successful LC webinar! @CRSScience @ChenYBecky @nz_crs @KoreaCRS #chinacrs Local Chapter
Yunching Becky Chen
@ChenYBecky
🎉 Thank you to everyone who joined the CRS LC Webinar: China, New Zealand, and Korea!
🌏 With 200+ attendees and a lineup of outstanding talks, the event was a great success!
👏 Grateful to all the speakers, organizers, and LC hosts who made it possible.
#crs #drugdelivery -
J Controlled Release
@JCRnEDITORS
Sonopermeation combined with stroma normalization enables complete cure using nano-immunotherapy in murine breast tumors.
| Fotios Mpekris @UCYOfficial |
[Open Access]
#sonopermeation #mechanotherapeutics #machinelearning
doi.org/10.1016/j.jconrel.2025.113722 -
J Controlled Release
@JCRnEDITORS
A dual-action strategy: Wound microenvironment responsive hydrogel and exosome-mediated glucose regulation enhance inside-out diabetic wound repair.
| Yufei Ma @XJTU_China |
[50 days' free access]
#hydrogel #exosome #woundrepair
authors.elsevier.com/a/1kwLqcI2-9l1W -
J Controlled Release
@JCRnEDITORS
Multifunctional DNA nano-sponge system for targeted sensitization of ovarian cancer chemotherapy via metabolic reprogramming and ferroptosis induction.
| Xiao Xianjin @2024_HUST |
[50 days' free access]
#dnananosponge #metabolicreprogramming
authors.elsevier.com/a/1kwLqcI2-9kvI -
J Controlled Release
@JCRnEDITORS
Efficacy and safety of ultrasound combined with microbubbles for treating retinal artery occlusion in rats.
| Rongdi Yuan, Army Medical Univ. |
[Open Access]
#microbubble #ultrasound
doi.org/10.1016/j.jconrel.2025.113703 -
J Controlled Release
@JCRnEDITORS
Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activation.
| Yizhou Dong @IcahnMountSinai | @yizhoudonglab
[50 days' free access]
authors.elsevier.com/a/1kwmScI2-9kyf -
J Controlled Release
@JCRnEDITORS
Photothermal treatment of prostate tumor with micellar indocyanine green and napabucasin to co-ablate cancer cells and cancer stem cells.
| Zhiyuan Zhong, Soochow Univ. |
[50 days' free access]
#micelle #cancerstemcell #photothermal
authors.elsevier.com/a/1kv~9cI2-9k-i -
J Controlled Release
@JCRnEDITORS
Incorporation of cellular membrane protein extracts into lipid nanoparticles enhances their cellular uptake and mRNA delivery efficiency.
| Pieter Vader @UniUtrecht | @VaderPieter @CRSBeNeLuxFr
[Open Access]
#mrnadelivery #lipidnanoparticle
doi.org/10.1016/j.jconrel.2025.113676 -
J Controlled Release
@JCRnEDITORS
Splenic B cell-targeting lipid nanoparticles for safe and effective mRNA vaccine delivery.
| Yusuke Sato @HokkaidoUni |
[Open Access]
#mrnadelivery #bcelltargeting
doi.org/10.1016/j.jconrel.2025.113687 -
J Controlled Release
@JCRnEDITORS
Pathogen-targeting biomineralized bacterial outer membrane vesicles for eradicating both intracellular and extracellular Staphylococcus aureus.
| Yun He @CQU1929 |
[50 days' free access]
#outermembranevesicle #siderophore
authors.elsevier.com/a/1kvePcI2-9k-K -
J Controlled Release
@JCRnEDITORS
STING-activable immunomodulatory bio-glue for multiple postsurgical management.
| Xue-Bo Yin, Shanghai Univ. of Engineering Science |
[50 days' free access]
#bioglue #postsurgical
authors.elsevier.com/a/1kvbIcI2-9l1J -
J Controlled Release
@JCRnEDITORS
TGFBI R124H mutant allele silencing in granular corneal dystrophy type 2 using topical siRNA delivery.
| Tara Moore @UlsterUni | @UKICRS
[50 days' free access]
#sirnadelivery #topical
authors.elsevier.com/a/1kvVUcI2-9ky5 -
J Controlled Release
@JCRnEDITORS
Reversible engineering of cell membrane receptors based on host-guest recognition for on-demand regulation of cellular behavior.
| Qing Wang @hunanuniv |
[50 days' free access]
#cyclodextrin
authors.elsevier.com/a/1kv7PcI2-9k-J -
J Controlled Release
@JCRnEDITORS
s6.goeshow.com/ipec/annual/2025/biologics_summit.cfm
Controlled Release Society
@CRSScience
Have You Registered? CRS is teaming up with @ExcipientWorld for their Third Annual Biologics Summit, Advances in Cell and Gene Therapy: s6.goeshow.com/ipec/annual/2025/biologics_summit.cfm
Already a CRS member attending Part 2? Visit: s6.goeshow.com/ipec/annual/2025/Biologics Summit Registra… to register for Part 1 with an exclusive discount! -
J Controlled Release
@JCRnEDITORS
Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy.
| Zhiyuan Zhong, Soochow Univ. |
[50 days' free access]
#radionuclide #immunotherapy
authors.elsevier.com/a/1kv7PcI2-9kys -
J Controlled Release
@JCRnEDITORS
FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics.
| Zhide Guo @xmuchina |
[50 days' free access]
#radioligand #theranostic #fibroblastactivationprotein
authors.elsevier.com/a/1kv7PcI2-9kxg -
J Controlled Release
@JCRnEDITORS
PD-L1 targeted antibody-polymer-Epirubicin conjugate prolongs survival in a preclinical murine model of advanced ovarian cancer.
| Jiyuan Yang @PHCEUutah |
[Open Access]
#antibodypolymerconjugate
doi.org/10.1016/j.jconrel.2025.113682 -
J Controlled Release
@JCRnEDITORS
Hybrid micellar preparations for co-delivery of PARP-1 siRNA and quercetin for cataract treatment.
| Xiang Li, Jiangxi Univ. of Chinese Medicine |
[50 days' free access]
#micelle #sirna #codelivery #cataract
authors.elsevier.com/a/1kun-cI2-9k-7 -
J Controlled Release
@JCRnEDITORS
Enzymatic absorption promoters for non-invasive peptide delivery.
| Jean-Christophe Leroux @ETH_en |
[Open Access]
#peptidedelivery #noninvasive
doi.org/10.1016/j.jconrel.2025.113675 -
J Controlled Release
@JCRnEDITORS
Innovative nanomedicine approaches for the management of non-alcoholic fatty liver disease.
| Ruiping Zhang, Shanxi Medical Univ. |
[50 days' free access]
#nanomedicine #fattyliver
authors.elsevier.com/a/1kv5wcI2-9kxv -
J Controlled Release
@JCRnEDITORS
Bone marrow vessels are hyperpermeable to macromolecules and nanoscale medicine in a size-dependent manner.
| Kazunori Kataoka, Kawasaki Institute of Industrial Promotion |
[Open Access]
#transvasculartransport #intravital #microscopy
doi.org/10.1016/j.jconrel.2025.113669 -
J Controlled Release
@JCRnEDITORS
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine.
| Antonio Rosato, University of Padua | @CRS_Italia
[Open Access]
#adjuvant #hyaluronan
doi.org/10.1016/j.jconrel.2025.113674 -
J Controlled Release
@JCRnEDITORS
www.sciencedirect.com/science/authShare/S0168365925002615…
Leila Arabi (Pharm.D., Ph.D.)
@LeilaPharmD_PhD
Excited to share our latest review published in the @JCRnEDITORS the official journal of @CRSScience:
“Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases”
Free access: www.sciencedirect.com/science/authShare/S0168365925002615…
#lipid_nanoparticles #lnp #mrna
#neurodegenerative_diseases -
J Controlled Release
@JCRnEDITORS
Design of lipid-based formulations for oral delivery of a BASP1 peptide targeting MYC-dependent gastrointestinal cancer cells.
| Andreas Bernkop-Schnürch, Univ. of Innsbruck |
[Open Access]
#oraldelivery #peptide #lipidformulation
doi.org/10.1016/j.jconrel.2025.113677 -
J Controlled Release
@JCRnEDITORS
Engineering durable antioxidative nanoreactors as synthetic organelles for autoregulatory cellular protection against oxidative stress.
| Kazunori Kataoka, Kawasaki Institute of Industrial Promotion |
[50 days' free access]
#syntheticorganelle
authors.elsevier.com/a/1ktp9cI2-9kyT -
J Controlled Release
@JCRnEDITORS
A comprehensive evaluation of stability and safety for HEK293F-derived extracellular vesicles as promising drug delivery vehicles.
| Bi-Cheng Liu, Southeast Univ. |
[Open Access]
#extracellularvesicle #stability #safety
doi.org/10.1016/j.jconrel.2025.113673 -
J Controlled Release
@JCRnEDITORS
Vaginally-delivered fast-dissolving antibody tablets (FDAT) for on-demand non-hormonal contraception and multi-purpose protection.
| Samuel K. Lai @DPMP_UNC |
[50 days' free access]
#vaginaldelivery #fastdissolving #tablet
authors.elsevier.com/a/1ktp9cI2-9kv6 -
J Controlled Release
@JCRnEDITORS
Monocyte-adhesive peptidyl liposomes for harnessing monocyte homing to tumor tissues.
| Bill Cheng, National Chung-Hsing Univ. | @CRS_TW_Local
[50 days' free access]
#liposome #monocyte #homing
authors.elsevier.com/a/1ktkWcI2-9kwj -
J Controlled Release
@JCRnEDITORS
Autonomic lysosomal escape via sialic acid modification enhances mRNA lipid nanoparticles to eradicate tumors and build humoral immune memory.
| Yihui Deng, Shenyang Pharmaceutical Univ. |
#mrnadelivery #lipidnanoparticle #sialicacid
authors.elsevier.com/a/1ktSqcI2-9ksq -
J Controlled Release
@JCRnEDITORS
A fusion protein that targets antigen-loaded extracellular vesicles to B cells enhances antigen-specific T cell expansion.
| Susanne Gabrielsson @karolinskainst |
[50 days' free access]
#extracellularvesicle #fusionprotein
authors.elsevier.com/a/1ktMIcI2-9kvg -
J Controlled Release
@JCRnEDITORS
DNA scaffold-framed natural killer cell with programmed drug release for chemo-adoptive cell therapy.
| Ying Liu @NanjingUnivers1 |
[50 days' free access]
#dnascaffold #celltherapy
authors.elsevier.com/a/1kt68cI2-9kxs -
J Controlled Release
@JCRnEDITORS
Breaking the barriers in effective and safe Toll-like receptor stimulation via nano-immunomodulators for potent cancer immunotherapy.
| Yibin Deng, Soochow Univ. |
[50 days' free access]
#tolllikereceptor #targeteddelivery #nanomodulator
authors.elsevier.com/a/1kt2TcI2-9kvt -
J Controlled Release
@JCRnEDITORS
Ultra-high gene transfection efficiency in suspension cells mediated by highly branched-linear poly(β-amino ester)s.
| Dezhong Zhou @XJTU_China |
[50 days' free access]
#transfection #branchedpolymer #suspensioncell
authors.elsevier.com/a/1ks-UcI2-9kw3 -
J Controlled Release
@JCRnEDITORS
On-site delivery of bioactive nanospheres utilizing lanthanides as crosslinkers and metastasis-inhibiting agents for breast cancer therapy.
| Tse-Ying Liu @NYCU_official | @CRS_TW_Local
[50 days' free access]
#crosslinker #lanthanide #hyaluronicacid
authors.elsevier.com/a/1ksi4cI2-9kwX -
J Controlled Release
@JCRnEDITORS
Intracellular redistribution of cell-penetrating peptide p28: A mechanism for enhanced anti-cancer activity.
| Tohru Yamada @uiccom |
[Open Access]
#cellpenetratingpeptide #endosomalescape
doi.org/10.1016/j.jconrel.2025.113660 -
J Controlled Release
@JCRnEDITORS
www.nobelprize.org/prizes/physics/2023/lhuillier/interview/
The Nobel Prize
@NobelPrize
“Science is not only working with machines and gas or lasers, it’s working with people,” says physics laureate Anne L’Huillier.
She shares the qualities she believes make a good scientist: www.nobelprize.org/prizes/physics/2023/lhuillier/interview/ -
J Controlled Release
@JCRnEDITORS
A “three-in-one” thermosensitive gel system that enhances mucus and biofilm penetration for the treatment of vulvovaginal candidiasis.
| Xue Ke, China Pharmaceutical Univ. |
[50 days' free access]
#thermosensitivegel #penetration
authors.elsevier.com/a/1krdW_3r0J7Nu~ -
J Controlled Release
@JCRnEDITORS
Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering.
| Wenhu Zhou @CentralSouth_U |
[50 days' free access]
#transdermal #exosome #psoriasis
authors.elsevier.com/a/1krFIcI2-9kvU -
J Controlled Release
@JCRnEDITORS
Engineered vesicular cancer vaccines for immunosuppressive microenvironment reversion and in situ vaccine generation.
| Li Kong @HUST_China |
[50 days' free access]
#cancervaccine #insitu
authors.elsevier.com/a/1kr20cI2-9kuS -
J Controlled Release
@JCRnEDITORS
Biological effects of rapid short pulses of focused ultrasound for drug delivery to the brain.
| Sophie V. Morse @imperialcollege | @UKICRS
[Open Access]
#focusedultrasound #braindelivery
doi.org/10.1016/j.jconrel.2025.113646 -
J Controlled Release
@JCRnEDITORS
Impact of administration route and PEGylation on alpha-1 antitrypsin augmentation therapy.
| Rita Vanbever, Université catholique de Louvain | @CRSBeNeLuxFr
[50 days' free access]
#pegylation #inhalation
authors.elsevier.com/a/1kqvJcI2-9ksF -
J Controlled Release
@JCRnEDITORS
Unsaturated fatty acid-doped liposomes deliver piperine to deactivate defensive mechanism for ferroptosis in cancer therapy.
| Meiwan Chen @UM_1981 |
[50 days' free access]
#liposome #fattyacid #ferroptosis
authors.elsevier.com/a/1kqrlcI2-9kuF -
J Controlled Release
@JCRnEDITORS
Delivery of a novel neuroprotective compound to the retina in rat and rabbit animal models.
| Michail Kastellorizios @UNTHSC_Pharmacy |
[Open Access]
#oculardelivery #insituforming #implant #intravitreal
doi.org/10.1016/j.jconrel.2025.113659 -
J Controlled Release
@JCRnEDITORS
Decellularized extracellular matrix as a drug delivery carrier.
| Antonios G. Mikos @Rice_BIOE |
[50 days' free access]
#extracellularmatrix
authors.elsevier.com/a/1kqhqcI2-9kuw -
J Controlled Release
@JCRnEDITORS
Acetyl-lysine human serum albumin nanoparticles activate CD44 receptors, with preferential uptake by cancer stem cells, leading to tumor eradication.
| Ijeoma F. Uchegbu @School_Pharmacy | @UKICRS
[Open Access]
#albuminnanoparticle #cancerstemcell
doi.org/10.1016/j.jconrel.2025.113632 -
J Controlled Release
@JCRnEDITORS
Wearable transdermal drug delivery system controlled by wirelessly powered acoustic waves.
| Yong-Qing Fu @NorthumbriaUni | @UKICRS
[Open Access]
#transdermal #wearablesystem #acousticwave
doi.org/10.1016/j.jconrel.2025.113619 -
J Controlled Release
@JCRnEDITORS
High-efficiency antioxidant ROS-responsive thermosensitive hydrogel encapsulated Fenofibrate for the treatment of corneal neovascularization.
| Cheng Li @xmuchina |
[50 days' free access]
#hydrogel #thermosensitive
authors.elsevier.com/a/1kqcAcI2-9ktI -
J Controlled Release reposted
Marianne Ashford
@AshfordFell
Delighted to see this published, great team work, well done
J Controlled Release
@JCRnEDITORS
HER2-targeted star polymer conjugates for improved tumor distribution and efficacy.
| Silvia Sonzini @AstraZeneca | @UKICRS
[Open Access]
#polymerconjugate #her2
doi.org/10.1016/j.jconrel.2025.113654 -
J Controlled Release
@JCRnEDITORS
docs.google.com/forms/d/e/1FAIpQLSckBupGIJBPdaZOaqSBJOJxn…
Young Scientist Committee YSC-CRS
@CRS_YSC
🚨 Happening TOMORROW! 🚨
Don’t miss this FREE @CRS_YSC event showcasing new databases that could transform your research. This one won’t be recorded, so be sure to register! 📊🔍
🔗 docs.google.com/forms/d/e/1FAIpQLSckBupGIJBPdaZOaqSBJOJxn…
#researchtools #academicresources #crsysc @CRSScience -
J Controlled Release
@JCRnEDITORS
Safety of nanoparticle therapies during pregnancy: A systematic review and meta-analysis.
| Cristina Fornaguera @uramonllull | @CRS_SPLC
[Open Access]
#nanoparticle #safety #pregnancy
doi.org/10.1016/j.jconrel.2025.113655 -
J Controlled Release
@JCRnEDITORS
Inhalable neutrophil-mimicking nanoparticles for chronic obstructive pulmonary disease treatment.
| Yang Yang @TJU_China |
[50 days' free access]
#membranecoating #neutrophil
authors.elsevier.com/a/1kqPwcI2-9kt0 -
J Controlled Release
@JCRnEDITORS
Prodrug-designed nanocarrier co-delivering chemotherapeutic and vascular disrupting agents with exceptionally high drug loading capacity.
| Xuesi Chen, Changchun Institute of Applied Chemistry |
[50 days' free access]
#prodrug #loadingcapacity
authors.elsevier.com/a/1kqSTcI2-9kpc -
J Controlled Release
@JCRnEDITORS
HER2-targeted star polymer conjugates for improved tumor distribution and efficacy.
| Silvia Sonzini @AstraZeneca | @UKICRS
[Open Access]
#polymerconjugate #her2
doi.org/10.1016/j.jconrel.2025.113654 -
J Controlled Release
@JCRnEDITORS
Quercetin liposomes conjugated with hyaluronidase: An efficient drug delivery system to block pancreatic cancer.
| Xianming Kong, Shanghai Univ. of Traditional Chinese Medicine |
[Open Access]
#liposome #hyaluronidase
doi.org/10.1016/j.jconrel.2025.113642 -
J Controlled Release
@JCRnEDITORS
Intracellular delivery of proteins for live cell imaging.
| Xiaohu Gao @UWBioE |
[50 days' free access]
#cellimaging #intracellulardelivery
authors.elsevier.com/a/1kqFMcI2-9ktU -
J Controlled Release
@JCRnEDITORS
Poly-lysine-modified recombinant protein nanocages for effective delivery of small activating RNA.
| Haiqin Huang, Nantong Univ. |
[50 days' free access]
#rnadelivery #polylysine #proteinnanocage
authors.elsevier.com/a/1kq3RcI2-9krP -
J Controlled Release
@JCRnEDITORS
Visible-light-triggered recovery of biologically intact cells using smart fluoropolymer-nanocoated materials.
| Masamichi Nakayama, Tokyo Women's Medical Univ. |
[50 days' free access]
#photoresponsive #fluoropolymer #photoisomerization
authors.elsevier.com/a/1kq3RcI2-9kth -
J Controlled Release
@JCRnEDITORS
ATP-responsive tumor targeted lipid nanoparticle for enhanced siRNA delivery and improved treatment efficacy in melanoma.
| Qin He @SCUCN |
[50 days' free access]
#sirnadelivery #atpresponsive #melanoma
authors.elsevier.com/a/1kq0bcI2-9koN -
J Controlled Release
@JCRnEDITORS
Shear force and cholesterol affinity responsive drug delivery system for treating inflammation and abnormal lipid metabolism in atherosclerosis.
| Lin Hou @ZZU_China |
[50 days' free access]
#stimuliresponsive #cholesterol #efflux #atherosclerosis
authors.elsevier.com/a/1kq0KcI2-9kqS -
J Controlled Release
@JCRnEDITORS
Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases.
| Leila Arabi @mumspr | @LeilaPharmD_PhD
[50 days' free access]
#mrnadelivery #lipidnanoparticle #neurodegenerativediseases
authors.elsevier.com/a/1kpuNcI2-9krt -
J Controlled Release
@JCRnEDITORS
Preparation of thermoresponsive core-corona particles for controlled phagocytosis via surface properties and particle shape transformation.
| Akihiko Kikuchi @TUS_PR_en |
[Open Access]
#shapechange #photoresponsive #phagocytosis
doi.org/10.1016/j.jconrel.2025.113652 -
J Controlled Release
@JCRnEDITORS
Polyaminoglycoside nanosystem expressing antimicrobial peptides for multistage chronic wound management.
| Fu-Jian Xu @BeijingChemical |
[50 days' free access]
#polyaminoglycoside #antimicrobial
authors.elsevier.com/a/1kpu3cI2-9kuR -
J Controlled Release
@JCRnEDITORS
CRS Focus Group - Ocular Delivery
@CRS_FG_Ocular
🚨 Attention #oculardelivery researchers!
We’re excited to announce another edition of our Trainee Video & Image Competition!📸
Show off your best work for a chance to win amazing prizes!🏆
📅April 24th, 11:59 PM EST
🔗: forms.gle/8RiXy1KHiJMMw9uG6
#crs2025 #drugdelivery @CRSScience -
J Controlled Release
@JCRnEDITORS
Inhalable pH-responsive charge-reversal polymer-small interfering RNA polyplexes for directed gene therapy of anaplastic lymphoma kinase fusion-positive lung cancer.
| Jiang Yang @sysu_1924 |
[50 days' free access]
#polyplex #sirnadelivery #phresponsive
authors.elsevier.com/a/1kpuNcI2-9ksG -
J Controlled Release
@JCRnEDITORS
Overcoming P-glycoprotein-mediated multidrug resistance in cancer cells through micelle-forming PHPMA-b-PPO diblock copolymers for doxorubicin delivery.
| Milada Šírová @CharlesUniPRG |
[Open Access]
#micelle #diblockcopolymer #multidrugresistance
doi.org/10.1016/j.jconrel.2025.113645 -
J Controlled Release
@JCRnEDITORS
Blood-brain barrier crossing biopolymer targeting c-Myc and anti-PD-1 activate primary brain lymphoma immunity: Artificial intelligence analysis.
| Julia Y. Ljubimova @TerasakiInst |
[50 days' free access]
#bloodbrainbarrier #artificialintelligence
authors.elsevier.com/a/1ko4vcI2-9kml -
J Controlled Release
@JCRnEDITORS
Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma.
| Andrew E.-Y. Chuang @TaipeiMedicalU | @CRS_TW_Local
[50 days' free access]
#intranasal #extracellularvescile #glaucoma
authors.elsevier.com/a/1ko4vcI2-9kj8 -
J Controlled Release
@JCRnEDITORS
Photopharmacological activation of adenosine A1 receptor signaling suppresses seizures in a mouse model for temporal lobe epilepsy.
| Robrecht Raedt @ugent | @CRSBeNeLuxFr
[Open Access]
#photouncaging #photopharmacology
doi.org/10.1016/j.jconrel.2025.113626 -
J Controlled Release
@JCRnEDITORS
crs2025annualmeeting.eventscribe.net/aaStatic.asp?SFP=UUF…
Controlled Release Society
@CRSScience
💫The Deadline to Submit Late-Breaking Abstracts is, March 28, 2025! #crs2025 offers you the opportunity to share your research with experts in designing, developing, & implementing novel delivery technologies: crs2025annualmeeting.eventscribe.net/aaStatic.asp?SFP=UUF…
Tips for exploring Philadelphia: @discoverPHL -
J Controlled Release
@JCRnEDITORS
Supramolecular oral delivery technologies for polypeptide-based drugs.
| Jiaheng Zhang @HIT_China |
[50 days' free access]
#oraldelivery #supramolecule #polypeptide
authors.elsevier.com/a/1koQpcI2-9kbi -
J Controlled Release
@JCRnEDITORS
Effects of silica nanoparticles with varied physicochemical properties on the survival and functionality of saturated macrophages.
| Hamidreza Ghandehari @PHCEUutah |
[50 days' free access]
#silicananoparticle #macrophage #nanotoxicology
authors.elsevier.com/a/1koQpcI2-9krh -
J Controlled Release
@JCRnEDITORS
Evaluation of focused ultrasound modulation of the blood-brain barrier in gray and white matter.
| Alessandro De Maio, Sunnybrook Research Institute |
[Open Access]
#focusedultrasound #bloodbrainbarrier
doi.org/10.1016/j.jconrel.2025.113631 -
J Controlled Release
@JCRnEDITORS
Investigation of the impact of lipid nanoparticle compositions on the delivery and T cell response of circRNA vaccine.
| Guizhi Zhu @UMichPharmacy |
[50 days' free access]
#circularrna #vaccine #lipidnanoparticle
authors.elsevier.com/a/1koz-cI2-9knc -
J Controlled Release
@JCRnEDITORS
Identification of functional biomarkers for personalized nanomedicine in advanced breast cancer in vitro models.
| María J. Vicent @CIPFciencia | @VicentPTLab @CRS_SPLC
[50 days' free access]
#polypeptidedrugconjugate #organoid #extracellularvesicle
authors.elsevier.com/a/1kp0gcI2-9khC -
J Controlled Release
@JCRnEDITORS
Engineered dendritic cells-derived extracellular vesicles for cancer immunotherapy.
| Flávia Castro @i3S_UPorto | @CRS_SPLC
[Open Access]
#extracellularvesicle #dendriticcell
doi.org/10.1016/j.jconrel.2025.113620 -
J Controlled Release
@JCRnEDITORS
Codelivery Ce6 and curcumin in antibacterial poly(β-amino ester) for anti-inflammatory and photodynamic antimicrobial combination therapy.
| Huayu Tian @xmuchina |
[50 days' free access]
#codelivery #photodynamic #antimicrobial
authors.elsevier.com/a/1kp8GcI2-9kpb -
J Controlled Release
@JCRnEDITORS
In situ peptide assembly for cell membrane rewiring in tumor therapy.
| Gaolin Liang, Southeast Univ. |
[50 days' free access]
#peptideassembly #membranecoating
authors.elsevier.com/a/1knvocI2-9krD -
J Controlled Release reposted
Nature Materials
@NatureMaterials
A lipid nanoparticle-based formulation incorporating engineered lipis containing a blood-brain-barrier-crossing moiety effectively delivers mRNA to neurons and astrocytes following systemic administration in mice. @yizhoudonglab
www.nature.com/articles/s41563-024-02114-5 -
J Controlled Release
@JCRnEDITORS
Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection.
| Laura M. Ensign @HopkinsMedicine | @LauraEnsignPhD @CRS_FG_Ocular
[50 days' free access]
#nanocrystal #subconjunctival #ocularinfection
authors.elsevier.com/a/1knvocI2-9kqe -
J Controlled Release
@JCRnEDITORS
Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma models.
| Fernanda Andrade @vallhebron | @CRS_SPLC
[50 days' free access]
#micelle #preclinical #glioblastoma
authors.elsevier.com/a/1knhRcI2-9knQ -
J Controlled Release
@JCRnEDITORS
Application of in-silico approaches in subunit vaccines: Overcoming the challenges of antigen and adjuvant development.
| Xun Sun @SCUCN |
[50 days' free access]
#insilico #subunitvaccine #adjuvant
authors.elsevier.com/a/1knWWcI2-9kpo -
J Controlled Release
@JCRnEDITORS
Enhancing immunogenicity and release of in situ-generated tumor vesicles for autologous vaccines.
| Chao Zhang, China Pharmaceutical Univ. |
[50 days' free access]
#extracellularvesicle #tumorvaccine
authors.elsevier.com/a/1knUHcI2-9knD -
J Controlled Release
@JCRnEDITORS
Effective transcatheter intracoronary delivery of mRNA-lipid nanoparticles targeting the heart.
| Shigeru Miyagawa @osaka_univ_e |
[Open Access]
#intracoronary #mrnadelivery #lipidnanoparticle
doi.org/10.1016/j.jconrel.2025.113623 -
J Controlled Release
@JCRnEDITORS
Assembled granular hydrogels loaded with growth factors for enhanced mesenchymal stem cell therapy in abdominal wall defect repair.
| Tianzhu Zhang, Southeast Univ. |
[50 days' free access]
#hydrogel #stemcell
authors.elsevier.com/a/1knAEcI2-9kp~ -
J Controlled Release
@JCRnEDITORS
Next generation of porphysomes for improved photodynamic therapy applications.
| Ali Makky @UnivParisSaclay | @CRSBeNeLuxFr
#porphysome #photodynamic
authors.elsevier.com/a/1km~f_3r0J7NuE -
J Controlled Release
@JCRnEDITORS
Exosomal delivery of rapamycin modulates blood-brain barrier penetration and VEGF axis in glioblastoma.
| Betty Yuen Kwan Law, Macau Univ. of Science and Technology |
[Open Access]
#exosome #bloodbrainbarrier
doi.org/10.1016/j.jconrel.2025.113605 -
J Controlled Release
@JCRnEDITORS
YTHDF1-targeting nanoassembly reverses tumoral immune evasion through epigenetics and cell cycle modulation.
| Minjie Sun, China Pharmaceutical Univ. |
[50 days' free access]
#sirnadelivery #cellcycle
authors.elsevier.com/a/1kmQE_3r0J7NtN -
J Controlled Release
@JCRnEDITORS
Disulfiram-loaded electrospun fibers with antimicrobial and antitumoral properties for glioblastoma treatment.
| Carmen Alvarez-Lorenzo @usc_farmacia | @CRS_SPLC
[Open Access]
#silkfibroin #cyclodextrin #electrospinning
doi.org/10.1016/j.jconrel.2025.113615 -
J Controlled Release
@JCRnEDITORS
Synergistic photothermal-sonodynamic therapy for antibacterial and immune reprogramming in chronic osteomyelitis.
| Aixi Yu @WHU_1893 |
[50 days' free access]
#sonodynamic #photothermal #osteomyelitis
authors.elsevier.com/a/1km4bcI2-9kmx -
J Controlled Release
@JCRnEDITORS
Biofilm-disrupting DNA nanomedicines for targeted elimination of resistant wound microbiota.
| Junjie Cheng, Southeast Univ. |
[50 days' free access]
#dnananomedicine #biofilm #microbiota
authors.elsevier.com/a/1km4bcI2-9kno -
J Controlled Release
@JCRnEDITORS
An industry perspective on hyaluronidase co-formulated biopharmaceutics.
| Fangyuan Zhou @WuXiBiologics |
[50 days' free access]
#biopharmaceutics #hyaluronidase
authors.elsevier.com/a/1km4bcI2-9kfa -
J Controlled Release
@JCRnEDITORS
Microneedle-mediated hypoxic extracellular vesicle-encapsulated selenium nanoparticles delivery to treat androgenetic alopecia.
| Qingsong Ye @WHU_1893 |
[Open Access]
#microneedle #extracellularvesicle #alopecia
doi.org/10.1016/j.jconrel.2025.113597 -
J Controlled Release
@JCRnEDITORS
A Mannosylated peptidyl lipid CManDA doped into cytidinyl/cationic lipids efficiently delivers siG12Ss to lung cancer in vivo.
| Zhenjun Yang @PKU1898|
[Open Access]
#sirna #cationiclipid
doi.org/10.1016/j.jconrel.2025.113624 -
J Controlled Release
@JCRnEDITORS
Cell-free DNA-scavenging nano/microsystems for immunotherapy.
| Lichen Yin, Soochow Univ. |
[50 days' free access]
#dnascavenging #nanozyme
authors.elsevier.com/a/1kl~NcI2-9kl8 -
J Controlled Release
@JCRnEDITORS
Extracellular vesicle as a next-generation drug delivery platform for rheumatoid arthritis therapy.
| Zhifeng Gu, Nantong Univ. |
[50 days' free access]
#extracellularvesicle #arthritis
authors.elsevier.com/a/1klaRcI2-9klK -
J Controlled Release
@JCRnEDITORS
Stimuli-responsive polymer-dasatinib prodrug to reprogram cancer-associated fibroblasts for boosted immunotherapy.
| Jing Jing @SCUCN |
[50 days' free access]
#prodrug #stimuliresponsive
authors.elsevier.com/a/1kkfKcI2-9kkl -
J Controlled Release
@JCRnEDITORS
[Editorial] Extracellular vesicles for drug delivery: a major interest for the Journal of Controlled Release.
| Pieter Vader @UMCUtrecht |
[50 days' open access]
#extracellularvesicle #editorial
authors.elsevier.com/a/1kkbYcI2-9kjX -
J Controlled Release
@JCRnEDITORS
Transdermal delivery of ultradeformable cationic liposomes complexed with miR211–5p (UCL-211) stabilizes BRAFV600E+ melanocytic nevi.
| Paris Jafari @PHCEUutah |
[50 days' free access]
#transdermaldelivery #liposome #deformable #microrna
authors.elsevier.com/a/1kkXFcI2-9kha -
J Controlled Release
@JCRnEDITORS
Mechanisms of receptor-mediated transcytosis at the blood-brain barrier.
| Habib Baghirov @AboAkademi |
[Open Access]
#bloodbrainbarrier #transcytosis
doi.org/10.1016/j.jconrel.2025.113595 -
J Controlled Release
@JCRnEDITORS
Injectable biodegradable microchamber array films for long-term delivery of glucocorticoids.
| David Gould @QMUL | @UKICRS
[50 days' free access]
#injectablefiber #releasekinetics
authors.elsevier.com/a/1kk7ncI2-9ki9 -
J Controlled Release
@JCRnEDITORS
Myeloid-derived suppressor cell-targeted virus-like particles synergistically activate innate immune response for cancer immunotherapy.
| Bin Shao @SCUCN |
[50 days' free access]
#viruslikeparticle #immunotherapy
authors.elsevier.com/a/1kk7RcI2-9kkB -
J Controlled Release
@JCRnEDITORS
Bioinspired programmed antibiofilm strategies for accelerated wound healing via spatiotemporally controlled enzyme nanoreactors.
| Quan Luo, Jilin Univ. |
[50 days' free access]
#goldnanoparticle #biofilm #woundhealing
authors.elsevier.com/a/1kk6YcI2-9kg- -
J Controlled Release
@JCRnEDITORS
A nasally administrated reactive oxygen species-responsive carrier-free gene delivery nanosystem for Alzheimer's disease combination therapy.
| Huile Gao @SCUCN |
[50 days' free access]
#genedelivery #nasal #alzheimersdisease
authors.elsevier.com/a/1kk3PcI2-9kkN -
J Controlled Release
@JCRnEDITORS
Antibody-DNA nanostructure conjugate enables targeted delivery of gemcitabine to tumor and improves the anti-tumor efficacy.
| Hongxiu Yu @FudanUniv |
[50 days' free access]
#antibodydnaconjugate #gemcitabine
authors.elsevier.com/a/1kl5KcI2-9kn1 -
J Controlled Release
@JCRnEDITORS
authors.elsevier.com/a/1kiQ7cI2-9kfz
CRS Korea Chapter
@KoreaCRS
A great article reported by Prof. Won Jong Kim (@postech2020) on Dual ROS/pH responsive NO-releasing nanomedicine for cancer nanoimmunotherapy in @JCRnEDITORS.
-
J Controlled Release
@JCRnEDITORS
Pitavastatin and resveratrol bio-nanocomplexes against hyperhomocysteinemia-induced atherosclerosis via blocking ferroptosis-related lipid deposition.
| Yideng Jiang, Ningxia Medical Univ |
[50 days' free access]
#nanocomplex #ferroptosis #atherosclerosis
authors.elsevier.com/a/1kkz3_3r0J7Ntl -
J Controlled Release
@JCRnEDITORS
MicroRNA-induced reprogramming of tumor-associated macrophages for modulation of tumor immune microenvironment.
| Jaiwoo Lee, Korea Univ. | @jaiwoo_lee @KoreaCRS
[50 days' free access]
#microrna #reprogramming #macrophage
authors.elsevier.com/a/1kkz3cI2-9kia -
J Controlled Release
@JCRnEDITORS
Surfactant protein B-derived peptides as endosomal escape enhancers for pulmonary delivery of siRNA.
| Koen Raemdonck @UGent_Pharma | @koenraemdonck @CRSBeNeLuxFr
[50 days' free access]
#pulmonarydelivery #sirna #surfactant
authors.elsevier.com/a/1kkoscI2-9kfC -
J Controlled Release
@JCRnEDITORS
Engineering biocompatible carbon dots nano-enzymes hydrogel for efficient antioxidative and anti-inflammatory treatment of dry eye disease.
| Zebo Jiang @sysu_1924 |
[50 days' free access]
#carbondot #nanoenzyme #dryeyedisease
authors.elsevier.com/a/1kklecI2-9kRI -
J Controlled Release
@JCRnEDITORS
Multifunctional nanoparticle-mediated targeting of metabolic reprogramming and DNA damage response pathways to treat drug-resistant triple-negative breast cancer.
| Cheng Wang @OUC1924 |
[50 days' free access]
#metabolicreprogramming #lactylation
authors.elsevier.com/a/1kjew_3r0J7Nto -
J Controlled Release
@JCRnEDITORS
Harnessing the Potential of Human Breast Milk to Boost Intestinal Permeability for Nanoparticles and Macromolecules.
| Assaf Zinger @TechnionLive | @ZingerAssaf
[50 days' free access]
#liposome #dextran #permeability #breastmilk
authors.elsevier.com/sd/article/S0168-3659(25)00060-4 -
J Controlled Release
@JCRnEDITORS
Successful repositioning of mertansine for improved chemotherapy by combining a polymer prodrug approach and PET imaging.
| Charles Truillet @UnivParisSaclay | @CRSBeNeLuxFr
#prodrug #imaging #drugrepositioning
doi.org/10.1016/j.jconrel.2024.12.050 -
J Controlled Release
@JCRnEDITORS
Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation.
| Marta Monjo @UIBuniversitat | @CRS_SPLC
#peritonealdelivery #carcinomatosis
doi.org/10.1016/j.jconrel.2024.07.017 -
J Controlled Release
@JCRnEDITORS
Dependence of sonoporation efficiency on microbubble size: An in vitro monodisperse microbubble study.
| Tim Segers @UTwente | @CRSBeNeLuxFr
#microbubble #sonoporation #ultrasound #contrastagent
doi.org/10.1016/j.jconrel.2023.09.047 -
J Controlled Release
@JCRnEDITORS
Huge congratulations to the New Board of CRS Directors. Avi Schroeder (President-elect), Maria Vicent (Secretary), Paolo Caliceti (Treasurer-Elect), Yoon Yeo(Director-at-Large), Ryan Donnelly (Director-at-Large). @AviSchroeder @MariaJVicent1 @ryanfdonnelly @YoonYeo4 @CRSScience
-
J Controlled Release
@JCRnEDITORS
Targeted nanomedicine: Lessons learned and future directions.
| Dan Peer @TelAvivUni | @peer_lab
#nanomedicine #targeteddelivery
doi.org/10.1016/j.jconrel.2023.02.010 -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS congratulate Prof. Dan Peer @peer_lab, an associate editor of JCR, to be elected to the US National Academy of Engineering, part of three US National Academies: Science, Engineering and Medicine. He is a global expert in the field of RNA therapeutics and vaccines.
-
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS are pleased to announce Prof. Stefaan De Smedt @DesmedtSmedt as new Editor-in-Chief, succeeding Prof. Christine Allen @ChristineAllenW. Congratulations and great expectations of leading the JCR to new heights.
-
J Controlled Release
@JCRnEDITORS
Nanomedicine based strategies for oligonucleotide traversion across the blood–brain barrier.
| Saurabh Srivastava @NIPERHyd | @CrsIndian
[50 days' free access]
#bloodbrainbarrier #nanomedicine #oligonucleotide
authors.elsevier.com/a/1gSF7cI2-261O -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS appreciate @ChristineAllenW for her remarkable achievement as Editor-in-Chief over three years. JCR community will thank @ChristineAllenW for her sterling leadership with encouragement, stimulation, and a strong vision. Glad that she will stay with us as an EBM.
-
J Controlled Release
@JCRnEDITORS
On-demand delivery of protein drug from 3D-printed implants.
| Yu-Kyoung Oh @SNU_Pharm | @YuKyoungOh1 @KoreaCRS
#ondemand #proteindrug #3dprinting #implants
doi.org/10.1016/j.jconrel.2022.06.047 -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS are pleased to announce the new IF, 11.467. Thanks to all authors, reviewers, readers, and editorial team.
-
J Controlled Release
@JCRnEDITORS
Connect with the best and brightest in #deliveryscience this July in Montreal, Canada at the #crs2022 Annual Meeting! Learn more and register here: www.eventscribe.net/2022/CRSAnnualMeeting/aaStatic.asp?SF…
@ChristineAllenW @YuKyoungOh1 @DesmedtSmedt
@JCRnEDITORS @CRSScience -
J Controlled Release
@JCRnEDITORS
Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment.
| Chun Gwon Park @SKKU_1398 | @KoreaCRS
#inflammatoryboweldisease #microparticle #hydrogel
doi.org/10.1016/j.jconrel.2022.02.028 -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS are very pleased to announce that Dr. Davide Brambilla has joined the Journal of Controlled Release as an Assistant Editor. Read more here ➡️ www.sciencedirect.com/browse/journals-and-books
@DBrambilla_Lab @ChristineAllenW @YuKyoungOh1 @DesmedtSmedt -
J Controlled Release
@JCRnEDITORS
Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
| Soyoung Shin @WonkwangUniv | @shinso_0 @KoreaCRS
#sustainedrelease #pharmacokinetics #ivivc
doi.org/10.1016/j.jconrel.2022.01.048 -
J Controlled Release
@JCRnEDITORS
Heme oxygenase-1 gene delivery for altering high mobility group box-1 protein in pancreatic islet.
| Dong Yun Lee @i_hanyang | @KoreaCRS
#genedelivery #islettransplantation
doi.org/10.1016/j.jconrel.2022.01.031 -
J Controlled Release
@JCRnEDITORS
Delivery strategies of RNA therapeutics to leukocytes.
| Dan Peer @TelAvivUni | @peer_lab
[50 days' free access]
#rnatherapeutic #rnadelivery
authors.elsevier.com/a/1eRYW_3r0J6EbU -
J Controlled Release
@JCRnEDITORS
Delivery strategies of RNA therapeutics to leukocytes.
| Dan Peer @TelAvivUni | @peer_lab @CRS_FG_Gene
#rnatherapeutics #mrnadelivery
doi.org/10.1016/j.jconrel.2022.01.016 -
J Controlled Release
@JCRnEDITORS
RNA interference-based plasmonic nanomaterials for cancer diagnosis and therapy.
| Jeong-Woo Choi @sogangism | @KoreaCRS
#rnai #plasmonicnanoparticle #photothermal
doi.org/10.1016/j.jconrel.2022.01.012 -
J Controlled Release
@JCRnEDITORS
Evolution of drug delivery systems: From 1950 to 2020 and beyond.
| Kinam Park, Purdue Univ. |
#drugdelivery
doi.org/10.1016/j.jconrel.2021.12.030 -
J Controlled Release
@JCRnEDITORS
Effect of particle size on in vivo performances of long-acting injectable drug suspension.
| Myung Joo Kang @dkupr | @KoreaCRS
[50 days' free access]
#suspension #particlesize
authors.elsevier.com/a/1eFRWcI2~wVGV -
J Controlled Release
@JCRnEDITORS
Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial.
| Josbert M. Metselaar @RWTH | @CRS_GermanChapt
#pegylatedliposome
doi.org/10.1016/j.jconrel.2021.12.007 -
J Controlled Release
@JCRnEDITORS
The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines.
| Nat. Nanotechnol.|
doi.org/10.1038/s41565-021-01001-3 -
J Controlled Release
@JCRnEDITORS
Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells.
| Devika S. Manickam @duqedu | @dr_manickam @CRS_FG_Nervous
#mitochondrialtransfer #microvesicle #exosome #ischemicstroke
doi.org/10.1016/j.jconrel.2021.08.038 -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS are pleased to welcome Professor Jun Wang , Professor Dan Ding and Professor Lin Mei to the Journal of Controlled editorial board! Find out more about the editors here!
@ChristineAllenW @DesmedtSmedt @YuKyoungOh1
www.sciencedirect.com/browse/journals-and-books -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS is pleased to welcome Professor Jin Sun, Dr. Zhen Gu and Dr. Vibin Ramakrishnan to the editorial board! Find out more about the new editors here!
@guzhenlab @ChristineAllenW @DesmedtSmedt
@YuKyoungOh1 @CrsIndian
www.sciencedirect.com/browse/journals-and-books -
J Controlled Release
@JCRnEDITORS
Nanoparticles in the clinic: An update post COVID‐19 vaccines.
| Bioengineering & Translational Medicine | aiche.onlinelibrary.wiley.com/doi/10.1002/btm2.10246 -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS are pleased to welcome Dr. Sun Hwa Kim, Dr. Hyukjin Lee and Dr. Yu Seok Youn to the Journal of Controlled Release editoral board! Read more about the editors here! @KISTsunkim @nanobama @ysyoun0915 @ChristineAllenW @DesmedtSmedt @YuKyoungOh1
www.sciencedirect.com/browse/journals-and-books -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS are delighted to announce that Dr. Siowling Soh has joined the Journal of Controlled Release editorial board!
Read more about Dr. Siowling Soh here! @ChristineAllenW @DesmedtSmedt @YuKyoungOh1
www.sciencedirect.com/browse/journals-and-books -
J Controlled Release
@JCRnEDITORS
Concluded Editors’ meeting. @JCRnEDITORS are proud of the achievement. Huge thanks for the devotion of all editors and editorial team. @fernandaogochi @ChristineAllenW @DesmedtSmedt @YuKyoungOh1 @YoonYeo4 @ChenYBecky @KanjiroM @JONGOHKIM6 @peer_lab Zhiyuan, Xun, Paolo, Vladmir.
-
J Controlled Release
@JCRnEDITORS
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles.
| Dan Peer @TelAvivUni | @peer_lab
#lipidnanoparticle #sirna #targeteddelivery #headandneckcancer
doi.org/10.1016/j.jconrel.2021.07.034 -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS are proud to announce the new IF, 9.776. Thanks to our authors, AEs, reviewers & EB for their hard work & dedication. Shout out to
@CRSScience for continued support. @ChristineAllenW @DesmedtSmedt @YuKyoungOh1 @ELSpharma -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS would like to welcome Dr.Paolo Decuzzi to the Journal of Controlled Release Editorial Board!
Read more about @pgdecuzzi here!
@ChristineAllenW @DesmedtSmedt @YuKyoungOh1 @CRS_Italia
www.journals.elsevier.com/journal-of-controlled-release/n…" -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS are pleased to welcome Dr. Stefano Salmaso to the Journal of Controlled Release Editorial Board! Read more about Stefano here!
@ChristineAllenW @DesmedtSmedt @YuKyoungOh1
www.journals.elsevier.com/journal-of-controlled-release/n… -
J Controlled Release
@JCRnEDITORS
It gives us great pleasure to welcome Dr. Giovanna Lollo to the Editorial Board of the Journal of Controlled Release! Read more about Dr. Giovanna Lollo here!
@GioLollo @ChristineAllenW @DesmedtSmedt
@YuKyoungOh1
www.sciencedirect.com/browse/journals-and-books -
J Controlled Release
@JCRnEDITORS
Microneedles for gene and drug delivery in skin cancer therapy.
| Ryan F. Donnelly @QUBelfast | @ryanfdonnelly
#microneedle #genedelivery #skincancer
doi.org/10.1016/j.jconrel.2021.05.009 -
J Controlled Release
@JCRnEDITORS
Sustained release of peptides and proteins from polymeric nanocarriers produced by inverse Flash NanoPrecipitation.
| Robert K. Prud'homme @Princeton |
#sustainedrelease #proteindelivery #polymericcarriers
#nanoprecipitation
[50 days' free access]
authors.elsevier.com/a/1cxNJcI2~wU34 -
J Controlled Release
@JCRnEDITORS
The dawn of mRNA vaccines: The COVID-19 case.
| Stefaan C. De Smedt @UGent_Pharma | @DesmedtSmedt
#mrnavaccine #covid19vaccine
authors.elsevier.com/a/1cuvicI2~wU15 -
J Controlled Release
@JCRnEDITORS
Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives.
| Marlus Chorilli @Unesp_Global | @brazilcrs @CRS_FG_Oral
#oraldelivery #polysaccharide
doi.org/10.1016/j.jconrel.2021.04.026 -
J Controlled Release
@JCRnEDITORS
Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions.
| Eun Ji Chung @USC | @TheChungLab
#nanoparticle #targeteddelivery #kidneydisease
doi.org/10.1016/j.jconrel.2021.04.016 -
J Controlled Release
@JCRnEDITORS
Fucosylated lipid nanocarriers loaded with antibiotics efficiently inhibit mycobacterial propagation in human myeloid cells.
| Ulrich Kalinke, Hannover Medical School | #crsgermanchapter #liposomes #targeteddelivery #nanomedicine
doi.org/10.1016/j.jconrel.2021.04.012 -
J Controlled Release
@JCRnEDITORS
Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer.
| David Oupický @unmc |
#sirnadelivery #intraperitoneal #pancreaticcancer #metastatic
[50 days' free access]
authors.elsevier.com/a/1cqAqcI2~wT~p -
J Controlled Release
@JCRnEDITORS
The dawn of mRNA vaccines: The COVID-19 case.
| Rein Verbeke @UGent_Pharma | @DesmedtSmedt @CRSBeNeLuxFr
#rnavaccine #covidvaccine
doi.org/10.1016/j.jconrel.2021.03.043 -
J Controlled Release
@JCRnEDITORS
Preface: Sung Wan Kim Memorial Special Issue
| David W. Grainger, Wim Hennink, Raymond Schiffelers, You Han Bae | @UUtah @CRSScience
[50 days' free access]
authors.elsevier.com/a/1cnCqcI2~wTu1 -
J Controlled Release
@JCRnEDITORS
Stimuli responsive and receptor targeted iron oxide based nanoplatforms for multimodal therapy and imaging of cancer: Conjugation chemistry and alternative therapeutic strategies.
| Tejal Mehta @NirmaUniTweets | @CrsIndian
#phototherapy #radiotherapy
doi.org/10.1016/j.jconrel.2021.03.021 -
J Controlled Release
@JCRnEDITORS
“My First Sixty Years in Science”: - In celebration of 80th Birthday of Prof. Jindrich Henry Kopecek.
| Jiyuan Yang @PHCEUutah,, Chun Wang @UMNBME, David A. Putnam @CornellBME |
[50 days' free access]
authors.elsevier.com/a/1ccpLcI2~tqHh -
J Controlled Release
@JCRnEDITORS
Congratulations @YoonYeo4, @DesmedtSmedt for winning "Samyang Award in Honor of Sung Wan Kim" from @CRSScience
www.controlledreleasesociety.org/2021-awards-announced -
J Controlled Release
@JCRnEDITORS
Join the best & brightest in #drugdelivery at the #crs2021 Virtual Annual Meeting for Breakthrough Delivery Science taking place July 25-29, 2021!
@ChristineAllenW @YuKyoungOh1 @DesmedtSmedt
@JCRnEDITORS
2021.controlledreleasesociety.org?sf243632266=1 -
J Controlled Release
@JCRnEDITORS
Management of lymph node metastasis via local chemotherapy can prevent distant metastasis and improve survival in mice.
| Ji-Ho Park @kaistpr |
#localdrugdelivery #lymphnode
[50 days' free access]
authors.elsevier.com/a/1ccpLcI2~tqBH -
J Controlled Release
@JCRnEDITORS
Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
| Biomaterials Science | @brunocsarmento
pubs.rsc.org/en/content/articlelanding/2021/bm/d1bm00137j -
J Controlled Release
@JCRnEDITORS
mRNA Covid-19 Vaccines Are Fast to Make, but Hard to Scale.
| The Wall Street Journal |
www.wsj.com/articles/mrna-covid-19-vaccines-are-fast-to-m… -
J Controlled Release
@JCRnEDITORS
Dictamnine delivered by PLGA nanocarriers ameliorated inflammation in an oxazolone-induced dermatitis mouse model.
| Huey-Chun Huang, China Medical University | @CRS_TW_Local #plga #nanoparticles #dermatitis
[50 days' free access]
authors.elsevier.com/a/1ccpMcI2~tq9s -
J Controlled Release
@JCRnEDITORS
Extracellular vesicles in oncology: from immune suppression to immunotherapy.
| The AAPS Journal |
doi.org/10.1208/s12248-021-00554-4 -
J Controlled Release
@JCRnEDITORS
Drug pipeline 4Q20.
| Nature Biotechnology |
doi.org/10.1038/s41587-021-00818-6 -
J Controlled Release
@JCRnEDITORS
Light-activated genetic therapy to treat blindness enters clinic.
| Nature Biotechnology |
doi.org/10.1038/s41587-021-00823-9 -
J Controlled Release
@JCRnEDITORS
Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis.
| Rodrigo Naves @udechile | @CRS_FG_SkinMuco
#intranasal #neuroinflammation #nanoparticle
[50 days' free access]
authors.elsevier.com/a/1cXe9cI2~tqNy -
J Controlled Release
@JCRnEDITORS
Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing.
| Nature Materials | @DJSiegwart
doi.org/10.1038/s41563-020-00886-0 -
J Controlled Release
@JCRnEDITORS
Trajectories in nanotechnology: embracing complexity, seeking analogies.
| Drug Delivery and Translational Research | @DDTReMedia
doi.org/10.1007/s13346-020-00877-3 -
J Controlled Release
@JCRnEDITORS
Only 3 days left!
Don't miss the 2nd CRS LC Webinar hosted by
@CRSNordicLocal.
@CRS_TW_Local @AustralianCRS @nz_crs
@CRS_Italia @brazilcrs @CRSBeNeLuxFr @CRS_SPLC
@CrsIndian @CC_CRS @UKICRS
#crsgermanchapter @CRSScience @CRS_YSC @brunocsarmento @YuKyoungOh1CRS Nordic Local Chapter @CRSNordicLocal
Don't miss the next CRS webinar February 5 organized by the Nordic Local Chapter! Use this link (updated) to register for this exciting event: crs.site-ym.com/events/register.aspx?id=1477041&itemid=64…
-
J Controlled Release
@JCRnEDITORS
The right timing, right combination, right sequence, and right delivery for cancer immunotherapy.
| In-San Kim @KistPublic | @CRS_FG_Immuno #immunotherapy
[50 days' free access]
authors.elsevier.com/a/1cUlUcI2~wTht -
J Controlled Release
@JCRnEDITORS
Designing intelligent nano-bomb with on-demand site-specific drug burst release to synergize with high-intensity focused ultrasound cancer ablation.
| Tianfeng Chen, Jinan University | #ultrasound
[50 days' free access]
authors.elsevier.com/a/1cTiBcI2~tq8E -
J Controlled Release
@JCRnEDITORS
Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cure.
| Patrick S. Stayton @UW | #targeteddelivery #antimalaria
[50 days' free access]
authors.elsevier.com/a/1cSphcI2~tqdx -
J Controlled Release
@JCRnEDITORS
Engineered drug delivery devices to address Global Health challenges.
| Robert Langer @MIT | #langerlab
#drugdelivery #deliverydevice
doi.org/10.1016/j.jconrel.2021.01.035 -
J Controlled Release
@JCRnEDITORS
Oxygen-release microspheres capable of releasing oxygen in response to environmental oxygen level to improve stem cell survival and tissue regeneration in ischemic Hindlimbs.
| Jianjun Guan @WUSTL |
#stemcells #ischemic
doi.org/10.1016/j.jconrel.2021.01.034 -
J Controlled Release
@JCRnEDITORS
Targeting metabolism to influence aging.
| Science |
science.sciencemag.org/content/371/6526/234 -
J Controlled Release
@JCRnEDITORS
The 2nd CRS Local Chapter Webinar hosted by
@CRSNordicLocal coming soon; Feb. 5th.
@CRS_TW_Local @AustralianCRS @nz_crs @CRS_Italia
@brazilcrs @CRSBeNeLuxFr @CRS_SPLC @CrsIndian
@CC_CRS @UKICRS #crsgermanchapter @CRSScience @CRS_YSCCRS Nordic Local Chapter @CRSNordicLocal
Don't miss the next CRS webinar February 5 organized by the Nordic Local Chapter! Use this link (updated) to register for this exciting event: crs.site-ym.com/events/register.aspx?id=1477041&itemid=64…
-
J Controlled Release
@JCRnEDITORS
Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2.
| James Moon, University of Michigan | @CRS_FG_Immuno
[50 days' free access]
authors.elsevier.com/a/1cMT8cI2~tqbU -
J Controlled Release
@JCRnEDITORS
Nanomaterials for T-cell cancer immunotherapy.
| Nature Nanotechnology | @MJMitchell_Lab
doi.org/10.1038/s41565-020-00822-y -
J Controlled Release
@JCRnEDITORS
Breast tumor-on-chip models: From disease modeling to personalized drug screening.
| Subhas C. Kundu, University of Minho | @CRS_SPLC
doi.org/10.1016/j.jconrel.2020.12.057 -
J Controlled Release
@JCRnEDITORS
Congratulations for the successful and insightful 1st CRS Local Chapter Webinar.
@CRS_TW_Local @AustralianCRS @nz_crs @CRS_Italia @brazilcrs @CRSBeNeLuxFr @CRS_SPLC @CrsIndian @CC_CRS @UKICRS #crsgermanchapter @ChenYBecky @brunocsarmento @CRSScience
Yunching Becky Chen
@ChenYBecky
We have completed our first successful CRS LC webinar, congratulations!
-
J Controlled Release
@JCRnEDITORS
Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo.
| Wafa T. Al-Jamal, Queen's University Belfast |
@UKICRS
[50 days' free access]
authors.elsevier.com/a/1cHHbcI2~tqZI -
J Controlled Release
@JCRnEDITORS
A macrophage-targeted platform for extending drug dosing with polymer prodrugs for pulmonary infection prophylaxis.
| Patrick S. Stayton, University of Washington |
[50 days' free access]
authors.elsevier.com/a/1cIKAcI2~tqQ1 -
J Controlled Release
@JCRnEDITORS
Engineering exosomes for pulmonary delivery of peptides and drugs to inflammatory lung cells by inhalation.
| Minhyung Lee, Hanyang University |
doi.org/10.1016/j.jconrel.2020.12.053 -
J Controlled Release
@JCRnEDITORS
In situ-gelling starch nanoparticle/O-carboxymethyl chitosan nanoparticle network hydrogels for the intranasal delivery of an antipsychotic peptide.
| Todd Hoare, McMaster University | @CC_CRS @CRS_FG_SkinMuco
doi.org/10.1016/j.jconrel.2020.12.050 -
J Controlled Release
@JCRnEDITORS
Melanin-loaded CpG DNA hydrogel for modulation of tumor immune microenvironment.
| Yu-Kyoung Oh, Seoul National University | @GayongShim @YinaWu1103 @YuKyoungOh1 @SNU_Pharm
doi.org/10.1016/j.jconrel.2020.12.040 -
J Controlled Release
@JCRnEDITORS
Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2.
| James J. Moon, University of Michigan | @CRS_FG_Immuno
doi.org/10.1016/j.jconrel.2020.12.031 -
J Controlled Release
@JCRnEDITORS
Microneedles for painless transdermal immunotherapeutic applications.
| Hélder A. Santos, University of Helsinki | @Santos_Lab15 @CRS_FG_SkinMuco @CRS_FG_Immuno doi.org/10.1016/j.jconrel.2020.12.019 -
J Controlled Release
@JCRnEDITORS
Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo.
| Wafa T. Al-Jamal, Queen's University Belfast | @UKICRS
doi.org/10.1016/j.jconrel.2020.12.017 -
J Controlled Release
@JCRnEDITORS
Functionalized nanogel for treating activated astrocytes in spinal cord injury.
| Pietro Veglianese, Istituto di Ricerche Farmacologiche Mario Negri IRCCS | @CRS_Italia
doi.org/10.1016/j.jconrel.2020.12.006 -
J Controlled Release
@JCRnEDITORS
Advances in biodegradable and injectable hydrogels for biomedical applications.
| Doo Sung Lee, Sungkyunkwan University |
doi.org/10.1016/j.jconrel.2020.12.008 -
J Controlled Release
@JCRnEDITORS
Journal of Controlled Release is pleased to welcome Dr. Yunching Chen as a new Associate Editor for Asia.
@JCRnEDITORS @ChristineAllenW @YuKyoungOh1
@DesmedtSmedt @ChenYBecky
www.sciencedirect.com/browse/journals-and-books?dgcid=STM… -
J Controlled Release
@JCRnEDITORS
In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy.
| Ick Chan Kwon, Korea Institute of Science and Technology |
@DoubleParr @CRS_FG_Immuno
doi.org/10.1016/j.jconrel.2020.12.002 -
J Controlled Release
@JCRnEDITORS
Rational design and characterisation of a linear cell penetrating peptide for non-viral gene delivery.
| Helen O. McCarthy, Queen's University Belfast |
[50 days' free access]
authors.elsevier.com/a/1c9HAcI2~tqQ~ -
J Controlled Release
@JCRnEDITORS
Journal of Controlled Release is pleased to welcome Dr. Kanjiro Miyata as a new Associate Editor for Asia.
@JCRnEDITORS @ChristineAllenW @DesmedtSmedt
@YuKyoungOh1 @KanjiroM
bit.ly/37uurak -
J Controlled Release
@JCRnEDITORS
Perspectives – Something new for JCR.
| Randall J. Mrsny, University of Bath |
[50 days' free access]
authors.elsevier.com/a/1c6UKcI2~tqQc -
J Controlled Release
@JCRnEDITORS
Pulmonary surfactant and drug delivery: Vehiculization, release and targeting of surfactant/tacrolimus formulations.
| Antonio Cruz, Complutense University | @CRS_SPLC
doi.org/10.1016/j.jconrel.2020.11.042 -
J Controlled Release
@JCRnEDITORS
Protein encapsulation by electrospinning and electrospraying.
| Gareth R. Williams, University College London |
[50 days' free access]
authors.elsevier.com/a/1c2M7cI2~tqH6 -
J Controlled Release
@JCRnEDITORS
Self-assembling peptide hydrogels for the stabilization and sustained release of active Chondroitinase ABC in vitro and in spinal cord injuries.
| Fabrizio Gelain, Institute for Stem Cell Biology |
@CRS_Italia
doi.org/10.1016/j.jconrel.2020.11.027 -
J Controlled Release
@JCRnEDITORS
Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases.
| Nature Biomedical Engineering | @SMitragotri
rdcu.be/caRoj -
J Controlled Release
@JCRnEDITORS
Peptide conjugation enhances the cellular co-localization, but not endosomal escape, of modular poly(acrylamide-co-methacrylic acid) nanogels.
| Nicholas A. Peppas, University of Texas, Austin |
[50 days' free access]
authors.elsevier.com/a/1c0TTcI2~tqGw -
J Controlled Release
@JCRnEDITORS
Say no to drugs: Bioactive macromolecular therapeutics without conventional drugs.
| Ayelet David, Ben-Gurion University of the Negev |
doi.org/10.1016/j.jconrel.2020.11.026 -
J Controlled Release
@JCRnEDITORS
Decarboxylative Alkyl Coupling Promoted by NADH and Blue Light.
| J. Am. Chem. Soc. |
pubs.acs.org/doi/10.1021/jacs.0c09678 -
J Controlled Release
@JCRnEDITORS
Dendronized polymer conjugates with amplified immunogenic cell death for oncolytic immunotherapy.
| Jindřich Kopeček, University of Utah |
[50 days' free access]
authors.elsevier.com/a/1c0C7cI2~tqGG -
J Controlled Release
@JCRnEDITORS
Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy.
| Kosuke Kusamori, Tokyo University of Science |
[50 days' free access]
authors.elsevier.com/a/1c10CcI2~tqFh -
J Controlled Release
@JCRnEDITORS
TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination.
| Krishnendu Roy, Georgia Inst. of Tech. and Emory Univ. |
doi.org/10.1016/j.jconrel.2020.10.060 -
J Controlled Release
@JCRnEDITORS
Brain delivery of Plk1 inhibitor via chimaeric polypeptide polymersomes for safe and superb treatment of orthotopic glioblastoma.
| Zhiyuan Zhong, Zhiyuan Zhong |
[50 days' free access]
authors.elsevier.com/a/1b~dAcI2~tqGY -
J Controlled Release
@JCRnEDITORS
Light-induced release of the cardioprotective peptide angiotensin-(1–9) from thermosensitive liposomes with gold nanoclusters.
| Marcelo J. Kogan, Universidad de Chile | @CRS_FG_NANO
doi.org/10.1016/j.jconrel.2020.11.002 -
J Controlled Release
@JCRnEDITORS
Electrospraying as a novel method of particle engineering for drug delivery vehicles.
| Michael R. Hamblin, Harvard Medical School |
doi.org/10.1016/j.jconrel.2020.10.059 -
J Controlled Release
@JCRnEDITORS
Vat photopolymerization 3D printing for advanced drug delivery and medical device applications.
| Abdul W. Basit, University College London | @UKICRS
[50 days' free access]
authors.elsevier.com/a/1b~HKcI2~tqA2 -
J Controlled Release
@JCRnEDITORS
Protein encapsulation by electrospinning and electrospraying.
| Gareth R. Williams, University College London |
@UKICRS
doi.org/10.1016/j.jconrel.2020.10.046 -
J Controlled Release
@JCRnEDITORS
Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease.
| Eun Ji Chung, University of Southern California, Los Angeles | @TheChungLab
doi.org/10.1016/j.jconrel.2020.10.047 -
J Controlled Release
@JCRnEDITORS
Emerging trends in nano- and microencapsulation science: hallmarks of the 22nd International Symposium on Microencapsulation.
| Drug Delivery and Translational Research | @brunocsarmento @DDTReMedia
doi.org/10.1007/s13346-020-00865-7 -
J Controlled Release
@JCRnEDITORS
Zero-order drug delivery: State of the art and future prospects.
| Kevin J. McHugh, Rice University |
[50 days' free access]
authors.elsevier.com/a/1bvB4cI2~tq3O -
J Controlled Release
@JCRnEDITORS
Oral delivery of bacteria: Basic principles and biomedical applications.
| Mingqiang Li, Sun Yat-sen University | @CRS_FG_Oral
[50 days' free access]
authors.elsevier.com/a/1buldcI2~tq1z -
J Controlled Release
@JCRnEDITORS
Challenges in the development and establishment of exosome-based drug delivery systems.
| Emmanuel A. Ho, University of Waterloo | @HoResearchGroup
doi.org/10.1016/j.jconrel.2020.10.020 -
J Controlled Release
@JCRnEDITORS
Controlled release of immunotherapeutics for enhanced cancer immunotherapy after local delivery.
| Qian Chen, Soochow University | @CRS_FG_Immuno
doi.org/10.1016/j.jconrel.2020.10.019 -
J Controlled Release
@JCRnEDITORS
Bile acid-based dual-functional prodrug nanoparticles for bone regeneration through hydrogen peroxide scavenging and osteogenic differentiation of mesenchymal stem cells.
| Soo-Hong Lee, Dongguk University |
[50 days' free access]
authors.elsevier.com/a/1bps4cI2~tq3n -
J Controlled Release
@JCRnEDITORS
Iron-crosslinked Rososome with robust stability and high drug loading for synergistic cancer therapy.
| Yuanpei Li, University of California Davis |
doi.org/10.1016/j.jconrel.2020.10.013 -
J Controlled Release
@JCRnEDITORS
Tannic acid-functionalized boron nitride nanosheets for theranostics.
| Yu-Kyoung Oh, Seoul National University | @SNUnow @YuKyoungOh1
[50 days' free access]
authors.elsevier.com/a/1bk-vcI2~tq1b -
J Controlled Release
@JCRnEDITORS
Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy.
| Mamoni Dash, DBT-Institute of Life Sciences | @CrsIndian
[50 days' free access]
authors.elsevier.com/a/1bk27cI2~tq29 -
J Controlled Release
@JCRnEDITORS
Polymersomes with singlet oxygen-labile poly(β-aminoacrylate) membrane for NIR light-controlled combined chemo-phototherapy.
| Won Jong Kim, Pohang University of Science and Technology |
[50 days' free access]
authors.elsevier.com/a/1bk-vcI2~tq1n -
J Controlled Release
@JCRnEDITORS
Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine.
| Hideyoshi Harashima, Hokkaido University |
[50 days' free access]
authors.elsevier.com/a/1bk27cI2~tp-z -
J Controlled Release
@JCRnEDITORS
Not Sweet: Glucocorticoids from Intratumoral Myeloid Cells Disable T Cells.
| Immunity |
www.cell.com/immunity/fulltext/S1074-7613(20)30362-9?rss=yes -
J Controlled Release
@JCRnEDITORS
Cytopharmaceuticals: An emerging paradigm for drug delivery.
| Can Zhang, China Pharmaceutical University |
[50 days' free access]
authors.elsevier.com/a/1biM6cI2~tp~A -
J Controlled Release
@JCRnEDITORS
Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug.
| Ick Chan Kwon, Korea Institute of Science and Technology | @DoubleParr
[50 days' free access]
authors.elsevier.com/a/1bhz7cI2~tpxl -
J Controlled Release
@JCRnEDITORS
Nanozyme-mediated cascade reaction based on metal-organic framework for synergetic chemo-photodynamic tumor therapy.
| Xuesi Chen, Changchun Institute of Applied Chemistry |
doi.org/10.1016/j.jconrel.2020.09.029 -
J Controlled Release
@JCRnEDITORS
Hydrogel Network Dynamics Regulate Vascular Morphogenesis.
| Cell Stem Cell |
www.cell.com/cell-stem-cell/fulltext/S1934-5909(20)30401-X -
J Controlled Release
@JCRnEDITORS
Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.
| Advanced Drug Delivery Reviews |
doi.org/10.1016/j.addr.2020.05.007 -
J Controlled Release
@JCRnEDITORS
Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity.
| ACS Central Science | @AppelGroup
pubs.acs.org/doi/10.1021/acscentsci.0c00732 -
J Controlled Release
@JCRnEDITORS
Advances in drug delivery technology for the treatment of glioblastoma multiforme.
| Dae-Hyeong Kim, Seoul National University | @SNUnow
doi.org/10.1016/j.jconrel.2020.09.002 -
J Controlled Release
@JCRnEDITORS
Cytopharmaceuticals: An emerging paradigm for drug delivery.
| Can Zhang, China Pharmaceutical University |
doi.org/10.1016/j.jconrel.2020.08.063 -
J Controlled Release
@JCRnEDITORS
Top 5 Use Cases for Artificial Intelligence in Medical Imaging
healthitanalytics.com/news/top-5-use-cases-for-artificial… -
J Controlled Release
@JCRnEDITORS
Living, Self‐Replicating Ferrofluids for Fluidic Transport
| Advanced Functional Materials |
onlinelibrary.wiley.com/doi/10.1002/adfm.202003912 -
J Controlled Release
@JCRnEDITORS
Engineered albumin-functionalized nanoparticles for improved FcRn binding enhance oral delivery of insulin.
| Bruno Sarmento, University of Porto | @brunocsarmento @CRS_SPLC
[50 days' free access]
authors.elsevier.com/a/1bZqQcI2~tpph -
J Controlled Release
@JCRnEDITORS
The dose threshold for nanoparticle tumour delivery.
| Nature Materials |
doi.org/10.1038/s41563-020-0755-z -
J Controlled Release
@JCRnEDITORS
A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer.
| Siddharth S. Kesharwani, Roseman University of Health Sciences |
[50 days' free access]
authors.elsevier.com/a/1bWQ-cI2~tpgR -
J Controlled Release
@JCRnEDITORS
Splenic Capture and In Vivo Intracellular Biodegradation of Biological-Grade Graphene Oxide Sheets.
| ACS Nano |
pubs.acs.org/doi/10.1021/acsnano.0c03438 -
J Controlled Release
@JCRnEDITORS
Engineered albumin-functionalized nanoparticles for improved FcRn binding enhance oral delivery of insulin.
| Bruno Sarmento, University of Porto | @AndersenJT @brunocsarmento
doi.org/10.1016/j.jconrel.2020.08.005 -
J Controlled Release
@JCRnEDITORS
Photolabile Linkers: Exploiting Labile Bond Chemistry to Control Mode and Rate of Hydrogel Degradation and Protein Release.
| Journal of the American Chemical Society |
pubs.acs.org/doi/10.1021/jacs.9b11564 -
J Controlled Release
@JCRnEDITORS
Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.
| Yvonne Perrie, University of Strathclyde | @YvonnePerrie
[50 days' free access]
authors.elsevier.com/a/1bWRk_3r0J5bAQ -
J Controlled Release
@JCRnEDITORS
Lymphatic targeting by albumin-hitchhiking: Applications and optimisation.
| Natalie L. Trevaskis, Monash University |
doi.org/10.1016/j.jconrel.2020.07.046 -
J Controlled Release
@JCRnEDITORS
Optimizing the anti-tumor efficacy of protein-drug conjugates by engineering the molecular size and half-life.
| Andreas Plückthun, University of Zurich |
doi.org/10.1016/j.jconrel.2020.08.004 -
J Controlled Release
@JCRnEDITORS
'Top Tweet JCR Article of July'
Delivering the power of nanomedicine to patients today.
| Matthieu Germain, Curadigm SAS | @ruthbs
[Open access]
doi.org/10.1016/j.jconrel.2020.07.007 -
J Controlled Release
@JCRnEDITORS
JCR article on nanotoxicity (Hamid Ghandehari, Univ. of Utah) was featured in the NIH Fredrick National Lab news.
frederick.cancer.gov/news/nanotechnology-characterization….
doi.org/10.1016/j.jconrel.2020.05.027 -
J Controlled Release
@JCRnEDITORS
Nanotechnology-based disinfectants and sensors for SARS-CoV-2.
| Nature Nanotechnology | @AviSchroeder @frstella @GordonGWallace
rdcu.be/b5X43 -
J Controlled Release
@JCRnEDITORS
FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL www.fda.gov/news-events/press-announcements/fda-approves-…
-
J Controlled Release
@JCRnEDITORS
In 2019, authors from over 57 countries published in Journal of Controlled Release – standing by our commitment to diversity and inclusion within our author network. @JCRnEDITORS @ChristineAllen @DesmedtSmedt @YuKyoungOh1 @fernandaogochi @ELSpharma
www.sciencedirect.com/browse/journals-and-books?dgcid=STM… -
J Controlled Release
@JCRnEDITORS
Intravitreal hydrogels for sustained release of therapeutic proteins.
| Tina Vermonden, Utrecht University |
doi.org/10.1016/j.jconrel.2020.07.031 -
J Controlled Release
@JCRnEDITORS
Delivering the power of nanomedicine to patients today.
| Matthieu Germain, Curadigm SAS | @ruthbs
[Open Access]
doi.org/10.1016/j.jconrel.2020.07.007 -
J Controlled Release
@JCRnEDITORS
New Bioink for Cell Bioprinting in 3D Developed www.technologynetworks.com/cell-science/news/new-bioink-f…
-
J Controlled Release
@JCRnEDITORS
Silica nanoparticles: A promising platform for enhanced oral delivery of macromolecules.
|Amirali Popat, The University of Queensland| @popatlab
doi.org/10.1016/j.jconrel.2020.07.021 -
J Controlled Release
@JCRnEDITORS
TRAIL therapy and prospective developments for cancer treatment.
| Hasan Uludağ, University of Alberta |
doi.org/10.1016/j.jconrel.2020.07.013 -
J Controlled Release
@JCRnEDITORS
@JCRnEDITORS announce new exceptional invited only contributions - Perspectives, Magna Opera and Orations – to be published in the Journal of Controlled Release. Find out more @ChristineAllen @DesmedtSmedt @YuKyoungOh1 @fernandaogochi
www.journals.elsevier.com/journal-of-controlled-release/n… -
J Controlled Release
@JCRnEDITORS
Journal of Controlled Release stands against racism and discrimination; committing to diversity and inclusion within our editorial board @JCRnEDITORS @ChristineAllen @DesmedtSmedt @YuKyoungOh1
www.sciencedirect.com/journal/journal-of-controlled-relea… -
J Controlled Release
@JCRnEDITORS
Delivering the power of nanomedicine to patients today.
| Matthieu Germain, Curadigm SAS |
doi.org/10.1016/j.jconrel.2020.07.007 -
J Controlled Release
@JCRnEDITORS
Formulation technologies and advances for oral delivery of novel nitroimidazoles and antimicrobial peptides.
| James Robert Falconer, University of Queensland | @popatlab @uqjamesfalconer
[50 days' free access]
authors.elsevier.com/a/1bNNhcI2~tpQv -
J Controlled Release
@JCRnEDITORS
Magnetically-driven implantable pump for on-demand bolus infusion of short-acting glucagon-like peptide-1 receptor agonist.
| Young Bin Choy, Seoul National University |
[50 days' free access]
authors.elsevier.com/a/1bM7ccI2~tpdC -
J Controlled Release
@JCRnEDITORS
Robotic screening of intestinal drug absorption.
| Nature Biomedical Engineering |
rdcu.be/b3X17 [N&V]
rdcu.be/b3X18 [Paper] -
J Controlled Release
@JCRnEDITORS
Neutrophil ‘safety net’ causes cancer cells to metastasize and proliferate.
| Nature |
www.nature.com/articles/d41586-020-01672-3 -
J Controlled Release
@JCRnEDITORS
Nano and Microparticle Emerging Strategies for Treatment of Autoimmune Diseases: Multiple Sclerosis and Type 1 Diabetes.
| Advanced Healthcare Materials |
onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202000164 -
J Controlled Release
@JCRnEDITORS
Sequential and Timely Combination of a Cancer Nanovaccine with Immune Checkpoint Blockade Effectively Inhibits Tumor Growth and Relapse.
| Angewandte Chemie Int. Ed. |
onlinelibrary.wiley.com/doi/abs/10.1002/anie.202006117 -
J Controlled Release
@JCRnEDITORS
Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
| Advanced Healthcare Materials |
onlinelibrary.wiley.com/doi/full/10.1002/adhm.201901862?af=R -
J Controlled Release
@JCRnEDITORS
Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.
| Kinam Park, Purdue University |
doi.org/10.1016/j.jconrel.2020.06.023 -
J Controlled Release
@JCRnEDITORS
Fully stretchable active-matrix organic light-emitting electrochemical cell array.
| Nature Communication |
rdcu.be/b5pv1 -
J Controlled Release
@JCRnEDITORS
In vivo gene delivery mediated by non-viral vectors for cancer therapy.
| Ali Zarrabi, Sabanci University |
doi.org/10.1016/j.jconrel.2020.06.038 -
J Controlled Release
@JCRnEDITORS
A great JCR editors' meeting. @JCRnEDITORS are thankful to all editors for active engagement and support for #edi. Looking forward to the year ahead. @CRSScience @ChristineAllenW @DesmedtSmedt @YuKyoungOh1 @JustinHanesPhD @YoonYeo4 @peer_lab @kikuchi_akihiko @fernandaogochi
-
J Controlled Release
@JCRnEDITORS
Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.
| Yvonne Perrie, University of Strathclyde |
doi.org/10.1016/j.jconrel.2020.06.027 -
J Controlled Release
@JCRnEDITORS
Relationship between particle size and lung retention time of intact solid lipid nanoparticle suspensions after pulmonary delivery.
| Chuanbin Wu, Sun Yat-Sen University |
doi.org/10.1016/j.jconrel.2020.06.004 -
J Controlled Release
@JCRnEDITORS
Bactericidal coating to prevent early and delayed implant-related infections.
| S. Amin Yavari, University Medical Center Utrecht |
[Open access]
doi.org/10.1016/j.jconrel.2020.06.014 -
J Controlled Release
@JCRnEDITORS
Importance of the fatty acid chain length on in vitro and in vivo anticancer activity of fattigation-platform albumin nanoparticles in human colorectal cancer xenograft mice model.
| Beom-Jin Lee, Ajou University |
[50 days' free access]
authors.elsevier.com/a/1b3w4cI2~tpQj -
J Controlled Release
@JCRnEDITORS
Journal of Controlled Release is pleased to welcome Prof. Randy Mrsny as Perspective Editor @JCRnEDITORS @ChristineAllenW @YuKyoungOh1 @DesmedtSmedt Read more..www.sciencedirect.com/browse/journals-and-books?dgcid=STM…
-
J Controlled Release
@JCRnEDITORS
Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment.
| Theranostics |
pubmed.ncbi.nlm.nih.gov/31754382/ -
J Controlled Release
@JCRnEDITORS
Micelleplexes as nucleic acid delivery systems for cancer-targeted therapies.
| Ana Figueiras, University of Coimbra |
[50 days' free access]
authors.elsevier.com/a/1b2UMcI2~tpNU -
J Controlled Release
@JCRnEDITORS
JCR is proud of announcing the newly released 2019 CiteScore of 14.4. The latest assessment of thousands of scholarly serial publications is now available for free on @Scopus with the release of the 2019 #citescore values.
blog.scopus.com/posts/citescore-2019-now-live?dgcid=RN_AG… -
J Controlled Release
@JCRnEDITORS
Virtually screening antiviral compounds to model interactions with the #sarscov2 virus may enable quicker and easier identification of antiviral drugs while informing the search for viable vaccine candidates, according to a new study.
| Science |
advances.sciencemag.org/lookup/doi/10.1126/sciadv.abb8097 -
J Controlled Release
@JCRnEDITORS
A superstable homogeneous lipiodol-ICG formulation for locoregional hepatocellular carcinoma treatment.
| Gang Liu, Xiamen University |
[50 days' free access]
authors.elsevier.com/a/1bDoxcI2~tpK4 -
J Controlled Release
@JCRnEDITORS
Challenges & opportunities for phage-based in situ microbiome engineering in the gut.
| Samuel K. Lai, University of North Carolina-Chapel Hill |
doi.org/10.1016/j.jconrel.2020.06.016 -
J Controlled Release
@JCRnEDITORS
Poly(2-methyl-2-oxazoline) conjugates with doxorubicin: From synthesis of high drug loading water-soluble constructs to in vitro anti-cancer properties.
| Richard Hoogenboom, Ghent University |
doi.org/10.1016/j.jconrel.2020.06.018 -
J Controlled Release
@JCRnEDITORS
Chitosan hydrogels for sustained drug delivery.
| C. Ladavière, Lyon 1 University |
doi.org/10.1016/j.jconrel.2020.06.012 -
J Controlled Release
@JCRnEDITORS
Black phosphorus nanophototherapeutics with enhanced stability and safety for breast cancer treatment.
| Chemical Engineering Journal |
doi.org/10.1016/j.cej.2020.125851 -
J Controlled Release
@JCRnEDITORS
Iron nanoparticles augmented chemodynamic effect by alternative magnetic field for wound disinfection and healing.
| Lingyun Zhao, Tsinghua University |
[50 days' free access]
authors.elsevier.com/a/1bDzKcI2~tpZz -
J Controlled Release
@JCRnEDITORS
Design of amino acid-based self-assembled nano-drugs for therapeutic applications.
| Yukio Nagasaki, University of Tsukuba |
doi.org/10.1016/j.jconrel.2020.06.009 -
J Controlled Release
@JCRnEDITORS
Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency.
| Wei Li, Naval Medical University |
[50 days' free access]
authors.elsevier.com/a/1bCP0cI2~tpYY -
J Controlled Release
@JCRnEDITORS
Development of a long acting FGF21 analogue-albumin fusion protein and its anti-diabetic effects.
| Toru Maruyama, Kumamoto University |
[50 days' free access]
authors.elsevier.com/a/1bB-o_3r0J5b9g -
J Controlled Release
@JCRnEDITORS
Nanoparticle–hydrogel superstructures for biomedical applications.
| Liangfang Zhang, University of California San Diego |
[50 days' free access]
authors.elsevier.com/a/1bBfdcI2~tpXJ -
J Controlled Release
@JCRnEDITORS
Controlled release of odontogenic exosomes from a biodegradable vehicle mediates dentinogenesis as a novel biomimetic pulp capping therapy.
| Peter X. Ma, University of Michigan |
doi.org/10.1016/j.jconrel.2020.06.006 -
J Controlled Release
@JCRnEDITORS
Mucoadhesive nanoparticles based on ROS activated gambogic acid prodrug for safe and efficient intravesical instillation chemotherapy of bladder cancer.
| Zhihua Gan, Beijing University of Chemical Technology |
[50 days' free access]
authors.elsevier.com/a/1bBfdcI2~tpBg -
J Controlled Release
@JCRnEDITORS
One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility.
| Hamidreza Ghandehari, University of Utah |
[50 days' free access]
authors.elsevier.com/a/1bBBccI2~tpV7 -
J Controlled Release
@JCRnEDITORS
Megalin-targeting liposomes for placental drug delivery.
| Sandro R.P. da Rocha, Virginia Commonwealth University |
[50 days' free access]
authors.elsevier.com/a/1b95UcI2~tpV~ -
J Controlled Release
@JCRnEDITORS
Reactive oxygen species and enzyme dual-responsive biocompatible drug delivery system for targeted tumor therapy.
| Hongguang Liu, Northeastern University |
[50 days' free access]
authors.elsevier.com/a/1b88zcI2~tpVi -
J Controlled Release
@JCRnEDITORS
Transforming a toxic drug into an efficacious nanomedicine using a lipoprodrug strategy for the treatment of patient-derived melanoma xenografts.
| Hangxiang Wang, Zhejiang University |
[50 days' free access]
authors.elsevier.com/a/1b7RxcI2~tpUl -
J Controlled Release
@JCRnEDITORS
The Ouzo effect: A tool to elaborate high-payload nanocapsules.
| Fabienne Gauffre, Univ Rennes |
[50 days' free access]
authors.elsevier.com/a/1b9No_3r0J5b9S -
J Controlled Release
@JCRnEDITORS
Preclinical study of influenza bivalent vaccine delivered with a two compartmental microneedle array.
| Jung-Hwan Park, Gachon University |
[Open access]
doi.org/10.1016/j.jconrel.2020.05.024 -
J Controlled Release
@JCRnEDITORS
Platelet membrane-cloaked paclitaxel-nanocrystals augment postoperative chemotherapeutical efficacy.
| Qiang Zhang, Peking University |
[50 days' free access]
authors.elsevier.com/a/1b8cTcI2~tpTN -
J Controlled Release
@JCRnEDITORS
A peptide for transcellular cargo delivery: Structure-function relationship and mechanism of action.
| Kalina Hristova, Johns Hopkins University |
doi.org/10.1016/j.jconrel.2020.05.030 -
J Controlled Release
@JCRnEDITORS
Efficiently restoring the tumoricidal immunity against resistant malignancies via an immune nanomodulator.
| Xinyi Jiang, Shandong University |
doi.org/10.1016/j.jconrel.2020.05.039 -
J Controlled Release
@JCRnEDITORS
STAR particles for enhanced topical drug and vaccine delivery.
| Nature Medicine |
doi.org/10.1038/s41591-020-0787-6 -
J Controlled Release
@JCRnEDITORS
Nanostructured toxins for the selective destruction of drug resistant human CXCR4+ colorectal cancer stem cells.
| Naroa Serna, Universitat Autònoma de Barcelona |
doi.org/10.1016/j.jconrel.2020.01.019 -
J Controlled Release
@JCRnEDITORS
Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update.
| Nature Reviews Clinical Oncology |
www.nature.com/articles/s41571-019-0293-2 -
J Controlled Release
@JCRnEDITORS
Clinical and Therapeutic Implications of Cancer Stem Cells. | N Engl J Med | www.nejm.org/doi/full/10.1056/NEJMra1804280
-
J Controlled Release
@JCRnEDITORS
Widespread changes in transcriptome profile of human mesenchymal stem cells induced by two-dimensional nanosilicates. | PNAS | www.pnas.org/content/early/2018/04/10/1716164115
-
J Controlled Release
@JCRnEDITORS
Amphiphilic Beads as Depots for Sustained Drug Release Integrated into Fibrillar Scaffolds.
www.sciencedirect.com/science/article/pii/S0168365914002545 -
J Controlled Release
@JCRnEDITORS
"Robert S. Langer Receives Wolf Prize".
cen.acs.org/articles/91/i19/Robert-S-Langer-Receives-Wolf…


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































